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Abstract  
Inherited retinal dystrophies are a heterogeneous group of degenerative 
disorders characterised by genetically induced photoreceptor loss, leading to 
vision loss. Despite their genetic and clinical complexity, most inherited retinal 
dystrophies follow a common pathological pathway characterised by 
photoreceptor death and glial activation. Although glial activation has been 
widely reported in retinal degenerative diseases, the underlying mechanisms 
involved in the neuron-glial interaction and the role of glial activation in the 
degenerative process remain unclear. In this thesis, investigation of the 
relationship between glial activation and photoreceptor loss was conducted 
using a mouse model of Leber congenital amaurosis, the cone-rod homeobox 
(Crx) knockout mouse. The first part of the study aimed to establish a 
framework of photoreceptor death and glial activity during the degeneration 
process. Thinning of the outer nuclear layer suggested that, in the Crx retina, 
photoreceptors do not die at a constant rate, but occurred mostly during two 
rapid degeneration periods. Analysis of the glial activities revealed that 
changes in both microglial activity and Müller activity are highly correlated 
with the two waves of photoreceptor death. The second part of the study 
investigated the role of microglial activation in the photoreceptor 
degeneration process using a microglial inhibitor, Neurostatin. The results 
suggest that microglial activation accelerates photoreceptor loss and that 
inhibiting microglial activity could slow the process down.  
These findings demonstrate a spatiotemporal relationship between microglial 
activity and photoreceptor degeneration, indicating a possible contribution of 
microglial cells towards photoreceptor loss. Taken together, these 
observations suggest that microglial inhibition is a promising strategy for 
visual restoration in retinal degeneration and provides important insights for 
future studies on microglial activation in retinal diseases.  
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1. Overview 
Hereditary retinal dystrophies are a group of degenerative disorders of the outer retina with 
heterogeneous clinical patterns and severities. They are one of the leading causes of untreatable 
blindness. The prevalence of retinitis pigmentosa, the most common form of hereditary retinal 
dystrophy, is 1 in 3000 individuals (Francis, 2006). Currently, none of the therapeutic approaches can 
successfully stop the progress of these diseases. 
So far, over 100 genes and multiple biochemical pathways have been found to be affected in retinal 
dystrophies. This genetic complexity makes it difficult for gene replacement strategies. However, 
despite such genetic and clinical heterogeneity, most hereditary retinal dystrophies follow a 
common pathological pathway characterized by progressive photoreceptor loss concomitant with 
glial activation.  
Recent evidence has shown that glial cells do not act as simple bystanders of retinal degeneration, 
but may make a primary contribution to the neuronal loss (Ransohoff, 2016, Karlstetter et al., 2015). 
Hence, being able to control the level of glial activation during the degenerative process may be a 
potential target for improving photoreceptor survival.  
This thesis focuses on the interaction between glial activation and photoreceptor degeneration in 
inherited retinal dystrophies, and the contribution of glial activation to photoreceptor survival.  
2. Retinal anatomy and physiology 
As the light transduction organ of the visual system, the retina converts light into electrical signals 
and performs all the initial processing of information about the visual scene. The cellular 
architecture of the retina is highly organized, consisting of nine layers, each of which has its own 
distinct cellular constitution (Figure 1-1).  
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Figure 1-1 Schematic diagram of retinal anatomy 
The diagram highlights the principle cells in the mammalian retina and the organization of neural retina. The retina 
comprises five types of neurons and three types of glial cells. The neurons are arrayed across the retina. The photoreceptors 
are neatly packed in the ONL, while the nuclear of bipolar cells, horizontal cells and amacrine cells reside in the INL. The 
ganglion cells are in the inner surface of the retina. As the scaffold of the retina, Müller cells span all the retinal layers from 
the inner surface to the outer limiting membrane. The astrocytes are mostly located in the nerve fibre layer with an intimate 
relationship with retinal vessels, while the microglial cells distribute across the inner retina in a dynamic manner. 
There are over 60 distinct types of neurons in the retina, which can be sub-divided into five classes: 
photoreceptors (PRs), bipolar cells (BCs), horizontal cells (HCs), amacrine cells (ACs) and ganglion 
cells (GCs) (Masland, 2012). The ability of the retina to respond to visual stimuli in a highly 
specialized fashion is facilitated by its complex laminar structure.  
PRs respond to light through phototransduction, which occurs in their outer segments (OS). The OS, 
in close apposition with the inner surface of the retinal pigment epithelium (RPE), are where the 
photons are captured and converted into neural signals, while PR cell bodies are in the outer nuclear 
layer (ONL). PR synaptic terminals are in the outer plexiform layer (OPL), where they form functional 
contacts with BCs and HCs. BCs, HCs, and ACs have their cell bodies in the inner nuclear layer (INL). 
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The BCs process the signals from PRs and transmit them to the GCs via synaptic contacts in the inner 
plexiform layer (IPL), where the responses are modulated by lateral interactions originating from 
ACs. The GCs encode the output of information from the entire network, generating spike trains that 
are conveyed to the visual centres of the brain via the optic nerve (Masland, 2012, Sernagor, 2006). 
The mammalian retina has three types of glial cells: Müller cells (MGs), astrocytes and microglia. As 
the main macroglial cells in the retina, MGs span the entire thickness of the neural retina, 
ensheathing neurons to generate columns, which anatomically supports retinal neurons, and 
ensures the metabolic symbiosis between MGs and neurons. MGs supply oxygen and nutrients for 
neurons and remove neuronal metabolic waste (Bringmann et al., 2006), as well as acting in the 
isomerisation of cone retinoids and neurotransmitter recycling.  
The other retinal macroglial cell is the astrocyte, which is responsible for retinal vascularization 
during development. Astrocytes are found in the nerve fibre layer (NFL) which covers the GC layer 
and blood vessels(Provis, 2001). 
As the innate immune cells in the central nervous system (CNS), microglial cells are normally located 
in the inner retina, performing a surveillance function against insults and changes in physiological 
environment (Hamel, 2006).  
3. Photoreceptors in the healthy retina 
3.1 The anatomy of the photoreceptor 
As the first cell of the visual pathway, photoreceptors are highly specialised cells, responsible for 
phototransduction. Each photoreceptor consists of an outer segment, an inner segment, a cell body 
that contains the nucleus, and a large presynaptic terminal complex. The outer segment, where 
phototransduction occurs, is formed from stacks of tightly-packed disc-shaped membranes filled 
with photopigments (rhodopsin or cone opsins). The inner segment, which is the energy conversion 
and protein synthesis centre, connects to the outer segment via a cilium. The inner side of the inner 
segment connects to the cell body. The synaptic terminal (cone pedicle or rod spherule) is located on 
the innermost part of the cell, in the OPL, where it releases glutamate onto BCs and HCs.  
PRs are classified into two types, based on their function and the morphology of their OS. (1) Rods, 
which are very sensitive to dim light, and are responsible for dark vision (scotopic vision), have long, 
cylinder shaped OS, formed by a stack of discs with no connection to the plasma membrane. (2) 
Cones, which possess shorter and tapering outer segments, with the disc stack connected to the 
plasma membrane, are sensitive to a much broader range of brighter light (photopic vision) and 
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have different types of photopigments, with different peak absorption, enabling colour vision 
(Hildebrand and Fielder, 2011).  
Another feature that distinguishes rods from cones is the photopigments in the cells. Rods only 
contain one kind of photopigment, called rhodopsin, which resides almost exclusively in the outer 
segments, but is absent from anywhere else in the rods. Rhodopsin is highly efficient in absorbing 
light and also contributes to the morphogenesis of the outer segments. It is made up of opsin and a 
chromophore, 11-cis-retinal. Upon photon absorption, as the first step of the visual cycle, light 
triggers the isomerisation of 11-cis-retinal into all-trans-retinal, which activates rhodopsin to transfer 
into the “active” state (metarhodopsin 2). 
By contrast, there are different types of cones, depending on the photopigment they express. 
Human cones are classified into three types: S (short wavelength, blue light) cones, M (medium 
wavelength, green light) cones, and L (long wavelength, red light) cones. The lack of a particular type 
of cone (most commonly, M or L cones) results in ‘colour blindness’. 
3.2 The phototransduction cascade 
Phototransduction in rods and cones follows a classic G-protein signalling pathway. Following 
photon absorption, the activated rhodopsin protein catalyses the activation of the G-protein 
transducin, which sequentially activates phosphodiesterase (PDE). PDE decreases the concentration 
of cytoplasmic free cyclic guanosine monophosphate (cGMP) by hydrolysis, which results in the 
closure of the cGMP-gated Na+ channels, resulting in hyperpolarization of the plasma membrane 
(Figure 1-2) (Fu, 1995). The cCMP-gated Na+ channels are responsible for the influx of Ca2+ in the 
outer segments, while the clearance of Ca2+ is done by the Na/Ca-K exchanger, which continuously 
extrude Ca2+ to the extracellular space. The steady state of Ca2+ level in the OS, which relies on the 
balance between the influx via the cCMP-gated Na+ channels and the extrusion of Na/Ca-K 
exchanger, is the basis of phototransduction. 
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Figure 1-2 Schematic representation of phototransduction cascade (From dark to light states) 
The activation of rod phototransduction pathway following photo absorption. The phototransduction cascade results in the 
closure of cGMP-gated channels. The phototransduction process begins with the capture of photons by rhodopsin. 
Following that, the G-protein transducin activates, which sequentially activates PDE. The activation of PDE causes in a 
decrease of cGMP, which results in the closure of cGMP-gated Na+ channels.  
The functionality of the phototransduction pathway and the fast recovery of visual pigments are 
both essential for visual function, as well as for the survival of photoreceptors. Defects involving any 
part of the pathway or the metabolism of visual pigments, will not only lead to visual loss, but also 
result in photoreceptor death.  
The recovery of bleached opsins following phototransduction occurs in the RPE, where all-trans-
retinol is converted back into 11-cis-retinol, and then hydrolysed to 11-cis-retinal before being 
transported back to the photoreceptor outer segment.  
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3.3 Photoreceptor metabolism 
Whilst only 2% of human body weight, CNS takes up 20% of overall oxygen consumption and 25% of 
glucose uptake. Within CNS, retina ranks amongst the most energy-consuming systems (German et 
al., 2015, Wong-Riley, 2010).  
The phototransduction cascade, as well as protein synthesis and transport, are highly energy-
dependent. This means that photoreceptors are very sensitive to any disruption of energy 
metabolism, for example, due to blood supply, glucose uptake, or oxidative stress. 
Glycolysis in the cytosol and aerobic respiration (oxidative phosphorylation) in the mitochondria 
both contribute to energy (adenosine triphosphate, ATP) production, although the efficiency of 
glycolysis outweighs oxidation (Wong-Riley, 2010). In photoreceptors, glucose uptake is highly active 
in the outer segments, as light transduction relies on a high concentration of ATP. By contrast, 
energy consumption for protein synthesis and transport in the inner segments largely relies on 
aerobic respiration, which is facilitated by the high expression of cytochrome c oxidase and high 
concentration of mitochondria in the inner segments. 
Another factor that is essential for the function and survival of photoreceptors is the precise balance 
of the retinal microenvironment. RPE cells constantly remove metabolic waste (such as waste 
products of respiration) via phagocytosis. Furthermore, although photoreceptors are categorized as 
permanent cells, the outer segments undergo continuous renewal throughout the lifetime of the 
cell. The RPE cells contribute to phagocytosis of the discs (disc shedding), allowing the outer 
segments to maintain a relatively constant length. Overgrowth of outer segments triggers 
photoreceptor degeneration (Schietroma et al., 2017, Kevany and Palczewski, 2010). 
3.4 Distribution of photoreceptors in the retina 
There is much heterogeneity in the distribution of photoreceptors between human and rodents, due 
to the different demands on vision. Humans are diurnal, hence their vision relies on photopic vision 
(high acuity, chromatic), mediated by cones in the macula. Rodents, on the other hand, are 
nocturnal, with their vision relying on rods which are distributed throughout the retina (they have no 
fovea). In the mouse retina, rods account for 97.2% of the photoreceptor population, taking the 
dominant responsibility for phototransduction, whereas cones make up only 2.8% of the 
photoreceptor population (Jeon et al., 1998).  
Although in rodents, the distribution of rods and cones is almost symmetric between the ventral 
retina and dorsal retina, the density of photoreceptors is not evenly distributed, showing a 
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decreasing gradient from the perioptic nerve area to the periphery (Jeon et al., 1998). In the mouse 
retina, there are only two types of cones, UV (S) and green (M) cones. M cones are previously 
reported to locate predominantly in dorsal retina (Szel et al., 1992, Applebury et al., 2000). However, 
results from a later study with larger sample size suggested that the M cones are evenly distributed 
across the retina (Ortin-Martinez et al., 2014). By contrast, the S cones are more abundant in the 
ventral area and rare in the far periphery of the dorsal retina (Ortin-Martinez et al., 2014). 
4. Hereditary Retinal Dystrophies 
4.1 Retinitis pigmentosa 
4.1.1 General view 
RP is the generic name given to the most common phenotype of retinal dystrophies with a global 
prevalence of 1 in 3000 individuals (Francis, 2006). Clinical symptoms typically start with night 
blindness and impairment of peripheral vision (characteristic of rod degeneration), and in advanced 
cases, it leads to cone degeneration and ensuing blindness. The genes affected in RP are most 
commonly rod-specific, and cause malfunction in the phototransduction pathways which then 
triggers rod apoptosis. By contrast, cones are usually unaffected by these mutations, and cone death 
in RP is usually secondary to rod loss, due to oxidative stress. 
The mutations that lead to RP are remarkably heterogeneous (Figure 1-3). Over 150 mapped 
chromosomal loci and one hundred genes are known to be responsible for the phenotype 
[http://www.sph.uth.tmc.edu/RetNet/]. Autosomal recessive (ar) mutations account for the 
majority of the defined RP mutations, but some are also autosomal dominant (ad) and X linked. 
Table 1-1 shows the differential diagnoses for RP(Ferrari et al., 2011, Verbakel et al., 2018) 
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Figure 1-3 Diagram summarizing the genetic overlap between RP and other inherited retinal dystrophies by S.K. Verbakel 
et.al. 
Downloaded from https://www.sciencedirect.com/science/article/pii/S1350946217300721#fig1. Licensed under the 
Creative Commons Attribution. Original Caption: Venn diagram summarizing the genetic overlap between RP and other 
inherited retinal dystrophies. Modified from S.K. Verbakel et.al (2018). The circle represents a condition of inherited retinal 
dystrophy. The gene names in the overlapped areas indicate that these mutations can lead to different phenotypes. *: 
mutations for non-syndromic RP. MD: macular dystrophy; CRD: cone-rod dystrophy; LCA: leber congenital amaurosis; ESCS: 
enhanced S-cone syndrome; CSNB: congenital stationary night blindness.  
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Table 1-1 Differential diagnoses for non-syndromic retinitis pigmentosa by S.K. Verbakel et.al 
Inherited retinal dystrophies Syndromic forms of retinitis pigmentosa Pseudoretinitis pigmentosa 
Progressive retinal dystrophies Ciliopathies Durg-induced 
• Cone-rod dystrophy 
• Cone dystrophy 
• Leber congenital 
amaurosis 
• Bietti crystalline 
corneoretinal dystrophy 
• Late-onset retinal 
degeneration 
• Macular dystrophy 
(Stargardt disease, 
Sorsby fundus 
dystrophy) 
Stationary retinal disease 
• Congenital stationary 
night blindness 
(including fundus 
albipunctatus and 
Oguchi disease) 
Inherited vitreoretinopathies 
• X-linked juvenile 
retinoschisis 
• Ebgabced S-cone 
syndrome/Goldmann-
Fevre syndrome 
• Wagner 
syndrome/erosive 
vitreoretinopathy 
• Snowflake 
vitreoretinopathy 
Chorioretinal dystrophies 
• Chorioderemia 
• Gyrate atrophy 
• Helicoid peripapillary 
chorioretinal 
degeneration (Sveinsson 
chorioretinal atrophy) 
• Progressive bifocal 
chorioretinal atrophy 
Female carriers of inherited retinal 
dystrophies 
• Retinitis pigmentosa 
• Choroideremia 
• Ocular albinism 
• Usher syndrome 
• Bardet-Biedl syndrome 
• Cohen syndrome 
• Joubert syndrome 
• Senior-Løken syndrome 
• Sensenbrenner syndrome 
(cranioectodermal 
dysplasia) 
• Short-rib thoracic dysplasia 
with or without polydactyly 
(includes Jeune, Mainzer-
Saidino, Ellis-Van Creveld 
and short-rib polydactyly 
syndrome) 
Metabolic disorders 
• Alfa-tocopherol transfer 
protein deficiency (familial 
isolated vitamin E 
deficiency) 
• Bassen-Kornzweig 
syndrome 
(abetalipoproteinemia) 
• Mucopolysaccharidoses 
• Neuronal ceroid-
lipofuscinoses, childhood 
onset (Batten disease) 
• Refsum disease (phytanic 
acid oxidase deficiency) 
• Mevalonate kinase 
deficiency 
• HARP syndrome 
(hypoprebetalipoproteinemi
a, acanthocytosis, RP and 
pallidal degeneration) 
• PHARC syndrome 
polyneuropathy, hearing 
loss, ataxia, RP, and 
cataract) 
Mitochondrial disorders 
• Kearn-Sayre syndrome 
• NARP syndrome 
(neuropathy, ataxia, and RP) 
 
• Thioridazine and 
chlorpromazine 
• Quinolines (e.g.: 
(Hydroxy) 
chloroquine) 
Chorioretinal infections 
• Syphilis, Lyme 
disease, acute 
retinal necrosis 
and other viral 
infections (rubella, 
chicken pox, 
measles, 
cytomegalovirus) 
Sequela of inflammatory 
disease 
• Sarcoidosis 
• Acute posterior 
multifocal placoid 
pigment 
epitheliopathy 
• Birdshot 
chorioretinopathy 
• Serpiginous 
choroidopathy 
• Diffuse unilateral 
subacute 
neuroretinitis 
• Systemic lupus 
erythematosus 
Miscellaneous 
• Vitamin A 
deficiency 
• Paraneoplastic 
• Trauma 
• Siderosis bulbi 
• Old retinal 
detachment 
• Pigmented 
paravenous 
retinochoroidal 
atrophy 
• Acute zonal occult 
outer retinopathy 
Modified from S.K. Verbakel et.al (2018). 
https://www.sciencedirect.com/science/article/pii/S1350946217300721?via%3Dihub#tbl1. Licensed under the Creative 
Commons Attribution. Original Caption: Differential diagnoses for non-syndromic retinitis pigmentosa.  
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RP related mutations may affect different steps of the visual cycle which lead to different 
pathological outcomes (Figure 1-4). Rhodopsin (RHO) gene was the first identified RP gene, in which 
various mutations make up for 30-40% of adRP. Mutations in RHO gene can affect protein folding, 
11-cis retinal chromophore binding, G protein coupling, cellular trafficking of rhodopsin proteins. 
Retinitis pigmentosa 1 (RP1) is expressed in the photoreceptors and involved in correct stacking of 
outer segment discs including orientation and higher order structure. Mutations in RP1 account for 
about 5-10% of adRP. The retinal pigment epithelium 65 (RPE65) gene is expressed in the RPE and is 
crucial for pigment recycling for both cone and rod function. Mutations in RPE65 accounts for 2% of 
recessive RP patients and 16% of LCA patients.  
 
Figure 1-4 The prevalence of functional process affected by RP mutations. 
RP related mutations may affect a range of different genes affecting several different pathways. Although the majority 
remain to be defined, several have been identified to be affected. A quarter of the mutations are involved in 
phototransduction, and the second most prevalent mutations identified affect pre-mRNA splicing. Zn-containing enzymes, 
transcription factors, cell growth regulation, photoreceptor OS structure (‘ciliopathies’) as well as those affecting tissue 
development and maintenance are also identified to be affected by the RP related mutations. Summarized from Ferrari et 
al. (2011) 
4.1.2 Animal models 
As RP encompasses genetically diverse diseases, a large number of animal models of RP have been 
developed or discovered over the years. The rd1 mouse, also known as “rd” (retinal degeneration), is 
one of the most common RP models. The rd1 mice are substrains of the C3H mice, which are 
homozygous for the retinal degeneration 1 mutation. The mutation is on the gene which is 
responsible for encoding the rod cGMP-PDE6β subunit (Bowes et al., 1990). The defect in this gene 
induces malfunction of cGMP cycling, which in turn triggers the rod apoptotic cascade. The rd1 
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mouse retina undergoes a fast degenerating process, with rod death occurring between postnatal 
(P) day 10 and P21. Cones remain unaffected at the rod apoptosis stage, but they start degenerating 
secondarily with rod depletion during the fourth postnatal week. The PDE6β mutation is also 
observed in human autosomal recessive RP, which undergoes a similar degenerating process as rd1 
(Bayes et al., 1995). Thus, the well-documented rd1 mouse is a good model to study human RP. 
However, in addition to the PDE6β mutation, another mutation in Gpr179 allele has recently been 
identified in many of the strains from the C3H background (Balmer et al., 2013, Nishiguchi et al., 
2015, Chang, 2015). The Gpr179 mutation is responsible for the depletion of b wave and the 
depolarization of bipolar cells, but this phenotype can be masked with the presence of rd1 mutation. 
Considering the impact of the Gpr179 mutation on the retinal function, the possible presence of this 
mutation needs to be taken into account when conducting functional test using mice models from 
C3H strains.  
There are also slow degeneration models of RP, such as rd2. Rd2 mice suffer from mutations in the 
gene Prph2, which is responsible for the maintenance of the outer segments discs. Although the 
abnormality of outer segments develops as early as P7, the photoreceptors in rd2 retina survive for 
up to a year (Chang et al., 2002). 
Rd10 mice suffer from the mutation on the same gene as rd1, but present in a slower progression 
phenotype. Indeed, the retinal degeneration in the rd10 retina is caused by a missense mutation in 
exon 13 of the beta subunit (Chang et al., 2002). Anatomical signs of degeneration emerge at P16 in 
the rd10 retina, and degeneration is completed by P30 (Chang et al., 2007). The slower and milder 
degenerating process in the rd10 mice makes it a better model than rd1 mice for pharmacological 
intervention. (Gargini et al., 2007, Pennesi et al., 2012) 
4.2 Leber congenital amaurosis 
4.2.1 General view  
LCA is a severe phenotype of retinal dystrophy with a prevalence of 1 in 40000 individuals (van Huet 
et al., 2013). Affected individuals typically present with early onset blindness, wandering nystagmus, 
and a pigmentary retinopathy (Koenekoop, 2004).  
LCA is highly clinically and genetically heterogeneous. Histo-pathological studies of LCA cases suggest 
three possible disease categories: Degenerative (cases with progressive atrophy in the 
photoreceptors and RPE, and sometimes in the inner retina), Aplasic (cases that fail to form 
photoreceptors from early developmental stages), and Dysfunctional (cases with intact retinal 
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anatomy but manifesting biochemical dysfunction) (Porto et al., 2002, Porto et al., 2003, Koenekoop, 
2004).  
Mutations have been found in six genes, affecting a wide range of retinal pathways including 
retinoid metabolism (RPE65), photoreceptor outer segment development (CRX), Phototransduction 
(GUCY2D), zonula adherens formation (CRB1), cell-cycle progression (AIPL1) and disk morphogenesis 
(RPGRIP1) (Koenekoop, 2004). 
Unlike RP, the mutations in LCA often lead to abnormalities equally in rods and cones in both 
developing and adult retina. Individuals with GUCY2D mutations have a reduced ability to produce 
cGMP (Tucker et al., 2004), which manifests as a cone dystrophy. The RPE65 gene encodes for retinal 
pigment epithelial protein-65, RPE65, which is responsible for pigment recycling (Redmond et al., 
1998) in the RPE. Defects on this gene can develop early onset severe rod-cone dystrophy (Lorenz et 
al., 2000). CRX refers to a class of genes that encode the cone-rod homeobox protein. Individuals 
who have mutations in CRX will not only fail to form outer segments from development, but also 
develop an early onset form of cone-rod degeneration.  
The AIPL1 gene encodes the Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1), which is 
specifically expressed in the photoreceptors and pineal gland. A defect in this gene results in a 
reduction in rod cGMP phosphodiesterase (PDE) levels (Liu et al., 2004), leading to phenotypes that 
are similar to RP. The RPGRIP-1 and CRB1 genes encode the proteins that are essential for 
photoreceptor morphogenesis (Zhao et al., 2003, Pellikka et al., 2002). Mutation in these genes 
results in abnormalities in photoreceptors such as oversized outer segments and develop into severe 
retinal degeneration.  
4.2.2 Animal models 
Several animal models have been developed to study the pathological process of LCA. The 
biochemical dysfunction caused by LCA related mutations tends to be more severe than RP. In most 
LCA animal models, although photoreceptor degeneration is slow, retinas are often characterised by 
a complete inability to generate light responses from the earliest developmental stages.  
The Crx knockout mouse model carries a targeted disruption of the CRX homeobox gene (Furukawa 
et al., 1999). Although cones and rods are present during early postnatal life, their outer segments 
exhibit severe atrophy from the onset, and they cannot generate responses to light. Photoreceptor 
degeneration starts at P30 in the Crx mouse, presenting a concomitant loss of cones and rods. The 
ONL decreases from 8-10 to only 1-3 rows within 5 months. The Crx mouse represents a good model 
for human LCA with aplasia followed by a cone-rod degeneration. 
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In the RPE65 knockout mouse model, although rods and cones maintain intact outer segments until 
15 postnatal weeks, rods cannot generate responses to light from the onset because there is no 
functional rhodopsin. RPE65 mice exhibit a late onset photoreceptor degeneration. The ONL 
thinning starts from 15 weeks and declines from 10-11 layers to 7 layers at 28 weeks. The RPE65 
mouse is thus a good model for human LCA with a rod-cone degeneration.  
There are also naturally occurring LCA animal models such as RPE65 dog (which exhibits an initial 
normal gross retinal anatomy, but with no photoreceptor activity) and RetGC-1 bird (early onset of 
photoreceptor degeneration and RPE dystrophy). In these models, the mutations cause a similar 
degenerative process as in human LCA, providing the opportunity to study pathological processes 
and attempt rescue strategies.  
4.3 The pathology of hereditary retinal dystrophies 
Despite being a polygenic disorder with many possible different origins, the pathological changes 
seen in retinal dystrophies are always characterised by different degrees of photoreceptor death 
concomitant with activation of glial cells. Inner retinal neurons such as BCs, ACs or RGCs survive the 
degeneration process, but undergo profound neural remodelling. The progression of retinal 
degeneration in hereditary retinal dystrophies can be classified into three pathological phases: phase 
1, photoreceptor stress; phase 2, photoreceptor death; phase 3 neural remodelling (Figure 1-5) 
(Jones and Marc, 2005).  
In the photoreceptor stress phase, the mutations interrupt encoding of essential proteins in the 
visual cycle, which commonly lead to accumulation of their metabolic products. The resultant 
metabolic stress induces the deconstruction of photoreceptors in terms of shortening the rods or 
cones (Jones and Marc, 2005). Furthermore, metabolic stress may also lead to the exposure of 
surface proteins such as phospholipid PS (known as “eat me signal” ) and triggers early microglial 
activation (Zhao et al., 2015), which sequentially mediates the activation of Müller cells (Figure 
1-5B).  
In phase 2, the retina undergoes progressive photoreceptor loss. The mechanisms involved may 
include primary cell death induced by metabolic stress (Chang et al., 1993), but they may also 
include non-cell autonomous processes such as autophagy and/or phagoptosis (Koenekoop, 2009, 
Zhao et al., 2015). Although the mechanisms of neuron-glial communication during this phase are as 
yet unclear, microglial cells are actively engaged throughout this phase, as indicated by microglial 
cells reaching peak density during that phase and maintained until the end of photoreceptor 
depletion (Noailles et al., 2016, Zeng et al., 2005). Meanwhile, Müller cells undergo profound 
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morphological changes and form a glial seal around the neural retina, resulting in separation from 
the RPE (Jones and Marc, 2005) (Figure 1-5 C).  
With the depletion of photoreceptors, inner retinal “rewiring” is triggered Neighbouring Müller 
cells hypertrophy and coalesce into large vertical columns and separate the retina into new vertically 
segregated domains. Meanwhile, the neurons including ACs, HCs, as well as BCs undergo 
morphological remodelling such as dendritic loss and sprouting of ectopic processes, and they 
migrate into the GCL. These cells together with RGC processes tangle together to form 
microneuromas (Jones and Marc, 2005) (Figure 1-5 D).  
 
Figure 1-5 Schematic diagram of retinal degeneration progression. 
A: shows the normal lamination of a healthy retina; B: shows stage 1 of retinal degeneration: the photoreceptor stress 
phase. C: Stage 2 of retinal degeneration: the photoreceptor death phase; D: Stage 3 of retinal degeneration: The 
“rewiring” phase.  
4.4 Mechanisms for photoreceptor death in hereditary retinal dystrophies 
The survival of photoreceptors relies on the precise regulation of metabolic homeostasis and visual 
pigment recycling. In RP, apoptosis is the main cause that attributes to photoreceptor loss. Evidence 
has shown that apoptosis in RP follows a common downstream pathway regardless of the mutation. 
The mutations that trigger photoreceptor degeneration usually disrupt either the phototransduction 
cascade or the pigment cycle. In rd1 retina, the mutations result in defects in the cGMP-PDE6β 
subunit, leading to excessive accumulation of metabolic products such as cGMP (Figure 1-6 red 
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square). This causes a persistent opening of cGMP-gated Na+ channels, resulting in dysregulation of 
intracellular calcium (Chang et al., 1993, Rohrer et al., 2004) (Figure 1-6 red oval).  
 
 
Figure 1-6 Schematic representation of phototransduction cascade phototransduction in RP photoreceptors 
The RP-related mutations commonly affect the cGMP-PDE6β subunit which leads to the accumulation of cytoplasmic cGMP. 
This sequentially causes the persistent opening of the cGMP-gated Na+ channels and results in the increase of cytoplasmic 
Ca2+ level.  
The homeostasis of intracellular calcium is essential to oxidative metabolism and hence increased 
calcium results in a rise of oxidative activity and ER stress, which sequentially lead to mitochondrial 
energy depletion and the production of ROS (Figure 1-7). The upregulation of calcium level also 
contributes to the mediation of Calpain activation. The activation of Calpain together with 
overproduction of ROS and ATP causes mitochondrial membrane permeabilization (MMP), the 
process of releasing the pro-apoptotic factors into the mitochondrial intermembrane space such as 
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cytochrome c, apoptotic inducing factor (AIF) and procaspases into the cytosol (Ferri and Kroemer, 
2001). Meanwhile, the stimuli that cause MMP will also trigger lysosomal membrane 
permeabilization (LMP), the mechanism that is responsible for the release of cathepsins. These 
cytoplasmic pro-apoptotic factors eventually induce the apoptotic process (Johansson et al., 2010).  
 
 
Figure 1-7 Proposed mechanisms involved in photoreceptor death in RP 
The metabolic dysfunction caused by RP-related mutations usually begin with the upregulation of cGMP, which leads to the 
opening of cGMP-gated channel and ER stress. Following that, the increase of Ca2+ level and ER stress will trigger Calpain 
activation, microglial activation and upregulation of ROS production. These events will eventually lead to apoptosis, 
autophagy, and phagoptosis (phagocytosing photoreceptor alive), which contribute to photoreceptor loss. 
Although mutations in RP are usually rod specific, cones are not immune from degeneration, 
suggesting the involvement of non-cell autonomous death. Cone death in RP may be caused by 
endotoxins released by the degenerating rods, the loss of anatomical organization, and oxidative 
damage caused by rod death (Koenekoop, 2009, Punzo et al., 2009). 
In retinal dystrophies such as LCA, the pathways that are affected by mutations are more 
heterogeneous. The degenerative process in LCA can follow an opposite sequence of events, as 
primary cone death or concomitant cone and rod loss may happen due to the mutation. 
Nevertheless, disruption of the phototransduction cascade and pigment cycle is still considered to be 
the main cause of primary photoreceptor death (Roosing et al., 2014).  
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5. Microglia in the Healthy and Diseased CNS 
5.1 Microglia and brain macrophages 
5.1.1 The myeloid cells in the brain 
For a long time, the brain has been referred as an immune privileged site, which is devoid of 
lymphatic leakage. However, recent evidence suggested that there is a broad spectrum of innate 
myeloid cells in the brain, including parenchymal macrophages, namely microglia, and non-
parenchymal macrophages, such as perivascular macrophages, meningeal macrophages and 
choroid-plexus macrophages (Prinz et al., 2017).  
The classification of CNS macrophages is mainly based on their location, morphology and expression 
of surface markers. Despite all CNS myeloid cells sharing surface markers such as iba-1, F4/80, 
CD11b and CX3CR1, expression of MHC II is low in microglia in contrast to the high expression in 
non-parenchymal macrophages. In addition, microglia exhibit a unique ramified structure 
surrounded by neurons, astrocytes and oligodendrocytes, whereas non-parenchymal macrophages 
are found in the interface between the circulation and parenchyma (Li and Barres, 2018).  
5.1.2 The ontogeny of myeloid cells 
As the myeloid cells in the CNS, the origin of microglia and macrophages is hematopoietic. The most 
widely accepted hypothesis of the resident microglial origin is a yolk sac (YS) origin (Kierdorf and 
Prinz, 2017, Alliot et al., 1999). During embryonic development, the early wave of the erythro-
myeloid progenitors (EMPs) in the YS generate the primitive microglial cells, which sequentially enter 
the CNS and become the major source of resident microglial cells (Ginhoux et al., 2010, Hoeffel et 
al., 2015). Foetal monocytes, which also arise from the EMPs during the later wave, contribute to the 
rest of the resident microglial cells (Hoeffel et al., 2015).  
Although bone marrow (BM) derived cells are the reservoir that contributes to microglial cells 
proliferation under pathological condition (Xu et al., 2007), recent evidence suggests that 
maintenance of the microglial population in the healthy CNS may be independent from BM derived 
cells, and instead, relies on self-renewal of proliferating intrinsic microglial cells (Gomez-Nicola and 
Perry, 2015). 
While the steps of the non-parenchymal macrophages origin remain to be elucidated, the previously 
proposed ontogeny that the non-parenchymal macrophages are initially derived from EMPs and 
then constantly replenished by BM derived cells is also being challenged by the recent evidence from 
fate-mapping experiments (Goldmann et al., 2016). Although the choroid-plexus macrophages are 
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partially differentiated from BM derived monocytes, the maintenance of the perivascular and 
meningeal macrophages is exclusively via self-renewal.  
During the embryonic phase, microglial progenitors migrate into the retina via two sources: through 
the retinal margins and optic nerve, and via blood vessels in the ciliary and retinal circulation (Jin et 
al., 2016, Santos et al., 2008). The location of these cells can be identified by macrophage/microglial 
markers. Another wave of microglial cells entering the retina from the vitreous occurs at the end of 
the first postnatal week and is complete by the end of the second postnatal week. From then on, 
microglial cells present similar characteristics as they do in the mature retina. They are distributed 
across all retinal layers except for the ONL and outer segments and exhibit ramified processes 
(Santos et al., 2008). Similarly, to the microglia in CNS, although there is no anatomical barrier, BM 
derived cells do not migrate into the retina under normal physiological conditions. Instead, they 
reside in the optic nerve and in the blood vessels of the ciliary body, which allows them to 
differentiate into microglial cells and enter the retina immediately following retinal damage (Kaneko 
et al., 2008).  
5.2 The function of microglial cells in the healthy and diseased CNS 
Microglial cells have been referred to as the bodyguards of the CNS. They respond to any kind of 
chronic or acute insult to the retinal microenvironment. The status of microglial cells can be 
classified into two phenotypes; resting microglia, and activated microglia. The function of each is 
reflected by their morphology (Figure 1-8). 
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Figure 1-8 Phenotypic alteration of microglial cells  
The alteration of microglial profile under different conditions. The status of microglia can be identified by their morphology. 
M1 and M2 microglia interact with each other, and their overall effect determines the outcome 
5.2.1 The function of resting microglia  
Resting microglial cells have a distinct ramified structure with a tiny soma and numerous long 
branching processes. The term resting was originally used to define the status of microglial cells in 
healthy tissue, which assumed that those cells were functionally dormant in normal physiological 
conditions. Later evidence from time-lapse imaging appears to contradict this finding. Although 
there are no signs of migration, microglial cells in the healthy CNS are highly dynamic. Their 
processes are remarkably motile, efficiently monitoring the surrounding environment, capable of 
quickly clearing metabolic products to prevent their accumulation (Nimmerjahn et al., 2005, 
Tremblay et al., 2010).  
Evidence has also shown that resting microglia play an important role in supporting the 
development of neuronal connections and maintaining the functional integrity of mature tissue. 
5.2.1.1 Resting microglia and synaptic connectivity  
The dynamics of resting microglia are crucial for the establishment of neuronal connectivity. During 
synaptogenesis, microglial cells regulate developing synaptic connectivity by either reinforcing or 
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eliminating specific subsets of synapses via engulfment of perisynaptic processes based on the 
feedback from neural inputs such as visual experience. Microglial cells also sculpt the synaptic cleft 
via secretion of various proteases which can degrade extracellular proteins and in turn decrease the 
peri-synaptic extracellular space (Tremblay et al., 2010). The engulfment of synaptic processes by 
microglia during postnatal synaptic pruning is regulated by the complement signalling cascade 
CR3/C3. The synapses with weaker inputs are first identified by activated C3 and then eliminated by 
microglial engulfment, whilst the synapses with stronger inputs are retained and strengthened 
(Schafer et al., 2012). Furthermore, the anti-inflammatory cytokine TGF – β is also known to 
contribute to microglia-mediated synaptic refinement via regulating the expression of the 
complement component C1q during development (Bialas and Stevens, 2013). 
Meanwhile, microglial cells play an indispensable role in the maintenance of synaptic function in the 
adult retina. Sustained depletion of these cells can lead to a progressive functional defect in retinal 
light responses (Wang et al., 2016).  
5.2.1.2 Resting microglia in vascular formation  
Although microglial cells are not involved in the vascular pattern in mature CNS, lack of microglial 
cells during development will lead to failure of the vascular formation (Arnold and Betsholtz, 2013). 
In the developing CNS, microglial cells are associated with astrocytes, pericytes and endothelial cells 
to shape vascular sprouting (Rymo et al., 2011).  
In the retina, resident microglial cells, which arrive prior to angiogenesis, rather than circulating 
macrophages and monocytes, play the main role in vascular formation (Greenberg and Jin, 2005, 
Santos et al., 2008). Arnold and Betsholtz (2013) proposed that microglial cells may also contribute 
to facilitating vascular branching during vascular development in the CNS, and reduced vascular 
branching points were observed in microglia-deficiency retina in mouse.  
5.2.2 Microglial activation in the diseased CNS 
Under pathological conditions, microglial cells leave their resting mode and switch to a reactive 
status. Morphologically, they lose their ramified structure and transform into an amoeboid structure 
with enlarged soma and shortened processes. Associated with this morphological transformation, 
they undergo pronounced functional changes. 
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5.2.2.1 The main function of activated microglial cells 
5.2.2.1.1 Phagocytosis 
The main function of activated microglial cells is phagocytosis. Similar to phagocytosis in developing 
and healthy tissue, microglial cells actively engage in engulfing pathogens, apoptotic cells, as well as 
degenerated neurites. This process is considered to be secondary to cell-autonomous mechanisms 
triggered by mutations or other stimuli.  
However, evidence has shown that activated microglial cells can also contribute to neuronal loss by 
phagocytosing viable neurons. This process, as part of the non-cell autonomous neuronal death 
during degeneration, has been termed “phagoptosis” (Brown and Neher, 2012). Phagoptosis has 
been reported in multiple neurodegenerative diseases, including in the retina (Zabel et al., 2016, 
Zhao et al., 2015, Brown and Neher, 2014).  
Phagoptosis is caused by the imbalance of a variety of cell signals which have collectively been 
termed “eat-me” and “don’t eat me”. The “eat-me” signals include exposure of surface protein 
phospholipid (PS) (Brown and Neher, 2012), and calreticulin (CRT), which can activate phagocytosis 
via binding with lipoprotein receptor-related protein (LRP). The “don’t eat me signals”, on the other 
hand, can block phagocytosis via exposure of CD47 and sialic acid residues. The initialization of 
phagoptosis is usually a result of the overall effect of the presence of “eat-me” signals and the loss 
of “don’t eat me” signals (Brown and Neher, 2012). 
5.2.2.1.2 Antigen presentation 
Another important function of microglia is antigen presentation. Microglial cells are considered to be 
a major part of the antigen presenting cell (APC) population. The APCs are a group of immune cells 
that process and present surface antigens. These surface antigens can be recognized by receptors on 
T cells, triggering the adaptive immune response.  
In conditions presenting endogenous or exogenous stimuli, T cells cannot recognize and respond to 
“free” or soluble antigens primarily. Instead, following phagocytosis, APCs, process phagocytosed 
antigens, and then, by expressing carrier molecules like major histocompatibility complex (MHC), 
trigger T cell activation (Mantegazza et al., 2013). There are two classes of MHC molecules. The MHC 
class I can be recognized by cytotoxic T cells and stimulate cytotoxic T cell activation leading to T cell 
proliferation, while MHC II are recognized by T helper cells and trigger T helper cell activation that in 
turn, release substances to attract macrophages (Jakubzick et al., 2017).  
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5.2.2.2 Reactive phenotypes of Microglia.  
The concept of macrophage polarization was first brought up with the discovery of the different 
response of macrophages induced by cytokine IL-4. In contrast to the classical activation induced by 
lipolysaccharides (LPS) and interferon-γ (IFN γ), IL-4 stimuli trigger a different series of macrophage 
gene expression, which was originally termed as “alternative activation” (Martinez and Gordon, 
2014). The polarization of macrophage towards different stimuli was later termed as M1 and M2 
activation (Mills et al., 2000).  
In this concept, M1 activation is considered to be pro-inflammatory, with cytotoxic properties, while 
M2 activation is considered to be anti-inflammatory with regenerative properties. There are two 
subsets of the M2 phenotype: M2a is involved in repair and regeneration and M2b is involved in 
immunoregulation (Chhor et al., 2013).  
M1 activation, which is also called “classical” activation, can be experimentally induced by exposing 
macrophages to LPS and IFN γ in ex vivo conditions. M1 activation follows a Type I inflammatory 
pathway, which is widely observed during bacterial and viral infection. Activated macrophages boost 
the release of pro-inflammatory cytokines, which aggravate inflammation (Gordon, 2007).  
M2 activation is also called “alternative” activation, which can be experimentally achieved by 
exposure to the T helper type 2 (Th2) cytokines IL-4 and IL-3 (Gordon, 2003). M2 activation promotes 
tissue repair and cell proliferation, which are commonly seen in allergic conditions such as asthma as 
well as acute neuro-inflammation such as traumatic brain injury (Cherry et al., 2014).  
However, it should be noted that, the grouping of M1 and M2 activation is determined by their 
ability of either presenting inflammatory response or anti-inflammatory response, whilst the source, 
role and signalling pathways of the macrophages may be substantially different.  
Martinez and Gordon (2014) proposed that the occurrence of M1 and M2 activation is not mutually 
exclusive, and that the states overlap with each other. The mixed phenotype is determined by the 
balance of activatory and inhibitory activities under different circumstances. Accordingly, the 
complexity of activation states results in the diversity of microglial responses and underlies the dual 
role of microglial activation from pathological insults (Gomes-Leal, 2012). In acute diseases like 
infection and trauma, the function of microglial cells is dominated by repair and regeneration. The 
timely removal of toxic factors is also important for protecting neurons from further damage. Hence, 
the contribution of microglial cells during the early stage is considered to be protective (Davalos et 
al., 2005), but it is considered to be harmful in chronic conditions, as the pro-inflammatory profile 
usually outweighs the anti-inflammatory one in the long term.  
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5.2.2.3 Microglial activation in neurological disorders 
Microglial activation is found in almost all types of neurological disorders. Although the common 
pathological changes in these diseases are always the expansion of microglial population and 
microglial infiltration around the lesion, the origin of the microglial population and the pathways 
involved vary significantly amongst different diseases (Dheen et al., 2007).  
In acute diseases such as traumatic brain injury (TBI) and ischemic brain injury (IBI), BM derived cells 
enter the CNS and differentiate into microglial cells. These cells, together with the resident 
microglia, contribute to expanding the microglial population and to microglial infiltration into the 
lesion site. (Ziebell and Morganti-Kossmann, 2010, Patel et al., 2013). By contrast, in chronic 
conditions such as Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS), the expansion of 
the microglial population is exclusively attributed to innate microglial cells. (Dheen et al., 2007).  
5.2.2.4 Microglial cells in inherited retinal degeneration 
In the healthy retina, microglial cells reside across all retinal layers except in the ONL. They exhibit a 
ramified structure, monitoring the microenvironment of the retina. The hallmarks of microglial 
activation upon photoreceptor degeneration are microglial proliferation and morphological 
transformation, as well as microglial infiltration into the ONL. 
There are two sources that may contribute to the infiltrated microglial population in the ONL: 
microglial cells migrated from the GCL, and microglial cells that have differentiated from BM derived 
cells. The migration of microglial cells from GCL into the ONL following photoreceptor dystrophy has 
been well documented in the RCS retina (Thanos, 1992, Thanos and Richter, 1993, Ebert et al., 
2009). Recruitment of BM derived cells into the ONL has also been observed from the beginning of 
photoreceptor degeneration in the rd1 retina (Sasahara et al., 2008). 
Microglial activation is not merely a temporal response in retinal degeneration. Instead, the 
involvement of microglial-mediated process has been found throughout the degenerating phase in 
RP. The upregulation of microglial-specific transcripts has been detected prior to the onset of 
apoptosis or degeneration (Gehrig et al., 2007). In addition, the migration of microglial cells into the 
ONL has been observed at the very beginning of photoreceptor degeneration in several RP animal 
models (Zeng et al., 2005, Sasahara et al., 2008), suggesting that microglial cells may contribute to 
the initial pathological events of photoreceptor degeneration. 
A sustained activation status of microglial cells is also observed during the advanced stage of 
photoreceptor degeneration in rodent RP models such as rd1 mouse and P23H rat. In the P23H 
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retina, increased pro-inflammatory cytokines were found in the end phase of photoreceptor 
degeneration (Yoshida et al., 2013, Noailles et al., 2016). 
5.2.2.5 Mechanism involved in microglial activation  
The exact mechanisms that underlie the initiation of microglial activation in retinal dystrophies are 
still unknown. However, several pathways have been reported to contribute to trigger it.  
Toll-like receptors (TLRs) pathway has previously been reported to be involved in neuroinflammation 
and microglial activation. The TLRs are a family of pattern recognition receptors (PRR) expressed on 
the innate immune cells including microglial cells for recognising the molecular motif of a wide range 
of pathogens (Kielian, 2006). Previous work has shown that TLR4 activation is involved in several 
neurological diseases including ischemic brain injury and neurodegeneration. In retinal 
degeneration, evidence has also shown that delayed clearance of all-trans-retinal due to the 
disruption of RPE phagocytosis may trigger microglial activation via TLR4s (Kohno et al., 2013). The 
mechanism of TLR4 in microglial activation has been proposed using the classic inflammatory model, 
the LPS induced inflammation (Kacimi et al., 2011) (Figure 1-9). 
 
Figure 1-9 Proposed mechanism of microglial intracellular cascade induced by LPS. (2011)  
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LPS binds to TLR4 on the surface of microglial cells and triggers the microglial intracellular cascade, leading to the 
activation of several pathways (JNK, NF-kB, MAPK). Adapted from Kacimi et al 
The fractalkine/CX3CR1 pathway is known to regulate β cell function and insulin secretion (Lee et al., 
2013). However, recent studies have shown that, fractalkine/CX3CR1 signalling may contribute to 
modulating microglial activation (Arnoux and Audinat, 2015). Soluble fractalkine is able to 
ameliorate the microglial activation and reduced proinflammatory cytokine release in a drug-
induced Parkinson’s disease model (Morganti et al., 2012). The neuroprotective effect of 
fractalkine/CX3CR1 signalling has also been documented in animal models of amyotrophic lateral 
sclerosis and stroke. Nonetheless, the cytotoxic effect of fractalkine/CX3CR1 signalling has also been 
reported in several animal models of neurodegenerative diseases (Arnoux and Audinat, 2015), 
suggesting the neuroprotective and neurotoxic effect of the fractalkine/CX3CR1 signalling may 
depend on the pathological context. 
The colony-stimulating factor-1 (CSF-1), also known as macrophage-CSF(M-CSF), influences the 
proliferation and survival of microglial cells via an adaptor protein called DNAX activation protein of 
12kDa (DAP12). Furthermore, the activity of DAPI12 is relied on the transcription factor PU.1. The 
upregulation of DAP12 and PU.1 expression have been found in microglial cells from the RP retina 
(Otero et al., 2009, Weigelt et al., 2007). 
 5.2.2.6 Primed microglial cells in ageing and degenerative diseases 
Previous work has shown that microglial cells in the CNS undergo alteration of their morphology 
with age, characterised by shortening and branch pruning of their processes (Streit et al., 2004). 
These ageing cells have been referred to as “dystrophic microglia” (Figure 1-8). 
However, functional investigation of microglial cells in ageing CNS has revealed that their state 
actually shifts into an enhanced inflammatory status, in which the microglial cells:  
1) present increased sensitivity at baseline level, with a lower threshold to become activated;  
2) respond exaggeratedly towards immune challenges with increased production of pro-
inflammatory factors like IL-1β, cytokines (Godbout et al., 2005) (Norden et al., 2015). 
This process has been recently termed “priming” (Norden et al., 2015). Primed microglial cells have 
been found in ageing, albeit healthy neural tissue, in the chronic phase after traumatic brain injury 
(TBI), and in neurodegenerative diseases. The cause that underlies priming is still unclear. Possible 
mechanisms may be associated with various typical hallmarks of ageing including an increase in 
oxidative stress, as well as the increase of inflammasome activity (Fenn et al., 2013, Youm et al., 
2013).  
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5.2.2.7 Functional diversity of homogeneous microglia  
Microglial cells make up to 5-12% of the total cell population in the CNS (Lawson et al., 1990). Whilst 
our understanding of the function of different neuron subtypes has vastly improved over recent 
decades (Masland, 2012), a detailed knowledge of the components of the microglial population is 
still unclear.  
Currently, there is a consensus on the dual role of microglia; neuroprotective and cytotoxic (Jin et al., 
2016, Ferreira and Bernardino, 2015, Patel et al., 2013). However it is also clear that these cells 
should not be treated as a functional uniform population, instead, their functional diversity may be 
the result of differences of unknown functional subsets (Gomez-Nicola and Perry, 2015, Hanisch, 
2013).  
These authors have suggested that specific cytokines such as tumour necrosis factor α (TNFα) 
initially trigger the activation of a master subset of microglial cells. These ‘master’ cells then mediate 
the activity of neighbouring cells. Hence, the reactive phenotypes and their associated functions 
could be a reflection of different responding sets of microglial cells, instead of an overall effect of 
the entire microglial population. 
This concept is yet to be confirmed by more experimental validation. However, the differential 
expression of surface protein such as MHC I and MHC II on microglial cells may support the existence 
of these functional subsets. Considering the diversity of the sequential pathways that lead to 
completely different outcomes, a better understanding of the classification of these subsets and 
their function during the course of neuropathology may provide promising therapeutic targets. 
5.3 Microglial cell markers 
As ‘the macrophage’ of the CNS, microglial cells have been found to express most of the known 
macrophage-associated markers, which can facilitate their characterization. Ionized calcium binding 
adaptor molecule-1 (iba1) is considered to be the most reliable marker for microglial cells, and it is 
specifically expressed in both amoeboid (activated) and ramified (resting) microglial cells in the CNS 
from embryonic stages to adulthood (Ito et al., 1998, Santos et al., 2008). Other markers such as 
CD11b, CD45, CD68 are also expressed in both resting and activated microglial cells, which also can 
be used to label the overall microglial population.  
The hallmark of microglial activation is the transformation from ramified to amoeboid structure. 
However, practically, classification based on morphology can be subjective and ambiguous. Although 
none of the available markers are able to accurately differentiate activated from resting microglia, a 
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few biomarkers for the functional status have been used to broadly identify the involved subsets 
(Table 1-2). 
Table 1-2 Markers on microglial cells.  
Resting (ramified) microglia activated (amoeboid) microglia 
iba1 iba1 
CD11a, CD11b, CD11c CD11a, CD11b, CD11c 
MHC I MHC I 
 MHC II 
F4/80 (Only during embryonic 
period ) F4/80 
 CD64, CD36 
CX3Cr1 CX3Cr1 
CD45 CD45 
CD68 CD68 
Isolectin B4 Isolectin B4 
Mac-1 Mac-1 
CD18 CD18 
OX42 OX42 
 TSPO 
RMG-1 RMG-1 
RMG-2  
LN-1 LN-1 
OX6,OX3,OX18 OX6,OX3,OX18 
Summarized from Li et al (2015) and Greter et al (2015) 
The F4/80 antigen is a member of the macrophage- specific adhesion-GRCR family (Lin et al., 2010). 
The expression of F4/80 is similar to iba-1 in the developing retina, but it decreases after birth. In the 
adult retina, F4/80 is highly expressed in the amoeboid microglia, which can be used as a marker to 
identify microglial phagocytosis (Table 1-2). However, as expression of F4/80 decreases dramatically 
after birth, the sensitivity of F4/80 on detecting microglial cells in adult CNS is relatively low. Hence, 
it may be ideal to be used as a complementary marker rather than being used alone.  
As APCs, the expression of major histocompatibility complex MHC class I and class II are also found 
in microglial cells under pathological conditions (Penfold et al., 1997, Akaishi et al., 1998, Noailles et 
al., 2014). The differential expression of MHC classes on microglial cells may assist in distinguishing 
the population that contributes to downstream T cell activation. Furthermore, MHC II + cells are 
widely observed in aged CNS, and are considered to be a sign of priming (Perry and Teeling, 2013).  
The translocator protein (18kDa) (TSPO) is also highly expressed in reactive rodent and human 
retinal microglial cells, but it is weakly expressed in the healthy retina (Karlstetter et al., 2014), and 
therefore it is regarded as a reliable biomarker of neuroinflammation and gliosis (Karlstetter et al., 
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2015). CD64, a high affinity Fc gamma receptor, and CD36, a class B scavenger receptor, are also 
both known to have increased expression in phagocytic microglia (Indik et al., 1994, Martin et al., 
2007). 
Nevertheless, despite the numerous markers available, none of them are able to differentiate 
between resident microglia and BM derived microglia. One solution to this problem is to use a 
chimeric bone-marrow (BM) transplant model. This chimeric model is made by transplanting GFP+ 
bone marrow of a donor mouse into an irradiated mouse. Hence, the extrinsic microglial cells can be 
identified because they are GFP+, whereas intrinsic cells are GFP–. 
6. Müller cells in healthy and diseased retina 
6.1 The anatomy and physiology of Müller cells 
As the main glia cell in the vertebrate retina, the MGs span across the entire retinal thickness, with 
its cell body residing in the INL and two trunks processing towards the outer and inner surface of the 
retina where the trunks expand into endfeet and form the OLM and the inner limiting 
membrane(ILM). The important anatomical and metabolic functions played by MGs are reflected in 
their unique anatomical design. 
6.1.1 The anatomical homeostasis  
Acting as scaffolds spanning the entire retina thickness, MGs present a unique biomechanical 
character. These mechanical properties of MGs are confirmed via a technique called scan force 
microscope(SFM) measurement. It shows that MGs possess a softer property, especially in their 
processes, when compared to neurons(Lu et al., 2006). This viscoelastic characteristic of MGs allows 
more flexibility while neurites grow and branch during development(Lu et al., 2013). It also protects 
neurons from mechanical pressure(Lindqvist et al., 2010). Notably, this viscoelastic property 
undergoes alterations in pathological conditions. In an ischemic model, the MGs became stiff in 
accordance with the upregulation of the intermediate filaments(IFs) such as glial fibrillary acidic 
Protein(GFAP). Although IFs are not the main contributor to the viscoelastic behaviour of MGs in 
physiological conditions, overexpressed IFs are responsible for the stiffness behaviour of activated 
MGs. In an ischemic model, MGs from GFAP knock-out mice retain their softness whereas MGs from 
wild-type mice become activated and stiffer(Lu et al., 2011); (Lu et al., 2006). 
6.1.2 Metabolic homeostasis 
Neurons are highly vulnerable to oxidative stress, energetic deficiency and osmotic changes, 
whereas MGs are known to be relatively more resistant to oxygen and glucose deficiency. Such 
resistance to metabolic stress may allow MGs to spare oxygen and glucose for the neurons in their 
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vicinity, especially during ischemia and hypoglycemia(Winkler et al., 2000). On the other hand, MGs 
also provide crucial neurotrophic function for the survival of photoreceptors by releasing antioxidant 
such as glutathione and neuroprotective factors such as bFGF to increase the viability of 
photoreceptors(Harada et al., 2000, Penn et al., 1987). Transgenic ablation of MGs in a rat model of 
retinal dystrophy induces massive photoreceptor death(Shen et al., 2012). 
Water and potassium accumulate in the retinal extracellular space due to the constant oxidative 
activities and neuronal activity. MGs express high density of aquaporin-4 water channels and several 
types of membrane potassium channels, maintaining the balance of spatial K+ buffering for neural 
activity. These channels also facilitate water redistribution in the inner retina, supporting water 
homeostasis in the retina and the RPE and keeping neurons from swelling. (Bringmann et al., 2004).  
6.1.3 Neurotransmitter recycling 
Another important contribution MGs make to the balance of neural activity is the recycling of 
neurotransmitters. MGs express transporters for the uptake of glutamate and ϒ-aminobutyric 
acid(GABA)(Biedermann et al., 2002, Bringmann et al., 2013). Glutamate is released from the 
terminals of PRs and BCs. MGs take up glutamate and GABA from the extracelluar space and 
transform them into glutamine via the glutamine synthetase(GS) pathway. Glutamine will then be 
released back to neurons as a precursor for GABA and glutamate synthesis. The fast synaptic 
transmitter clearance function of MGs is necessary for the maintenance of excitatory synaptic 
function and neurotoxic prevention(Barnett et al., 2000).  
6.2 Activation of Müller cells in retinal degeneration 
Although photoreceptor apoptosis is considered to be the beginning of degeneration in RP, activated 
MGs have been reported at the early stage of the degenerative process in many RP animal 
models(Chua et al., 2013, Vogler et al., 2013). The activation of MGs goes in concert with PR 
degeneration. As an indicator of "retinal stress"(Lewis and Fisher, 2003, Bringmann and Wiedemann, 
2012), GFAP expression in MGs remains low during the rod degenerating phase, undergoing 
significant upregulation later on, at the beginning of the cone degeneration phase. GFAP expression 
decreases once both rods and cones photoreceptors have died (Chua et al., 2013). As mentioned 
above, GFAP overexpression causes alteration of viscoelastic properties in activated MGs. The 
processes of MGs become stiffer and this could help the PRs structural integrity when the cell 
number decreases during degeneration. The activation process of MGs is considered to be 
neuroprotective at the beginning of degeneration because of its contribution to anatomical support 
and neurotrophic factors releasing (Lu et al., 2011). However, in the longer term it will have toxic 
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effects by inducing the migration of cone cells, and by inhibiting the growth of neurites and 
regeneration.  
Notably, an alteration of glutamate uptake and degradation has been observed even before the 
onset of photoreceptor death, which indicates that the malfunction of MGs may play a role in the 
aetiology of retinal degeneration (Fletcher and Kalloniatis, 1996). 
Activation of MGs is non-proliferative before the onset of photoreceptor death, but it becomes 
proliferative once PRs begin to die. The potassium channels expressed in MGs commonly remain 
normal during the entire photoreceptor degeneration phase in the rd mouse model (Chua et al., 
2013). In Royal College of Surgeons (RCS) rats, another model of retinal dystrophy, potassium 
currents change at very late stage of degeneration (Zhao et al., 2012).  
In addition, as the major source of inflammatory mediator, MGs are also known to play an important 
role in the inflammatory process in the retina. A wide range of inflammatory mediators such as IL-6, 
TLRs, which can be mediated by microglial cells, are found to be expressed by MGs (Liu et al., 2015). 
Upon an insult, MGs are able to respond towards changes of the inflammatory factor IL-1β by 
modulating production of IL-6 through the p38 MARPK/NF- κB pathway (Liu et al., 2015). Evidence 
has also suggested that there is a bidirectional interaction between microglial cells and MGs through 
which activated microglial cells are able to influence MGs directly and initiate adaptive responses of 
both cells towards insults. Meanwhile, the inflammatory mediators expressed by MGs and the MG 
processes can facilitate the intraretinal migration of microglial cells. Hence, a better understanding 
of the role of microglial-Müller cells would provide potential therapeutic targets for diseases such as 
retinal degeneration.  
7. Aims and hypothesis 
The evidence presented above suggests that glial activation may contribute to exacerbating 
photoreceptor loss during retinal degeneration by:  
1) Developing a reactive phenotype related to the onset of photoreceptor degeneration and 
subsequently releasing inflammatory factors that lead to photoreceptor death.  
2) Primarily phagocytosing viable photoreceptors due to the imbalance of the “eat me” and “don’t 
eat me” signals.  
As noted in section 5.2.2, microglial activation occurs in heterogeneous states during the 
degeneration process. The overall effect of activation states is highly dynamic, and relies on the 
balance of micro-environmental change as well as the genetic defects albeit to a lesser. Hence, we 
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hypothesised that the status of microglial activation may change during the process of 
photoreceptor degeneration and may vary with the causative mutation, which may sequentially 
affect the response of MGs. Furthermore, we also hypothesised that regulating microglial activation 
may improve photoreceptor survival by reducing microglial-mediated cell death. 
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Chapter 2. Materials and Methods 
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1. Animals and Surgical Procedures 
1.1 Animals  
Three strains of mice were used: C3H/HeNHsd (also known as rd1) and Crx -/- (cone rod 
homeobox) were used to study the time course of retinal degeneration in a fast and a slow 
model respectively; C57BL/6 was used as wild-type (WT) control. C3H/HeNHsd was obtained 
from Harlan Laboratories (Indianapolis, USA) and bred in house. These mice were 
homozygous for the Pde6brd1 allele. The naturally occurring mutation results in abnormality 
of rod photoreceptor cGMP- phosphodiesterase, leading to an early onset of retinal 
degeneration (Bowes et al., 1990). The Crx -/- mice originated from our in-house colony, 
originally acquired from Connie Cepko (Harvard University). The Crx gene acts as the 
upstream gene for a series of outer segment-specific genes. Disruption of the Crx gene 
results in reduced expression of genes encoding for rhodopsin, opsin, recoverin, etc. 
Although the outer segments do not form normally in the first place, the Crx retina 
undergoes a relatively slow degeneration process, which takes 7 months for the ONL to 
decrease from over 12 rows to 1~2 rows (Pignatelli et al., 2004). Mice were aged from P10 to 
P240 in order to obtain a comprehensive overview of the retinal degenerative process in 
both strains. All mice were kept under 12 hours light/dark cycle with unrestricted food and 
water. All procedures on animals were conducted in accordance with the Animals (Scientific 
Procedures) Act 1986 issued by the UK Home Office. 
1.2 Drug preparation 
The lyophilized solid of Neurostatin (Disaloganglioside GD1b from bovine brain (Sigma) was 
firstly dissolved in CHCl3 and then aliquoted into 100μg per sample. The solution was then 
placed in a film hub, and the powder was collected after the liquid had evaporated and 
stored at -20°C.  
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2. Immunohistochemistry 
2.1 Tissue preparation 
 
Figure 2-1 Schematic graph of tissue preparation 
Schematic graphs showing how the retinal tissues were prepared for cryostat section and wholemount retina. 
Black line: sclera; Red line: retina; Light blue line: lens; Green line: cornea.  
Mice were sacrificed by cervical dislocation. For wholemount studies, the eyes were 
enucleated quickly and then transferred to carboxygenated artificial cerebrospinal fluid 
(aCSF). The anterior chamber was removed, and the sclera and choroid were gently peeled 
off. The isolated retina wholemount was then mounted on filter paper (Figure 2-1). The 
whole-mount retinas were fixed in 4% paraformaldehyde (PFA) with 200mM sucrose in 0.1M 
PB (1×, PH7.4) for 1 hour and then collected for immunohistochemistry.  
For cryostat sections, after enucleation, the anterior chamber and vitreous body were 
removed (Figure 2-1). The eyecups were then immersed in 4% PFA with 200mM sucrose in 
0.1M PB(1×, PH7.4), fixed for 1 hour at room temperature, and then transferred to sucrose 
solution in 0.1M PB (PH 7.4) for dehydration. The eyecups were kept in 10% sucrose for 1h, 
20% sucrose for 1h, and then 30% sucrose overnight. The eyecups were then embedded in 
OCT compound medium (Tissue-Tek, Elkhart, IN) and sectioned for immunohistochemistry 
(Bright OTF 5000 Cryostat, The United Kingdom). Sections within 400-600 μm (based on the 
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age of the mice) from the optic nerve on both sides were collected on gelatin-coated slices 
(MENZEL-GLÄSER, Germany) and stored at -20° C until used. 
2.2 Immunohistochemistry for wholemount  
Following fixation, retinas were transferred into 1.8 ml tubes for the following steps. They 
were washed with 0.1M PB for 30 min, and then incubated with primary antibodies for 72 h 
at 4° C. After incubation, retinas were rinsed with 0.1M PB for 30 min and then incubated 
with a secondary antibody with 5% serum and 0.3% TritonX-100 in 0.1M PB in dark at room 
temperature for 1.5 h. Retinas were then washed with 0.1M PB for another 30 min and then 
transferred to gelatine-coated slides with photoreceptors side up. The filter paper was 
gently removed, and retinas were flattened before adding antifade mounting medium (with 
DAPI) (Vectashield). Slides were stored at -20° C until observation. 
2.3 Immunohistochemistry for vertical sections 
For each antibody, three non-consecutive slices per mouse were selected for staining. The 
labelling for cryostat sections was similar to the procedure described above except that the 
incubation time for primary antibodies was shorter, lasting only 12 h. 
For terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay, the 
samples were incubated with freshly prepared permeabilization solution (0.1% TritonX-100 
and 0.1% sodium citrate) at 4° C for 10 min, followed by rinsing for 30 min with 0.1M PB. The 
samples were then incubated with freshly prepared TUNEL cocktail (labelling solution: 
enzyme solution = 9:1) (In Situ Cell Death Detection Kit, Roche Life Science) for 1h at 37° C. 
No secondary antibodies were required for TUNEL assay. 
Antibodies and serum used are summarized in Table 2-1 and Table 2-2.  
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Table 2-1 Primary antibodies used in this study 
Antigen  Antibody(clone) Dilution  Source  
Rhodopsin(1D4) Mouse monoclonal [1D4] to 
Rhodopsin 
1:200 Abcam 
S Opsin Goat polyclonal to S Opsin  1:150 Santa Cruz 
Iba1 Goat polyclonal to iba1 1:500 Abcam 
Glial fibrillary acidic 
protein (GFAP) 
Mouse monoclonal to GFAP 1:400 Sigma 
Glutamine synthetase 
(GS) 
Rabbit polyclonal to 
Glutamine Synthetase 
1:1000 Abcam 
Table 2-2 Secondary Antibodies used in This Study 
Antibody Host Dilution Source 
Anti-goat IgG(H+L), 
Alexa Fluor 586 
Donkey 1:150 Thermo Fisher 
Scientific  
Anti-mouse IgG, 
FITC 
Donkey 1:400 Jackson 
ImmunoResearch 
Anti-mouse 
IgG(H+L), Cy3 
Goat 1:400 Jackson 
ImmunoResearch 
Anti-rabbit IgG(H+L), 
Alexa Fluor 488 
Donkey 1:200 Thermo Fisher 
Scientific 
Anti-rabbit IgG, FITC Goat 1:150 Sigma-Aldrich 
3. Microscopy and Image Analysis 
3.1 Microscopy and image processing  
For wholemount retinas, images were scanned using either Nikon TE2000 Invert 
fluorescence microscope with 20× magnification or Zeiss AxioImager with apoptome (Zeiss, 
Germany) with 10× magnification. The Zeiss AxioImager widefield technique was used to 
capture images of widefield whole-mount retinas and tiled together automatically. The 
apoptome mode was used to obtain confocal-like Z stack images. Each field was scanned 
from top to bottom to cover the entire thickness of the retina with an interval of 3µm.  
For 20μm cryostat sections, images were acquired using Nikon TE2000 Invert fluorescence 
microscope with 20× objective (Nikon, Japan). Each slice was scanned systematically from 
dorsal to ventral ora serrata. For 30μm cryostat sections, images were acquired using Nikon 
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NiE upright fluorescence semi-automated microscope with 40× oil objective. Slices were 
scanned following the same protocol, except that each field of the images was scanned from 
the top to the bottom using automated Z drive platform with an interval of 3μm. All raw 
images were then processed using ImageJ to enhance the quality. 
3.2 Numbering for blind observation  
Each eye was randomly assigned an integer between 1 and 600. The randomization was 
done in Microsoft Excel. After randomization, the images were masked by a second person, 
and the observer for cell counting had no access to the specimen information of the images. 
3.3 Cell counting 
Following image enhancement, images were manually analysed using ImageJ cell counter. 
Each slice was divided into six equidistant areas from the dorsal to ventral ora serrata (two 
periphery, two medium, and two peri optic nerve). The density of cells was determined by 
the numbers of cells in each defined area divided by the length of the defined area 
measured at the GCL. 
3.4 Thickness of Outer Nuclear Layer 
The evaluation of the survival photoreceptors was conducted by the assessment of the 
thickness of the ONL. To analyse the ONL thickness, five positions were randomly selected in 
each image with an interval of 50-70μm to offset the uneven distribution of ONL thickness. 
Intervals were consistent within each image and were determined by the length of the retina 
in the image. The ONL thickness was measured on images labelled with DAPI at each 
selected position (Figure 2-2, black line), while the thickness of the retina was determined by 
measuring the distance between the outer edge to inner edge at each corresponding 
position in the same image (Figure 2-2, white line). The ONL ratio (ONL thickness/ retinal 
thickness) was also used to compensate for the bias of retinal thickness caused by 
sectioning.  
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Figure 2-2 Laminated retinal structure visualised by DAPI staining.  
Representative images showing how retinal thickness and ONL thickness were measured. White line defines the 
retinal thickness, and the black line defines the ONL thickness. Scale bar: 50µm. Image was taken from the central 
area of the retina of a P100 WT mouse.  
3.5 Iba1  
To evaluate the phenotype and location of microglia cells during retinal degeneration, 
ionized calcium binding adapter molecule 1 (iba1) was used to stain microglia. iba1 is 
recognised as a marker expressed in macrophages/microglia. A positive microglial cell was 
defined as a cell with the soma labelled by iba1 and the nucleus labelled by DAPI. Staining of 
cell processes but not the cell soma was not included. Based on their location, iba1+ cells 
were then differentiated into five categories according to the layers defined by DAPI staining 
(as shown in Figure 2-2). The position of microglial cells was determined by the location of 
their somata. 
3.6 GFAP 
To assess the activation of MGs, glial fibrillary acidic protein (GFAP) was used to stain 
activated MGs and astrocytes. Due to the unique distribution of MGs and astrocytes, These 
two cells are distinguishable using GFAP staining. Astrocytes are confined within NFL, whilst 
MGs spans across the entire thickness of the retina. GFAP is considered as a stress marker in 
CNS system. As opposed to the physiological status in which GFAP expression is confined 
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within NFL, activated MGs are defined as GFAP+ filaments extending towards outer retina. 
The filaments that passes half of the retinal thickness are counted as GFAP+ filaments. 
3.7 Apoptotic cells 
TUNEL assay was used to detect the presence of apoptotic cells by labelling the terminal end 
of nucleic acids on the DNA fragments. An apoptotic cell was determined by the presence of 
positive TUNEL staining overlapped with DAPI staining. The numbers of cells in the ONL and 
the areas proximally to ONL were recorded respectively.  
4. Data Processing and Statistical Analysis  
Statistical analysis was carried out using Matlab 2016b Statistics Toolbox (The Mathworks, 
Inc.). Data were shown as mean ± standard error. The Spearman’s rank correlation test was 
used to identify possible relationship between the iba1 positive cells in each layer and: i) 
thickness of ONL; ii) numbers of GFAP positive cells; numbers of TUNEL positive cells. The 
same correlation was performed to determine: i) the relationship of the iba1 positive cells in 
different retinal layers; ii) the relationship between ONL thickness and TUNEL positive cells. 
Repeated ANOVA was used to compare the changes in numbers of each cell type with age. 
Each cell type was analysed separately. Two way ANOVA was used to compare of the cells 
numbers and ONL thickness at different days post injection with/without drug. 
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Chapter 3. Photoreceptor Degeneration in Rd1 and 
Crx Retina 
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1. Introduction 
A common feature of hereditary retinal degenerations is photoreceptor depletion. However, despite 
the fact that there is no difference in the terminal stages of degeneration, the mechanisms that will 
eventually lead to photoreceptor death may vary across different gene mutations, allowing potential 
specific targets for preventing photoreceptor loss.  
Apoptosis is considered to be the cardinal feature of photoreceptor degeneration in RP (Cottet and 
Schorderet, 2009), where rod apoptosis is most prevalent, caused by rod specific mutations that 
disturb either the pigment cycle or phototransduction cascade (Cottet and Schorderet, 2009, Chang 
et al., 1993). Additionally, non-autonomous cell death such as autophagy, phagoptosis, have also 
been implicated during photoreceptor degeneration (Punzo et al., 2009). 
Although cones are not affected by mutations in RP, they eventually die as a result of the changes in 
the glucose level caused by rod death (Koenekoop, 2009), and also because of autophagy triggered 
by rod loss (Punzo et al., 2009).  
In other retinal dystrophies, however, such as Leber’s congenital amaurosis (LCA), which is related to 
mutations in several genes including RP65, CRX, CRB1 (den Hollander et al., 2001, Hamel, 2007, 
Furukawa et al., 1997), cone loss can be primary and events can follow the opposite sequence (cone 
to rod), or in the most severe cases, manifest as concomitant cone and rod loss.  
Rd1 mice, the most popular animal model for retinitis pigmentosa, undergo a fast degenerative 
process (Bowes et al., 1990). The time course of photoreceptor degeneration in rd1 retina has been 
well defined, due to rod apoptosis, while ensuing cone loss results from non-cell-autonomous 
mechanisms (Punzo and Cepko, 2007, Zeng et al., 2005). 
Unlike the single pathway affected in the rd1 retina, the Crx homeobox gene is expressed exclusively 
in photoreceptors and contributes to regulating the expression of other photoreceptor genes. The 
Crx retina is characterised by atrophied photoreceptor morphogenesis during the first three 
postnatal weeks, affecting both rods and cones. The defects not only lead to complete atrophy of 
outer segments, but also to extremely short inner segments. In addition to the abnormal formation 
of the inner and outer segments, other features have been noted including the presence of an 
unknown extracellular matrix material, displaced nuclei in the outer segments layer, and numerous 
vesicles with 100-200 nm diameter in the inner segment layer (Morrow et al., 2005). Hence, 
different mechanisms may be involved during the degenerating process.  
Nevertheless, the late onset of photoreceptor degeneration and slow degenerative process make 
the Crx retina a useful model to study the consequences of photoreceptor loss. Furthermore, the 
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absence of outer segments and the complete lack of a light response make it ideal to investigate cell 
interactions without the interference of retinal damage caused by light exposure. 
It has been previously demonstrated that the onset of photoreceptor loss starts from P30 and lasts 
for six months in the Crx retina (Furukawa et al., 1999). However, the kinetics of photoreceptor 
degeneration during the process and how apoptosis contributes to the photoreceptor loss remain 
unclear. The aim of this chapter was therefore to investigate the kinetics of photoreceptor 
degeneration in Crx retina and compare it with the well-defined rd1 mouse model in order to set up 
a basis for the following studies of glial activation. 
2. Specific Methods 
2.1 Animals  
To investigate the time course of retinal degeneration, a cohort of Crx mice were sacrificed from P10 
to P150, at 10 days intervals before P100, and then collected at P130 and P150. As the rd1 retina 
follows a fast degenerating process, rd1 retinas were harvested at initially shorter intervals, P10, 
P15, P20, P30, P60, and P110. Wild-type retinas were collected at P10, P20, P30, P80, and P100 for 
comparison. No less than three mice (one eye from each) from each strain were included in each 
time point.  
2.2 Tissue collection and immunohistochemistry  
The retinas were harvested and stored following the procedures described in Chapter 2, except that 
the thickness of the cryostat sections for TUNEL assay was 20μm. Immunohistochemistry used the 
protocol described in Chapter 2. 
Rhodopsin was used to label rods, while S opsin was used to label red/green cones. TUNEL assay was 
used to identify apoptotic cells.  
2.3 Microscopy  
Cryostat sections were scanned using a Nikon TE2000 Invert fluorescence microscope with 20× 
objective (with 10× eyepiece and 1×intermediate magnification) at a 1344 × 1024 pixel resolution. 
Each slice was scanned systematically from the dorsal to ventral ora serrata with only one single 
image in each field. 
Image processing, cell counting, data analysis and statistics used the same procedures as described 
in Chapter 2. 
3. Results 
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3.1 Photoreceptor degeneration in rd1 retina  
3.1.1 The depletion of Photoreceptors occurs during the first postnatal month in 
rd1 retina.  
To validate the time course of photoreceptor degeneration in rd1 retina, the cryostat retinal sections 
were examined to compare the ONL thickness at different ages in rd1 retina. In WT retina, the 
alignment of photoreceptor nuclei was consistent with that observed across different ages with a 
highly organized arrangement in the ONL (Figure 3-1 A and B). By contrast, although the 
photoreceptor nuclei were orderly arranged in the ONL and evenly distributed throughout the entire 
retinal length at P10, the ONL thickness was slightly reduced to approximately 12-15 layers of nuclei 
in the perioptic nerve area and 9-12 layers of cells in the peripheral area (Figure 3-1 C). At P15, the 
ONL started to lose its alignment and the ONL thickness was significantly reduced. By P20, there was 
only one layer of photoreceptor nuclei left, and these nuclei were still detectable at P30, but at a 
lower density, with gaps present between nuclei (Figure 3-1 F). 
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Figure 3-1 Fluorescence micrographs showing the change of ONL thickness against age in rd1 retina.  
A-B: DAPI stained retinal sections from developing retina (A) and adult retina (B) of WT mouse. In the healthy state, the 
photoreceptor nuclei maintained a regular appearance with organized alignment throughout all ages. C-F: DAPI stained 
retinal sections from rd1 retina between P10-30. In rd1 retina, the photoreceptor nuclei remain clearly aligned at P10, while 
the ONL is slightly thinner than in WT (C). The ONL thickness is sharply reduced by P15, and alignment of the cell nuclei 
becomes less organised (D). By P20, there is only one layer of photoreceptors left (E). Photoreceptors are still detectable at 
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P30, however, discontinuities in the ONL are widely observed (F). Images were taken from the central retina. Scale bar: 
50μm. 
To quantify changes in ONL thickness in the rd1 retina over time, we measured the thickness of the 
ONL and of the entire retina (the ratio between these two metrics was defined as the ONL ratio) and 
counted photoreceptor nuclei (Figure 3-2). Our results were in accordance with previous studies 
(Pennesi et al., 2012). Compared to the WT retina, there was a slight reduction in the ONL thickness 
at P10, and by P20, the ONL thickness had already decreased to less than 20% of its initial value. The 
largest drop occurred between P15 and P20. The ONL ratio and the number of photoreceptor nuclei 
were consistent with the ONL thickness. From P10 to P20, the ONL ratio decreased from 0.325 to 
0.069, while the numbers of nuclei decreased from 11 to 1 cell. By contrast, in the WT retina, the 
ONL thickness remained relatively stable between P10-30, with a mean thickness of 55µm, 0.36 for 
ONL ratio and 13 nuclei.  
 
Figure 3-2 The changes of ONL thickness and ONL ratio against age  
The quantitative measurements on the ONL thickness, ONL ratio as well as photoreceptor nuclei number all confirmed that 
photoreceptor loss occurs within the first month. By P20, there were fewer than 20% of photoreceptors left. A: Change of 
ONL thickness against age; B: Change of ONL ratio against age. C: Change in the numbers of photoreceptor nuclei. (** p < 
0.01, data seen in Table 3-1) 
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Table 3-1 Changes of ONL thickness, ONL ratio and numbers of photoreceptor nuclei against age 
Strain age n 
ONL thickness  ONL ratio 
Numbers of nuclei 
per measurement  
mean 
(μm) SEM 
mean 
(μm) SEM 
mean 
(μm) SEM 
rd1 
P10 3 50.136 0.841 0.325 0.004 11.763 0.291 
P15 3 43.957 1.754 0.281 0.009 9.922 0.462 
P20 3 5.660 0.244 0.069 0.003 1.402 0.070 
P30 3 2.462 1.537 0.026 0.015 0.527 0.068 
WT 
P10 3 54.782 1.187 0.375 0.004 13.355 0.198 
P15 3 69.134 0.616 0.356 0.004 15.508 0.123 
P20 3 56.189 1.073 0.379 0.010 13.789 0.194 
P30 3 55.776 1.192 0.362 0.005 13.352 0.208 
 
3.1.2 Time course of apoptosis in ONL of rd1 retina 
Apoptosis is considered to be the main cause of photoreceptor degeneration in RP retina. The 
apoptotic cells can be identified via morphological assessment such as pyknotic nuclei and 
biochemical techniques including TUNEL assays. As a result of apoptosis, the cells undergo pyknosis 
that leads to the condensation and formation of pyknotic nuclei. This can be visualized by light 
microscope using Haematoxylin and eosin (H&E) staining and by fluorescent microscope using DAPI 
staining. The apoptotic nuclei are slightly smaller with condensed chromatin comparing to the 
normal nuclei. TUNEL assay is another widely used method for the detection of apoptotic dells in 
tissue sections. The principle is to label the 3’-hydroxyl termini in double strand DNA breaks 
generated during apoptosis.  
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Figure 3-3 The fluorescent micrographs of apoptotic cells in P50 Crx retina 
Cryostat section of a P50 Crx retina stained with DAPI and TUNEL. Under 40× oil magnification, TUNEL +cells overlap with 
the DAPI stained nuclei and can be easily distinguished from the background (B, C, E and F, Arrow). On the DAPI channel, 
the apoptotic nucleus is subtly smaller and brighter than the surrounding normal nuclei (A and D, arrow). Green: TUNEL, 
Blue: DAPI. Scale bar: 25μm. 
To test the sensitivity of these two methods, DAPI staining and TUNEL were applied on retinal 
sections of P50 Crx mice (Figure 3-3). The results showed that, under 40× oil magnification, the 
TUNEL labelled cells were restricted within the ONL and were easily distinguished from the 
background. Although the apoptotic nuclei stained by DAPI tend to be subtly brighter and smaller, it 
was difficult to differentiate them from other nuclei at 40x magnification. The visualization of the 
condensed chromatin may require higher magnification or transmission electron microscopy (TEM) 
to improve the ability to discriminate them from healthy nuclei. Hence, in this study, TUNEL staining 
was used as the preferred approach to detect apoptotic cells.  
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Figure 3-4 Fluorescent micrographs of TUNEL cells (green) in vertical sections of rd1 retina.  
The TUNEL+ cells were detectable in the ONL of rd1 retina from P10 and maintained at a high level until P15. The TUNEL+ 
cells were rarely detected from P20 on. Green: TUNEL; Blue: DAPI. A: P10; B: P15; C: P20; D: P30. Scale bar: 50μm. 
To establish the time course of apoptotic activity in rd1 retina, TUNEL staining expression was 
investigated between P10 and P30. TUNEL+ cells were initially observed at very high density in the 
ONL between P10 and P15 (Figure 3-4 A and B). By P20, the number of TUNEL+ cells had already 
decreased significantly, and virtually no TUNEL+ cells were detected after P30 (Figure 3-4 C and D). 
By contrast, TUNEL+ cells were absent in the WT retina (data not shown). 
To determine if the onset of apoptosis matched the timing of ONL thinning, the number of TUNEL+ 
cells in the ONL was counted (Figure 3-5). The density of TUNEL+ cells was defined as the total 
number of TUNEL+ cells divided by the corresponding retinal length. TUNEL+ cells were initially 
observed at a very high density in the ONL at P10, and decreased by 50% between P10-15. By P20, 
the TUNEL density was only 10% of its value at P10, and no TUNEL+ cells were detected after P30. 
The results revealed an interesting observation that, although many TUNEL+ cells were detected at 
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P10-15, the dramatic reduction of ONL thickness occurred after P15, when few apoptotic cells were 
detected. This suggests that TUNEL+ expression may be a useful approach to detect photoreceptor 
loss prior to their actual apoptosis.  
When analysing the density of TUNEL+ cells and ONL thickness at different retinal eccentricities, it 
was observed that, the density of TUNEL+ cells was significantly lower in the periphery compared to 
the central retina (intermediate and perioptic) at the onset of degeneration (Post hoc test: P10, 
Periphery vs Intermediate: p = 0.000, Periphery vs Perioptic nerve: p = 0.000, Dunn’s test). However, 
this difference disappeared at later stages.  
In addition, although the absolute ONL thickness was not significantly different at different retinal 
eccentricities (Two way ANOVA: Age vs Location: effect of location: p = 0.624, Dunn’s test), the ONL 
ratio was significantly higher in the periphery compared to the other two areas during the early 
stage of retinal degeneration (Post hoc: P10: Periphery vs Intermediate: p = 0.000; P15: Periphery vs 
Intermediate: p = 0.000, Periphery vs Perioptic nerve: p = 0.000, Dunn’s test). 
 
Figure 3-5 Bar chart showing the change of ONL thickness and apoptosis against age in rd1 retina. 
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The apoptotic activity was intense between P10-15, while the most remarkable drop of ONL thickness was seen after 
P15. ,A: Change of absolute ONL thickness against age; B: Change of ONL ratio against age; C: Change of absolute TUNEL+ 
cells against age; D: Change of TUNEL density against age. 
3.1.3 Morphological photoreceptor changes in rd1 retinal sections 
Although rods degenerate rapidly in the rd1 retina, surviving cones nevertheless do not exhibit light 
responses (Chua et al., 2009, Stasheff, 2008). This is presumably due to functional changes reported 
in glutamatergic synapses between photoreceptors and bipolar cells (Nishiguchi et al., 2015). In 
order to characterize the remodelling of photoreceptors, immunolabelling for rhodopsin and S Opsin 
(to label UV cones) was performed on vertical sections to visualize the opsin distribution and 
morphological details. 
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Figure 3-6 Fluorescent micrographs of Rhodopsin in vertical sections of rd1 retina.  
Rhodopsin was employed to visualize the remodelling of rods in rd1 retina. A: Rhodopsin+ cells exhibited a round shape and 
composed the majority of the ONL at P10. B: The Rhodopsin+ cells remained vertically aligned at P15. C: Scatters of 
Rhodopsin+ cells were loosely stacked in the ONL at P20. D: Rhodopsin+ cells were detectable at P110 at a very low density. 
E: Selected area from A. The ONL remained relatively intact except for the shortening of the OS (the hyperintensity zone in 
the outmost of ONL, arrows ). F: Selected area from B. Arrow head indicates the processes projecting towards the INL.. 
In rd1 retinas, at P10, Rhodopsin+ cells were orderly arranged in the ONL with shorter segments 
(Figure 3-6A), compared to WT retinas. By P15, cells became more disorganized within the ONL 
(Figure 3-6B). Although in some areas the ONL remained relatively thick, processes were seen 
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projecting into the inner nuclear layer (INL) (Figure 3-6F, arrow head). These processes disappeared 
together with the depletion of Rhodopsin+ cells during degeneration. Rhodopsin+ cells were still 
detectable, but only very sparsely, in vertical sections until P110. with usually 1-2 cells per slice 
(Figure 3-6D). 
In the rd1 retina, S opsin+ cells remained vertically aligned at P10, with shortened outer segments 
(Figure 3-7A). By P15 the processes were much shorter compared to WT retina (Figure 3-7B), and 
this was particularly pronounced in the central retina. Cells lost their vertical alignment and were 
flattened along the ONL after P20 (Figure 3-7C). S opsin expression was still detectable, with only 1-2 
cells per slice (Figure 3-7D).  
 
Figure 3-7 Fluorescent micrographs of S opsin in the vertical sections of rd1 retina.  
S opsin was employed to visualise the remodelling of the short-wavelength cones. A: At P10, the S opsin+ cells were 
vertically aligned in the ONL. B: The S opsin cells+ remained vertically arranged but with shortened processes at P15; C: The 
S opsin+ cells lost their alignment and were stacked more loosely in the ONL.D: The S opsin cells were detectable at P110 
with a flattened shape at a very low density. Scale bar: 50µm. 
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3.1.4 The distribution of photoreceptors on whole mount retina of rd1 retina 
The results from vertical sections of rd1 retinas revealed that there was a significant change in the 
overall distribution of surviving photoreceptors, with more surviving cells in the peripheral area and 
fewer in the central retina, which is consistent with previous studies (Lin et al., 2009). To investigate 
the distribution pattern of photoreceptors in the rd1 retina, Rhodopsin immunoreactivity was 
examined on retinal wholemounts at P15 and P20.  
When viewing the WT retina from the photoreceptor side, it could be seen that the field was 
covered with a large number of elongated structure with extensive Rhodopsin expression (Figure 
3-8A). In dystrophic retinas at early degeneration stages, rhodopsin expression was also high in the 
outer/inner segments, however the outer/inner segments appeared as a dot-shape instead of the 
elongated shape seen in WT, suggesting a shortening of the outer segments (Figure 3-8B). At the 
later stages of degeneration, rhodopsin expression on cell bodies appeared with the degeneration of 
the outer/inner segments (Figure 3-8C-F), in agreement with the results from another RP model: the 
S334ter-line-3 rat (Zhu et al., 2013). Compared to the rod mosaic in WT retina, at P15, although 
there were fewer rhodopsin+ cells and their outer segments were shorter, at this stage, the 
distribution of Rhodopsin+ cells remained similar to WT (Figure 3-8). After P20, the number of 
Rhodopsin+ cells decreased significantly, and only a few scattered cells could be detected. A 
noticeable difference was seen between the perioptic and peripheral areas, with more rhodopsin 
expressing cells detected in the periphery, with extended cellular processes oriented towards the 
central retina. Most surviving rhodopsin+ cells in the central retina were lacking such oriented 
processes (Figure 3-8C-F). 
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Figure 3-8 Fluorescent micrographs of rhodopsin on wholemount retina 
A: In WT retina, extensive expression of Rhodopsin was observed in the OS exhibiting a hyperintense slim-rod shape while 
the cell bodies were not visible; B: Inrd1 retina at early stage of retinal degeneration, the expression of Rhodopsin was 
largely reduced. The OS appeared as a dot-shape; C and D: In late degeneration stage of the rd1 retina, there was a 
discrepancy in the distribution of Rhodopsin+ cells. The density of Rhodopsin cells was high in the periphery but low in the 
central retina. Meanwhile, the cellular processes of Rhodopsin+ cells in the periphery oriented towards the central area (F 
arrow), while cells in central area lacked these oriented processes (E arrow), Scale bar: 50μm 
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3.2 Photoreceptor degeneration in Crx retina 
3.2.1 Changes of ONL thickness in Crx retina 
 
Figure 3-9 Fluorescence micrographs showing the change of ONL thickness against age in Crx retina.  
DAPI stained retinal sections from Crx retina between P20-110. In Crx retina, the photoreceptor nuclei remained neatly 
alignment until P50 and the ONL thickness was only slightly reduced comparing to P20 (A and B). The ONL became 
disorganised and thickness was decreased sharply by P80 (C). There were only two or three layers of cells left after P110 (D). 
Images were taken from central area of the retina. Scale bar: 50μm. 
Compared to the fast degeneration process in the rd1 retina, degeneration was much slower in Crx 
retina. When analysing the DAPI stained retinal sections, the ONL was relatively intact up to P50 with 
only a moderate decrease in the thickness. By P80, the ONL thickness dropped sharply and the nuclei 
became disorganised. By P110, the ONL became reduced to 2-3 layers, and discontinuity was 
frequently observed (Figure 3-9). 
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In order to gain a detailed understanding of the kinetics of photoreceptor degeneration, transverse 
Crx retinal sections were then examined from a wide range of ages (from P10 to P150), which spans 
most of the degeneration period (Figure 3-10).  
 
Figure 3-10 Line graph showing group data for the changes of ONL thickness and ONL ratio against age in Crx retina. 
Quantitative measurements on the ONL thickness and ONL ratio both indicated that the ONL thickness did not reduce at a 
constant rate throughout the degenerating process. The ONL thickness was reduced by 40% and 30% during P30-50 and 
P60-80 respectively. By P80, there was less than 20% of photoreceptors left. A: Changes in ONL ratio with age; B: Changes in 
absolute ONL thickness with age (data seen in Table 3-2). 
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Table 3-2 Changes of ONL thickness, ONL ratio and numbers of photoreceptor nuclei against age 
Strain age n 
ONL thickness ONL ratio 
Numbers of nuclei per 
measurement 
mean 
(μm) 
SEM 
mean 
(μm) 
SEM mean (μm) SEM 
CRX 
 
 
 
 
P10 3 50.727 0.579 0.351 0.004 10.392 0.147 
P20 3 52.604 1.008 0.339 0.004 11.027 0.188 
P30 3 49.683 0.554 0.318 0.004 11.200 0.165 
P40 3 29.632 0.423 0.255 0.003 6.490 0.101 
P50 3 33.741 0.696 0.260 0.005 6.564 0.137 
P60 3 33.925 1.269 0.262 0.008 6.979 0.254 
P70 3 15.426 1.247 0.161 0.013 3.605 0.371 
P80 3 17.538 0.641 0.166 0.006 3.064 0.120 
P90 3 14.820 0.650 0.139 0.007 2.283 0.144 
P100 3 13.863 0.557 0.123 0.004 1.563 0.157 
P130 3 10.383 0.636 0.116 0.007 1.194 0.168 
WT 
P10 3 54.782 1.187 0.375 0.004 13.355 0.198 
P20 3 56.189 1.073 0.379 0.010 13.789 0.194 
P30 3 55.776 1.192 0.362 0.005 13.352 0.208 
P60 3 55.190 0.936 0.435 0.004 12.179 0.368 
P80 3 63.821 1.714 0.395 0.010 13.789 0.194 
P110 3 60.940 0.988 0.374 0.005 13.279 0.255 
 
The depletion of ONL was rather slow except for two sharp drops occurring at P30 and P60 
respectively (Figure 3-10 B, solid lines, arrows). The ONL thickness decreased by ~33% between P30-
40, and decreased further by 50% between P60-70. Although the absolute ONL thickness was similar 
at different retinal eccentricities during degeneration, there was a clear difference in the ONL ratio 
for periphery, intermediate and perioptic areas (Figure 3-10 A).  
In WT, the ONL ratio was around 11% larger in the periphery than in the central retina (intermediate 
area and perioptic nerve) at P10, and the difference decreased to 7% by P30 (Figure 3-10 A, dash 
lines). Despite fluctuations in ONL ratio during development, not much difference was seen at 
different eccentricities over time in the WT retina. 
In the Crx retina, the ONL ratio followed a pattern similar to WT, except that the difference between 
the perioptic nerve and the other two areas became more pronounced after the two sharp drops 
described above (Figure 3-10 A, solid lines). At P10, the ONL ratio was 7.6% larger in the central 
retina than in the periphery. By P30, the ONL ratio decreased by a moderate amount. However, after 
the first fast cell death wave between P30-40, although the ONL ratio was reduced in all areas, it 
decreased at a faster rate in the central area than in the periphery, yielding a difference of 0.07 
between periphery and central retina (accounts for 20% of the periphery ONL ratio). Another overt 
change was seen after the second wave of ONL thinning between P60-70, when it dropped from 
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0.23±0.01 to 0.13±0.01 µm in the perioptic nerve area, whereas in the periphery, it dropped only 
from 0.31±0.01 µm to 0.26±0.01 µm. The difference became less obvious after P100 when the 
depletion of photoreceptors had almost completed. 
3.2.2 Time course of apoptosis in the ONL of Crx retina 
To determine the contribution of apoptosis to the two “waves” of photoreceptor degeneration, the 
number of TUNEL+ cells in the ONL was used to evaluate apoptotic activity and to compare the 
timing of cell death with the timing of ONL thinning (Figure 3-11). Although the TUNEL+ cells were 
initially identified in the peripheral retina as early as P30, these apoptotic cells were too sparse to be 
captured on retinal sections.  
The first conspicuous sign of TUNEL + cells was observed at P50, with the average TUNEL density of 
9.0±0.76 cells/mm retinal length, and remained at a high level until P70 (8.9±1.10 cells/mm retinal 
length). Notably, the number of TUNEL+ cells in the intermediate zone was visibly higher than in the 
periphery between P50-70. The level of TUNEL+ cells dropped by 75% after P70. By P80, the average 
TUNEL density was only 1.70±0.43 cells/mm retinal length, while the difference in the incidence of 
TUNEL+ cells between locations was barely detectable, which may be due to the depletion of 
photoreceptors. At later stages, TUNEL+ cells remained at a very low level and were undetectable on 
sections at P150, although scattered TUNEL+ cells were still visible until P190. The TUNEL+ cells were 
completely undetectable after P190, suggesting the end of apoptosis. 
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Figure 3-11 Change in the density of TUNEL+ cells in retinal sections of Crx mice against age. 
A-D: Fluorescent micrographs of TUNEL+ cells. TUNEL+ cells (Green) were detectable in ONL from P50 and remained at a 
high level until P70. The number of TUNEL+ cells were largely reduced at P110 and these cells became undetectable by 
P150. Green: TUNEL; Blue: DAPI. Scale bar: 50µm. E: Line graph showing the change on TUNEL+ cell density in Crx retina 
with age. The density of TUNEL+ cells was peaked between P50-70 and reduced dramatically after P70. 
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Table 3-3 The density of TUNEL+ cells in the ONL at different retinal eccentricities 
age n 
Periphery Intermediate Perioptic nerve 
mean STD SEM mean STD SEM mean STD SEM 
P30 3 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
p50  3 6.200 5.500 1.000 11.400 9.300 1.500 8.900 7.800 1.200 
p60 3 6.800 5.800 1.400 9.400 7.900 1.600 8.900 10.600 1.900 
p70 3 10.200 7.700 1.900 12.400 9.300 2.200 5.000 6.200 1.300 
p80 3 0.900 1.800 0.600 2.200 2.500 0.700 1.700 2.900 0.800 
p90 3 3.300 3.600 1.300 3.800 5.000 1.400 2.600 4.200 1.200 
p110 3 1.500 2.000 0.800 1.800 1.700 0.500 2.900 5.000 1.200 
P130 3 0.700 1.300 0.300 1.400 2.900 0.800 0.400 1.000 0.300 
P150 3 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
 
3.2.3 Morphological changes of photoreceptors in vertical sections of Crx retina 
Although photoreceptors in the Crx retina are atrophied from the onset, they are able to survive for 
a relatively long period. Interestingly, after P50 there were areas with focal thinning in the ONL. This 
focal thinning pattern appeared more frequently with degeneration and became more obvious after 
P80 (Figure 3-12, arrows). 
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Figure 3-12 Fluorescent micrographs showing focal areas of thinning on retinal section of Crx retina.  
A: P50. Blue: DAPI. Arrow: thinned area. DAPI staining reveals focalized thinning in ONL. B: P110. Blue: DAPI. Arrow: area 
devoid of nuclei in ONL. DAPI staining reveals discontinuity of ONL. C: P90. Grey: Rhodopsin. Arrow: area that were devoid 
of rhodopsin+ cells. Arrow heads: area with cluster of cells. D:110. Grey: Rhodopsin. Arrow: area that was devoid of 
rhodopsin+ cells. Arrow heads: area with cluster of cells. Scale bar: 50μm. 
To characterize the remodelling of photoreceptors during the degenerative process and determine 
which cells were involved in the thinning pattern, immunolabelling for rhodopsin and S opsin was 
performed on Crx retinal sections to visualize the opsins’ distribution and morphological details. 
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While the outer segments were absent and only short inner segments were visible (Figure 3-13 A: 
the overexposed area adjacent to the outermost side of the ONL), the distribution and arrangement 
of Rhodopsin+ cells remained similar to WT before P20, which is not surprising, given that 
degeneration did not start until P30. The Rhodopsin+ cells did not change much beyond P50 (Figure 
3-13C). Notably, the outer segments had completely disappeared by this stage. Rhodopsin+ cells 
became less evenly distributed after P80, when there were areas with clusters of Rhodopsin+ cells 
next to areas that were devoid of cells bodies, with only processes visible (Figure 3-13C and D. 
Arrows: Areas that were devoid of cells bodies; Arrow head: Areas with cluster of Rhodopsin+ cells). 
As shown earlier, the rate of ONL thinning became slow after P80, but lasted for up to six months 
(Furukawa et al., 1999). The expression of Rhodopsin+ cells was in agreement with previous findings, 
with only one or two remaining cell layers after P110 (Figure 3-13E). However, clusters of 
Rhodopsin+ cells interspersed with areas devoid of these cells was seen more frequently with age. 
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Figure 3-13 Fluorescent micrographs of rhodopsin (A-C ) and S opsin (D-F) in Crx retina.  
A, C and E: Fluorescent micrographs of Rhodopsin on Crx retina at different age; The Rhodopsin+ cells arranged in a high 
density in the ONL before P50. There were remaining OS visible at P20 presenting as the lines with high intensity in the 
outermost of ONL, while this disappeared completely at P50. B, D and F: Fluorescent micrographs of S opsin on Crx retina at 
different age; The S opsin+ cells were vertically aligned in the ONL at very low density. The remaining of IS/OS can be 
observed in the outermost of the cells at P20 presenting as dots with high intensity. This also disappeared by P50. 
Meanwhile, the number of the S opsin+ cell was largely reduced, and the process of the cells were shortened. Scale bar: 
50μm. 
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In Crx retina, the distribution of S opsin followed the same pattern as in WT, but there was a distinct 
change in the morphology. The shortening of OS was conspicuous from the onset of degeneration, 
while the S opsin+ cells remained vertically aligned (Figure 3-13B). Until P50, the processes of S 
opsin+ cells became much shorter whereas the characteristic morphology of photoreceptor 
terminals in the OPL was still visible (Figure 3-13D ). By P110, almost all the cells lost their processes, 
and only scattered cell bodies could be seen (Figure 3-13F). 
3.2.4 The distribution of photoreceptors in Crx retinal wholemounts 
To further investigate which cells were attributed to those focalized thinning areas, Rhodopsin and S 
opsin labelling was performed on Crx retinal wholemounts. At P10, although the elongated structure 
was absent, the expression of Rhodopsin on wholemount retinas presented in a high density ( Figure 
3-14A), while the cell bodies of rhodopsin+ cells were not visible at this stage. By P50, the segments 
almost disappeared with a high density of round cell bodies left (Figure 3-14B). 
Areas with low density of rods, which were compatible with the vertical sections, were commonly 
seen in the peripheral retina from P80 onwards (Figure 3-14D, arrows: areas that are devoid of cell 
bodies). Although detected as early as P50, these areas of localised PR defects, which we termed 
‘holes’, were relatively small around P80-100, and became larger with degeneration. After P130, the 
surviving rhodopsin+ cells became very sparse, making it difficult to distinguish the holes clearly. 
Notably, these holes presented a unique pattern, with numerous photoreceptors on their rim, but 
none inside the holes (Figure 3-14D), suggesting cell migration was involved in their formation. On 
the other hand, although the ONL was confirmed to be much thinner than at P50, the areas that 
were free of holes maintained their organization, similarly to what we observed at the earlier stages 
(Figure 3-14B and C). Examination suggested that the distribution of both M opsin+ and S opsin+ 
cells was independent from the holes.  
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Figure 3-14 Fluorescent micrographs of rhodopsin on whole mount retina of Crx mice. Grey: Rhodopsin. 
A: P10.The retinas were covered with the remaining IS/OS, which presented as dots or slim lines with high intensity, while 
the cell bodies were not visible. Scale bar:100 μm. B: P50. The rhodopsin + outer segments were undetectable at this stage 
and the round shaped cell bodies can be seen at a high density. Scale bar:100 μm. C: P90. Hole-free areas. Retinas are 
covered with the round shaped cell bodies, albeit at a lower density than earlier on. Scale bar:200 μm. D: P90. Hole of cells. 
Cell-free zones were observed in some areas of the retina. The holes have abundant cell bodies on their rim. Scale bar:200 
μm. Arrows: Areas that were devoid of cell bodies. 
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3.3 The occurrence of mislocated opsin+ cells in the inner retina associated with 
degenerating activity 
 
Figure 3-15 Fluorescent micrographs of rhodopsin and S opsin in the inner retina of rd1 mouse  
A: P15. grey: Rhodopsin. Scale bar: 50µm. Expression of Rhodopsin was found in the inner retina and displayed a 
morphology which was different from the Rhodopsin+ cells in the outer retina. Arrows: Rhodopsin+ cells in the inner retina 
with a round cell body and two processes pointing towards inner and outer retina respectively.; B:P19, grey: Rhodopsin. 
Scale bar: 50µm. Arrows: Mislocated Rhodopsin+ cells; C: P19, grey: S opsin. Scale bar: 50µm. Arrows: Mislocated S opsin+ 
cells; D: selected area of A. scale bar: 20 µm; E: selected area of B. scale bar: 20 µm; F: selected area of C. scale bar: 20 µm 
An unexpected finding was that scattered cell bodies expressing Rhodopsin and S opsin were 
observed in the inner retina of both rd1 and Crx retina (from OPL to GCL), whereas the Rhodopsin+ 
cells and S opsin+ cells were restricted to the ONL in WT retinas. Some of these cells displayed 
similar morphological features to bipolar cells (Figure 3-15). Mislocated opsin+ cells were detectable 
from P20-80 in the Crx retina, but were most frequently seen before P50. In the rd1 retina, the 
mislocated opsin+ cells were detectable between P10-20, and most frequently observed between 
P15-20, coinciding with the second wave of photoreceptor depletion. They were not detected at 
later stages. A similar phenomenon has been reported in several rodent models of outer retinal 
degeneration including the RCS rat and rd1 retina (Semo et al., 2007). Although the morphology of 
those mislocated opsin+ cells looks similar to bipolar cells, Semo et al (2007) were not able to 
colocalise these cells with any other neurons or Müller cells. However, it is clear that the occurrence 
of mislocated opsin+ cells was highly related to the degenerating activity. 
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3.4 The spatiotemporal relationship of TUNEL+ cells in Crx retina 
3.4.1 Correlation between ONL thickness and apoptotic activity 
To explore the contribution of apoptosis in the process of photoreceptor degeneration, the time 
course of ONL thinning and apoptosis was compared in both rd1 retina and Crx retina (Figure 3-16). 
In rd1 retina, the ONL thickness declined at a fast rate from the onset of photoreceptors degenerate. 
At that time, the rate of apoptosis is high, as demonstrated by the large incidence of TUNEL+ cells. 
Apoptotic activity slows down with the depletion of photoreceptors. In Crx retina, the density of 
TUNEL+ cells was very low at the onset of degeneration. The increase in the incidence of TUNEL+ 
cells starts immediately after the first wave of photoreceptor degeneration. Large numbers of 
apoptotic cells were seen throughout the mid-phase of the degeneration process, slowing down 
beyond P80. The onset of the second wave of photoreceptor death started from the middle phase of 
intensive apoptosis.  
 
Figure 3-16 Comparison of the time course of apoptotic activity and ONL ratio against age in rd1 and Crx retina 
A: The time course of ONL thinning and apoptotic activity in rd1 retina. In rd1 retina, the ONL ratio and number of apoptotic 
cells peaked at P10 and then reduced over time. B: The time course of ONL thinning and apoptotic activity in Crx retina. 
While the ONL thickness reduced over time, the number of apoptotic cells was very low before P50. The peak of apoptosis 
was seen between P50-70 and the number of apoptotic cells dropped rapidly after P70. 
It has been reported in S334ter-line3 RP retina that the rods tend to die in clusters, spreading to the 
adjacent area, generating zones with low density of rods and cones. (Shin et al., 2016). This normally 
started with clusters of apoptotic cells appearing in the centre of areas with low density of 
photoreceptors and spread to the adjacent areas leading to further photoreceptor death and 
migration (Lee et al., 2011). To investigate the clustering pattern in rd1 and Crx retina, vertical 
sections of rd1 and Crx retinas were inspected during the mid-phase of the degenerating process 
(P15 for rd1 retina and P50 for Crx retina). As can been seen in Figure 3-17, in some parts of the 
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periphery and intermediate area of the rd1 retina, the density of apoptotic cells tends to be high. 
However, this phenomenon was less conspicuous in Crx retina as the density of the apoptotic cells 
was much lower.  
 
Figure 3-17 Representative images showing the localization of apoptotic cells in rd1 and Crx retina 
Fluorescent micrographs of DAPI on P15 rd1 (A,C and E) and P50 Crx retina (B, D and F). White dots represent the position of 
TUNEL+ cells. A, C and E: The localization of apoptotic cells in P15 rd1 retina. Clusters of apoptotic cells can be seen in the 
periphery (A) and intermediate (C) area, with some cells tending to be in close proximity. B, D and F: The localization of 
apoptotic cells in P50 retina. The density of the apoptotic cells was very low in the retinal sections of Crx mouse. 
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To further investigate the cell-to-cell relationship between apoptotic cells, TUNEL staining was 
performed on wholemount Crx retinas. Figure 3-18 A-C display the fluorescent micrographs of 
TUNEL+ cells on wholemount retina, and D-F shows the binary images of Figure 3-18 A-C. The inter-
cell distance was calculated between apoptotic cells. The distributions of these values are plotted in 
Figure 3-18 G-H.. From these histograms, it can be seen that cell-to-cell distances have a normal 
distribution at P40, but shift to a right-skewed distribution at P50, suggesting that more cells were 
closer to each other. By P70, the cell-to-cell distribution became multimodal, indicating that 
although many cells tend to be close to each other, the intimate pattern found in P50 was reducing 
with degenerating process.  
 
 
Figure 3-18 The distribution of apoptotic cells in wholemount Crx retina. 
A-C The representative fluorescent micrograph of TUNEL+ cells in the wholemount Crx retina at different ages. Images were 
taken from the central area of the retina with photoreceptor side up. Scale bar: 200µm. D-E The binary images generated 
from A-C. The density of TUNEL+ cells increased remarkably from P40 to P50 with some cells displayed some apoptotic cells 
clustering together. G-I Distribution histogram of TUNEL+ cells from D-E. The X axis represents the cell-to-cell distance 
between a random apoptotic cell to any other apoptotic cell in the image. The Y axis represents the number of cells. The 
smaller the distance is, the more intimate the cells are. As is shown in the figure, from age P40 to P70, the numbers of cells 
increased at P50 and then decreased slightly. Meanwhile, a reduced cell-to-cell relationship was seen in P50 (Skewed right 
histogram) while the histograms from the other two ages display a multimodal distribution.  
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3.5 Parameters to evaluate the remaining photoreceptors  
In this study, the ONL thickness and the nuclei counts of ONL were assessed to quantify the surviving 
photoreceptors. To assess how these two parameters were associated with each other, the 
correlation between ONL thickness and ONL nuclei counts was analysed. Data from WT, rd1 and Crx 
retina were assessed separately to determine the power of ONL thickness on evaluating the 
degenerating process. For all three mouse lines, the relationship between ONL thickness and ONL 
nuclear counts was linear, as illustrated in Figure 3-19. In all three lines, the Pearson correlation 
coefficient was high, indicating a linear relationship between the two parameters. Therefore, we 
may conclude that the ONL thickness and the number of cell nuclei in the ONL are both reliable 
estimates of ONL degeneration.  
 
Figure 3-19 The correlation between ONL thickness and ONL nuclei counts in different strains.  
There was a high correlation between ONL thickness and ONL nuclei counts in all three strains. The scatter dots were 
plotted using the average data from each age group. The x value was the average nuclei counts and the y value was the 
average value of the ONL thickness. A regression line was plotted based on the dots. A: WT retina. N = 18; B: rd1 retina, N = 
12; C: Crx retina, N = 42.  
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4. Discussion  
Results in this chapter presented an investigation into the degeneration process in two different 
types of animal RP models. Although both models followed a perioptic to peripheral retina 
degenerating pattern, the time course of the degenerating process was quite different. The rd1 
retina followed a fast degenerating process, in which the onset of photoreceptor loss started from 
P10. The ONL thickness decreased to less than 20% by P20. The Crx retina followed a slow 
degenerative pattern, in which the onset of photoreceptor loss started from P30. The 
photoreceptors in the Crx retina survived for a longer period of time and could be detected for up to 
7 months.  
4.1 ONL thickness, ONL nuclei counts and TUNEL+ cells as parameters to 
evaluate photoreceptor degeneration 
Photoreceptor loss during the degenerating process was assessed by measuring the ONL thickness 
and the nuclei counts identified by DAPI staining of all cell bodies (regardless of photoreceptor 
subtypes). The correlation between ONL thickness and nuclei counts was compared to validate these 
two measurements. Although it is assumed that loss of photoreceptors would cause a large variation 
in nuclei counts while the ONL thickness remain unchanged, the results suggest that decreases in ONL 
thickness and nuclei counts were highly correlated. That may be because the final value of ONL 
thickness and nuclei counts was obtained by averaging multiple measurements, and this would be 
able to compensate for local variation caused by sampling. Hence, we have shown that ONL thickness 
closely reflects the remaining number of photoreceptor nuclei in these two mice models of retinal 
degeneration.  
The TUNEL assay has been reported as a sensitive method to label dying cells, prior to their actual 
death (Chang et al., 1993). Once dead, cells are quickly removed by phagocytosis, and therefore 
TUNEL+ cells do not accumulate in the tissue beyond the period of apoptosis. TUNEL staining is thus 
an appropriate tool to visualise cells in the process of dying, but it is not useful to detect dead cells. 
The detection of pyknotic nuclei was also attempted in this study, however, it was found to be 
challenging to distinguish the pyknotic nuclei from normal ones at the magnification used. Hence, 
TUNEL staining was used as the method for detecting apoptotic cells. 
In WT retina, TUNEL+ cells were frequently seen in the inner retina during the first postnatal week 
due to programmed cell death in RGCs and amacrine cells (Vecino et al., 2004), but were barely 
detected at later stages. In this study, we visualised TUNEL+ cells in degenerating photoreceptors. 
The TUNEL staining was visible only in the ONL in both rd1 and Crx retina.  
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4.2 Photoreceptor degeneration in rd1 and Crx retina 
Despite a similar fate in the final stages, the differences in mutations lead to a heterogeneous 
pathway in the rd1 and Crx retina during the degenerating process, which is in agreement with other 
studies on RP. 
The ONL thickness and nuclei counts in WT retina did not exhibit any conspicuous changes 
throughout the entire life span studied. In rd1 retina, the change in ONL thickness with age was in 
accordance with previous publications (Kim et al., 2008). 
The results from Crx retina in this study demonstrate a slow degeneration pattern, in agreement 
with the original publication describing Crx KO mice (Furukawa et al., 1999). Notably, this current 
study also showed that the ONL thickness does not decrease at a constant rate. Indeed, two periods 
of rapid degeneration were observed: the first between P30-40, and the second between P60-80, 
with slower degeneration rate in between.  
The results of the TUNEL+ cells from rd1 retina were consistent with previous findings (Portera-
Cailliau et al., 1994, Zeng et al., 2005). In rd1 retina, apoptosis played a major part in the first wave 
of photoreceptor degeneration. TUNEL+ cells were detectable between P10 and P20 and the density 
of TUNEL+ cells was maintained at a high level up until P15. However, in previous publications, 
TUNEL+ cells were at a very low level at P10 and reached a peak at around P15, whereas in this 
current study, the highest TUNEL density was found at P10. Apoptosis in the rd1 retina was only 
detectable between P10-20 and varies significantly across the retina. It is unclear whether the 
difference in the peak of apoptosis between this study and previous publications is due to a change 
in phenotype or purely experimental variability and a low statistical power. A larger sample size 
combined with transcriptional data would yield further information.  
In Crx retinal sections, results from this study showed that TUNEL+ cells were not detectable until 
P50, whilst apoptosis was noted to start from P30 with sparse TUNEL+ cells observed in the 
wholemount retina. A possible explanation may be that the first fast degenerating wave takes only 
about 10 days to complete, whilst the TUNEL+ cells are quickly removed. Hence, sampling at 10-day 
intervals may not be able to capture fast apoptotic activity during this period. Further study with 
more frequent sampling may help to establish a more accurate timeline of the apoptotic activity. 
Examination of the spatial distribution of TUNEL+ cells in rd1 retina revealed that apoptotic cells 
appear in clusters in retinal sections, suggesting interactions between the apoptotic cells during 
degeneration process. The clustering phenomenon was not observed overtly in Crx retinal sections, 
but this may be due to the lower cell density. Indeed further examination of wholemount retinas 
 79 
 
suggested a closer cell-to-cell relationship at P50, suggesting that such interactions may occur in the 
Crx retina as well.  
A unique pattern of rod death, in which holes devoid of cell bodies develop in the retina, has been 
reported in several slow degeneration rodent models (Zhu et al., 2013, Ma et al., 1998). This study 
revealed that this same pattern of rod loss is also present in Crx retina. Although these holes can be 
spotted as early as P50, they are most commonly seen from P80 onwards. A previous study on 
S334ter-line-3 rats revealed an accumulation of TUNEL+ cells followed by a scattering of microglial 
cells in the centre of similarly shaped and sized holes during a limited period of degeneration (Lee et 
al., 2011). The TUNEL+ cells in the holes of the S334ter-line-3 retina were considered to reflect an 
interaction between activated microglia and dying photoreceptors. 
However, in the Crx retina, the highest density of TUNEL+ cells and the closer cell-to-cell relationship 
was observed at P50, whereas the holes were barely seen at this stage but were more frequently 
seen at later stages. Although the spatial relationship observed in S334ter-line-3 rats was not seen in 
Crx retina, it is speculated that the spatial relationship was masked by the concurrent rod and cone 
death and the clustering pattern of TUNEL+ cells in P50 may have contributed to the formation of 
the holes later on. Further studies including studying the specific photoreceptor subtype affected 
may provide a more comprehensive understanding of these cell-to-cell interaction. 
5. Conclusion 
In summary, by comparing the photoreceptor degeneration process in two different mouse models, 
we found that despite a similar fate in the end stages, there was heterogeneity in the pathways 
leading to photoreceptor death. Unlike the rd1 mouse that carries a specific rod mutation, where 
the time course of apoptosis was closely associated with the degeneration process, the Crx retina 
undergo a more complex degenerating process. While it is challenging to study these events in rd1 
retina due to the temporal overlap of development and degeneration periods and the fast 
degeneration process, the prolonged degeneration process in the CRX mouse provides an 
opportunity to view and compare the time course of different events. The following studies in this 
thesis therefore focused on Crx retina, examining the timeline of glial activation in Crx retina and 
investigating its relationship with the fast degenerating phases.  
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Chapter 4. Glial activity is correlated with the 
fast photoreceptor degenerating phases 
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1. Introduction 
As discussed in chapter 1, glial cells play an important role in both the healthy and diseased 
CNS, maintaining homeostasis of the microenvironment and protecting neurons from all 
sorts of potential insults.  
Glial activation is a prominent feature in neurodegenerative diseases including retinal 
degeneration, yet the exact role it plays in the degenerative process remains to be 
elucidated. Glial activation in retinal degeneration is characterized by gliosis and 
neuroinflammation. 
In the retina, gliosis is the term given to the non-specific reactive changes of Müller cells in 
response to insults, usually involving proliferation and/or hypertrophy, with upregulation of 
glial fibrillary acidic protein (GFAP), glutamine synthestase (GS) as well as vimentin. 
Neuroinflammation is an inflammatory process in response to a variety of injuries in the 
nervous tissue, mediated by the innate immune cell, the microglial cell.  
As discussed in Chapter 1, microglial activation is not dependent on the genetic mutation, 
but relies on local and systematic cytokines, while it is also reported that there is 
bidirectional communication between Müller cells and microglial cells that regulate the 
overall response towards insults (Aredo et al., 2015). Hence, fluctuations of the 
microenvironment during the degenerating process might affect both microglial and Müller 
cell activity.  
It was demonstrated in Chapter 3 that photoreceptor degeneration in the Crx retina occurs 
mostly during two fast degenerating waves, with much slower degeneration rate in between 
these two phases. Although the exact mechanism involved in these waves is unclear, it is 
presumed that some yet-to decipher factors may be involved in accelerating photoreceptor 
death. These factors, as well as photoreceptor death, may then shift the local or systemic 
cytokines which may sequentially influence activation of both microglial cells and Müller 
cells.  
This chapter will investigate the characteristics of microglia and Müller cells during 
photoreceptor degeneration in Crx retina and explore the possible correlation between 
these events.  
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2. Specific Methods 
2.1 Animals  
The same cohorts of Crx mice and WT mice that were used in Chapter 3 were also used to 
investigate microglial activation. No less than three mice (one eye per mouse) from each 
strain were included in each time point. 
2.2 Tissue collection and immunohistochemistry  
Iba1 was used to visualise microglial cells. The diameter of a resting microglial cell (including 
its processes) is around 15-30 μm (Torres-Platas et al., 2014). Hence, the thickness of retinal 
sections for examining microglial cells was adjusted to 30 μm. Immunohistochemistry used 
the protocol described in Chapter 2. 
2.3 Microscopy  
Cryostat sections were scanned using a Nikon NiE upright fluorescence semi-automated 
microscope with 40× oil object. Slices were scanned systematically from the dorsal to ventral 
ora serrata, while each field of the images was scanned from the top to the bottom using an 
automated Z drive platform at 3μm intervals. All raw images were then processed using 
ImageJ following the same protocol (background subtraction, Z projection and converting 
into 8 bit) to enhance the images.  
For the GFAP filaments analysis, all the GFAP stained images were converted into black and 
white binary images using ImageJ. Initially, a range of different algorithms for thresholding 
including the default mode, triangle algorithm and mean mode were compared. The 
histogram of GFAP stained images displayed a right skewed distribution, in which the best 
overlap of original image and processed image can be gained using the triangle algorithm 
(Figure 4-1A-D). Next, the correspondence GFAP and DAPI stained image was used to define 
the inner margin, the outer margin and the median line of the retinal section (Figure 4-1E 
and F). The filaments that crossed the median line in the binary images were counted.  
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Figure 4-1 Thresholding methods for GFAP filament counts. 
A: Representative fluorescent micrograph of GFAP staining. B: Binary image obtained using default mode 
(modified IsoData algorithm); C: Binary image obtained using triangle algorithm; D: Binary image obtained using 
mean algorithm. E: The inner margin (red solid line) and outer margin (white solid line) of the retina were defined 
using the overlay image of GFAP staining and DAPI staining. A virtual median line (white dash line) was drawn 
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based on the inner and outer margin. F: The margins defined in overlay image were then applied for GFAP 
filaments analysis. Image was taken from the central area of the retina. Scale bar: 50µm. 
Image processing, cell counting, data analysis and statistics used the same procedures as 
described in Chapter 2. 
3. Results  
3.1 The characteristics of Müller cells and microglial cells in WT and Crx 
retina 
3.1.1 Müller cells and microglial cells in WT retina 
GFAP is an intermediate filament protein expressed in differentiated astrocytes of the 
central nervous system. GFAP is considered to be a stress marker for the CNS and 
upregulation of GFAP in response to injury has been observed in both brain and retina. In 
the healthy retina, GFAP is normally expressed in astrocytes but is absent from Müller cells. 
Under normal physiological conditions, GFAP expression is restricted to within the NFL, 
where the astrocytes are located (Eisenfeld et al., 1984). The results from this study are in 
agreement with previous publications. In both the developing and adult WT retina, intensive 
GFAP expression was found on the vitreal surface of the retinal but nowhere else (Figure 4-2 
B and E).  
In WT retinas, iba+ cells manifested a tiny soma and a ramified structure with large numbers 
of branching processes (Figure 4-2A and D). Their morphology did not change significantly 
between P20-80. By P110, the number and size of ramifying processes had significantly 
decreased. Importantly, iba+1 cells were confined to the inner retina and OPL during the 
entire period studied, which is in agreement with findings of resting microglial cells as 
reported previously (Noailles et al., 2016, Wang et al., 2016).  
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Figure 4-2 Fluorescence micrographs showing the expression of iba1 in WT retinal sections.  
Representative images of retinal section of a P20 and P80 WT retina stained with GFAP, iba1 and DAPI. The 
expression of GFAP was strong near the ILM and highly restricted to the inner surface of the retina (NFL and GCL) 
both in developing and adult retina (B and E). Iba1+ cells exhibited a ramified structure with a tiny soma and 
numerous long processes. They were distributed across all retinal layers excepted for the ONL (A and D). A-C: P20; 
A: iba1; B: GFAP; C: Overlay: blue: DAPI; red: iba1, green: GFAP ; D-F: P80; ; A: iba1; B: GFAP; C: Overlay: blue: 
DAPI; red: iba1, green: GFAP; Scale bar: 50μm. All images were taken from the central retina. 
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3.1.2 The remodelling of Müller cells during degeneration in the Crx 
retina 
 
Figure 4-3 Fluorescent micrograph showing the remodelling of Müller cells in Crx retina 
Representative images of retinal section of Crx retina stained with GFAP at different ages. The expression of GFAP 
was ow and restricted to the vitreal surface (NFL and GCL) during the first postnatal month in the Crx retina (A 
and B). At P40, there is a strong increase in GFAP expression of GFAP, appearing as a thick band at the vitreal 
surface and filaments extending towards the outer retina (C). Expression decreased (band thickness and visible 
filaments) at P60, P90 and P130 (D, E and F). Images were taken from the central area of the retina. Green: GFAP, 
Blue: DAPI. Scale bar: 50µ 
In the Crx retina, the expression of GFAP was restricted to within the vitreal surface of the 
retina at a very low level before P30 (Figure 4-3 A and B). A sharp increase of GFAP 
expression was observed at P40 in the inner retina, in the vicinity of the GCL and NFL, with 
long filaments extending towards the outer retina (Figure 4-3C). An interesting phenomenon 
was that this high expression did not persist with age. Indeed, although the filaments were 
still visible in some areas, expression was significantly reduced at P60, P90 and P130 
compared to P40 (Figure 4-3 D, E and F). The results of the GFAP expression suggested that 
the gliosis in Crx retina did not maintain at a constant level but fluctuated throughout the 
degenerating process.  
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Figure 4-4 Clusters of GFAP+ filaments in the later stages of retinal degeneration in Crx retina. 
Representative images of retinal section of Crx retina stained with GFAP showing clusters of GFAP+ filaments. A: 
P90 Crx retina. Image was taken from central area of the retina. B: P90 Crx retina (the same retina as A). Image 
was taken from periphery area. Clusters of GFAP+ filaments were found to fill into the area devoid of ONL (arrow). 
C: P130 Crx retina. Image was taken from central area of the retina. D: P130 Crx retina (the same retina as C). 
Image was taken from periphery area. Clusters of GFAP+ filaments found in the area devoid of ONL. GFAP+ 
processes were found expanding to the adjacent area and invading the areas that beyond the outer margin 
(arrow). Green: GFAP; Blue: DAPI; Scale bar: 50µm. 
Notably, after P80, when the areas devoid of photoreceptors were frequently detected, 
clusters of GFAP+ filaments were found filling into the photoreceptor-free zones (Figure 4-4 
B and D). Although, the overall GFAP expression tend to be reduced (Figure 4-4 A and C), the 
areas with clusters of filaments presented high expression of GFAP. In the later stages, GFAP 
processes were seen invading the areas that beyond the outer margin. 
Visible GFAP filaments were counted at the different ages. Regardless of retinal eccentricity, 
the changes of filaments counts over age followed a bimodal distribution, with one peak 
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around P40-50, and a second peak at P70. At later stages, the number of filaments 
decreased and remained at a stable, lower level (Figure 4-5). 
 
Figure 4-5 Changes in the number of GFAP+ filament against age in Crx and WT retina. 
The quantitative measurements on the number of GFAP+ filament indicating that the sharp rise of GFAP filaments 
density start after P30 and fluctuated during the degenerating process regardless of retinal eccentricity. A: overall 
number of GFAP+ filaments; B: The number of GFAP+ filaments in the peripheral retinal; C: The number of GFAP+ 
filaments in intermediate retina; D: The number of GFAP filaments in the perioptic nerve. Data seen in Table 4-1. 
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 Table 4-1 The changes of GFAP filament density over age 
When reviewing the changes of GFAP filaments in the retinal sections of Crx retina, clusters 
of GFAP filaments were observed in the areas devoid of photoreceptors as observed in 
Chapter 3, section 3.3.4, Figure 3-14. To further investigate this phenomenon , wholemount 
Crx retinas were used at P70, when the holes of photoreceptors were rarely detected, and at 
P90 when the holes were frequently observed. As shown in Figure 4-6, when double-
labelling with the Müller cells specific marker GS and GFAP in areas without photoreceptor 
holes the end-feet of the GFAP+ filaments were relatively evenly distributed (Figure 4-6 A 
red signal), while the surface marker GS displayed a porous structure. This is in line with the 
structure of the activated Müller cells from a transversal view.  
Strain age n 
Periphery Intermediate Perioptic nerve 
mean 
(μm) 
SEM 
mean 
(μm) 
SEM 
mean 
(μm) 
SEM 
CRX 
 
 
 
 
P10 3 0.000 0.000 0.000 0.000 0.000 0.000 
P20 3 0.774 0.432 2.139 0.711 2.045 0.620 
P30 3 3.875 1.425 7.360 2.013 7.903 2.100 
P40 3 24.250 3.534 29.333 1.700 25.250 1.867 
P50 3 24.395 1.748 27.922 1.649 31.739 1.664 
P60 3 16.308 3.576 16.200 2.617 15.900 1.549 
P70 3 40.500 5.265 38.083 5.672 38.063 4.585 
P80 3 21.750 1.756 22.629 1.867 24.405 1.988 
P90 3 20.652 2.642 11.323 1.580 10.528 1.240 
P100 3 22 5.000 16.000 2.025 17.111 3.089 
P130 3 18.571 3.422 12.154 1.884 12.938 1.270 
WT 
P10 3 0.000 0.000 0.000 0.000 0.000 0.000 
P20 3 0.000 0.000 0.000 0.000 0.000 0.000 
P30 3 0.000 0.000 0.000 0.000 0.000 0.000 
P80 3 1.125 0.295 1.333 0.408 1.583 0.336 
P110 3 0.000 0.000 0.000 0.000 0.000 0.000 
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Figure 4-6 Fluorescent micrographs showing the remodelling of Müller cells into the photoreceptors holes. 
Representative images wholemount Crx retina showing the remodelling of Müller cells associated with the 
formation of photoreceptor holes. Retinas were viewed from the photoreceptor side up. A-C show the distribution 
of Müller cells in the absence of photoreceptor holes visualised by GFAP and GS staining. A: GFAP; B: GS, scale bar 
100µm. D-F show the co-localization of holes formed by Rhodopsin+ cells and the Müller cells clusters using GS 
staining. D: Rhodopsin, E: GS, scale bar 150µm. G-I show the detailed structure of the Müller cell cluster using 
GFAP and GS staining. G: GFAP, H: GS, scale bar 83.35 µm. 
By contrast, in areas with holes, clusters stained with both GS and GFAP were observed co-
localised with the area devoid of rhodopin+ cells (Figure 4-6 D-I). The GS staining presented 
round shapes with processes converging towards the centre, whilst the GFAP staining also 
formed a ‘firework’-like structure (Figure 4-6 G-I). The Double-labelling of GFAP and GS 
confirmed the remodelling of Müller cells to fill into the photoreceptor-free area.  
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3.1.3 The biological characteristics of iba1+ cells during retinal 
degeneration in Crx retina 
In Crx retinas, iba1+ cells had features similar to WT during the first postnatal month. From 
P30 on, some iba1+ cells exhibited a larger soma and a reduction in the number of 
processes. These changes became more pronounced with ageing, and at the same time, 
there was an overt increase in the number of iba+ cells (Figure 4-7). Notably, while iba1+ 
cells were absent in the ONL and subretinal area in WT retinas, in Crx there was infiltration 
of iba1+ cells into the outer retina from P20, prior to the onset of apoptosis (at P30). The 
accumulation of iba1+ cells in the ONL was observed throughout the entire course of 
photoreceptor degeneration.  
 
Figure 4-7 Fluorescent micrograph showing microglial activation in Crx retina 
Representative images of retinal section of Crx retina stained with iba1 at different ages. The expression of iba1 
was very low and restricted in the inner retina in most areas at P20 (A). The infiltration of iba1+ cells into ONL was 
increased slightly at P30 (B). At P40, the number of iba1+ cells increased in both inner and outer retina. The iba1+ 
cells also exhibited an amoeboid structure with large soma and fewer processes (C). The expression of iba1 
maintained at a high level at both P60 (D) and P90 (E) and were largely reduced at P130 (F).  
In the WT retina, microglial cells exhibit a classic ramified structure (Figure 4-8 A and B) with 
a tiny soma and long, thin processes. Upon activation, they undergo pronounced 
morphological changes in addition to migration and proliferation (Figure 4-8). Transverse 
sections reveal that microglial cells in the inner retina exhibit a dendritic shape with their 
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enlarged somata located within the INL, while numerous short branches emanate from the 
cell body in the IPL and OPL respectively (Figure 4-8 C and D).  
In the ONL, the infiltrated microglial cells presented a similar dendritic structure as the cells 
seen in the INL, except that they extended abundant processes towards the OPL, and fewer 
processes towards the RPE (Figure 4-8 E-F). However, the vertical alignment of these cells 
relied on the architectural support of photoreceptors, and therefore, such vertical alignment 
disappeared after P80 with the depletion of photoreceptors. 
Notably, iba1+ cells with unique morphology were present on the surface of the RPE (Figure 
4-8 G and H). Different from iba1+ cells seen in the inner retina and ONL, these cells had an 
elongated soma without processes.  
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Figure 4-8 Representative micrographs of microglial cells in WT and Crx retina. 
The micrographs display the morphological change of microglial cells from resting mode to activated status. In 
WT retina, microglial cells are restricted within the inner retina presenting a ramified structure with a tiny soma 
and numerous long branched processes (A and B). In the inner retina, activated microglial cells appear a dendritic 
shape in a vertical position with enlarged soma and short branches on both side (C and D). Infiltrated microglial 
cells were also seen in the ONL, which also present in a vertical, dendritic shape with enlarged soma and short 
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branches (E and F). A small amount of iba+ cells were seen in the subretinal space, exhibiting a tapered soma with 
no processes.  
3.2 The distribution of iba1+ cells during retinal degeneration 
To quantify changes in iba1+ cells numbers over time, the number of iba1+ cells in the inner 
and outer retina were counted separately. The density of iba1+ cells was initially estimated 
using the relative number of cells per retinal length, without taking changes in retinal 
thickness into account.  
3.2.1 The distribution of microglial cells in Wt retina  
Results obtained from WT retinas were in agreement with previous studies (Paolicelli et al., 
2011, Li et al., 2015) (Figure 4-9, dash lines). The average density of iba1+ cells in the inner 
retina was at a low level at P10 and then increased by five times at P15. The density of iba1+ 
cells dropped dramatically between P15-20, and the iba1+ cell density was decreased by half 
at P20. Notably, the high level of iba+ cell density at P15 may be attributed to a transient 
accumulation of iba1+ cells in the OPL, which may relate to synaptic pruning during 
development (Tremblay et al., 2010, Schafer et al., 2012). After P30, the incidence of iba+1 
cells did not change significantly, with only a slight decrease over three months, which is in 
agreement with previous studies (Karlstetter and Langmann, 2014). No iba1+ cells were 
detected in the ONL at any age in WT retinas.  
3.2.2 The distribution of microglial cells in Crx retina  
At P10, the density of iba1+ cells in the Crx inner retina was significantly higher than in WT 
(Two way anova: strain vs location, effect of the strain: p = 0.000), indicating that the 
microglial activity may have already shifted at this stage. Notably, the dramatically 
fluctuation of iba1+ density in the WT inner retina between P10-30 was not observed in the 
Crx retina. Instead, the iba1+ cell density was decreased by half between P10-15, and 
maintained at a similar level as it was in adult WT retina from then on (Figure 4-9, solid blue 
lines). Although there was a significant decrease in the incidence of iba1+ cells in the Crx 
inner retina at early postnatal stages, differences were much more pronounced in the outer 
retina. At P10, no iba+1 cells were detected in the ONL. At P20, however, few cells were 
detected, and their incidence increased between P20-30 and presented in a fluctuating 
manner during degeneration until P100 (Figure 4-9, red solid lines).  
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Figure 4-9 Changes in iba1+ cell density with age in Crx and WT retina 
The line graphs display the change of iba1+ cell density in Crx and WT retina at different locations. The number of 
iba1+ cells were normalised by the length of the retinal section to obtain a density per unit retinal length (µm). A: 
Overall density of iba1+ cells against age; B: Density of iba1+ cells in periphery against age; C: Density of iba1+ 
cells in intermediate area; D: Density of iba1+ cells in perioptic area against age. Data points: Mean; Error bar: 
SEM; n = 3 at each time point. Data shown in Table 4-2 and Table 4-3. 
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 Table 4-2 Density of iba1+ cells in the inner retina of Crx and WT retina 
Strain age n 
Periphery Intermediate Perioptic nerve 
mean  
(cells/mm) 
SEM 
mean  
(cells/mm) 
SEM 
Mean 
 (cells/mm) 
SEM 
CRX 
 
 
 
 
P10 3 19.969 19.969 19.969 19.969 19.969 19.969 
P20 3 12.092 12.092 12.092 12.092 12.092 12.092 
P30 3 11.931 11.931 11.931 11.931 11.931 11.931 
P40 3 8.359 8.359 8.359 8.359 8.359 8.359 
P50 3 5.896 5.896 5.896 5.896 5.896 5.896 
P60 3 11.481 11.481 11.481 11.481 11.481 11.481 
P70 3 11.159 11.159 11.159 11.159 11.159 11.159 
P80 3 11.181 11.181 11.181 11.181 11.181 11.181 
P90 3 8.729 8.729 8.729 8.729 8.729 8.729 
P100 3 11.188 11.188 11.188 11.188 11.188 11.188 
P130 3 3.331 3.331 3.331 3.331 3.331 3.331 
WT 
P10 3 7.500 1.100 10.100 2.500 8.400 2.100 
P20 3 18.500 2.300 22.800 2.100 24.300 2.100 
P30 3 12.000 2.000 12.300 1.100 11.500 1.000 
P80 3 6.800 1.800 8.200 1.700 6.800 1.600 
P110 3 6.500 1.000 5.900 1.100 7.800 0.700 
Table 4-3 Density of iba1+ cells in the outer Crx retina 
age n 
Periphery Intermediate Perioptic nerve 
mean  
(cells/mm) 
SEM 
mean  
(cells/mm) 
SEM 
Mean 
 (cells/mm) 
SEM 
P10 3 0.000 0.000 0.000 0.000 0.000 0.000 
P20 3 1.167 1.167 1.167 1.167 1.167 1.167 
P30 3 3.231 3.231 3.231 3.231 3.231 3.231 
P40 3 7.533 7.533 7.533 7.533 7.533 7.533 
P50 3 4.224 4.224 4.224 4.224 4.224 4.224 
P60 3 11.310 11.310 11.310 11.310 11.310 11.310 
P70 3 3.626 3.626 3.626 3.626 3.626 3.626 
P80 3 9.255 9.255 9.255 9.255 9.255 9.255 
P90 3 4.974 4.974 4.974 4.974 4.974 4.974 
P100 3 3.257 3.257 3.257 3.257 3.257 3.257 
P130 3 0.000 0.000 0.000 0.000 0.000 0.000 
Note: The iba1+ cells were absent in the outer retina of WT mouse. 
Due to the variation of ONL thickness with age and the dynamic nature of microglial cells, it 
is not clear whether these fluctuations were caused by thinning of the ONL thinning or by 
changes in microglial activity. While the initial analysis did not take the ONL thickness into 
account, the density of iba1+ cells was then corrected by the corresponding area size. Figure 
4-10 and Figure 4-11 shows the results after correction. Results from WT retinas were similar 
to those before correction. In Crx retinas, the overall density of iba1+ cells showed a bimodal 
curve in both inner and outer retinas (Figure 4-10A and Figure 4-11A, blue lines). In the outer 
retina, the first peak appears around P40, followed by a 40% drop. The density of iba1+ cells 
rose again after P50, and reached peak values at P70 in the inner retina and at P80 in the 
outer retina. Later on, the density of iba1+ cells showed a downward trend in all areas, 
though in the outer retina it continued to be higher than at early stages of degeneration. The 
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density of iba1+ cells in inner and in the outer retina maintained at a low level after P90, and 
these changes were concurrent in the inner and outer retina.  
 
Figure 4-10 Change in iba1+ cell density in the inner Crx and WT retina with age after correction by area size.  
The line graphs display the change of iba1+ cell density in Crx and WT retina at different locations after correction 
by the area size of the inner retina. Unit: Cell per µm2. A: Overall density of iba1+ cells against age; B: Density of 
iba1+ cells in periphery against age; C: Density of iba1+ cells in intermediate area; D: Density of iba1+ cells in 
perioptic area against age. Data points: Mean; Error bar: SEM; n = 3 at each time point. Data seen in Table 4-4. 
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Table 4-4 Density of iba1+ cells in the inner retina of Crx and WT retina after correction 
Strain age n 
Periphery Intermediate Perioptic nerve 
mean (× 10-
2/µm2) 
SEM 
mean (× 10-
2/µm2) 
SEM 
mean (× 10-
2/µm2) 
SEM 
CRX 
 
 
 
 
P10 3 2.511 2.511 2.511 2.511 2.511 2.511 
P20 3 1.290 1.290 1.290 1.290 1.290 1.290 
P30 3 1.321 1.321 1.321 1.321 1.321 1.321 
P40 3 0.902 0.902 0.902 0.902 0.902 0.902 
P50 3 0.785 0.785 0.785 0.785 0.785 0.785 
P60 3 1.493 1.493 1.493 1.493 1.493 1.493 
P70 3 2.002 2.002 2.002 2.002 2.002 2.002 
P80 3 1.631 1.631 1.631 1.631 1.631 1.631 
P90 3 1.249 1.249 1.249 1.249 1.249 1.249 
P100 3 1.369 1.369 1.369 1.369 1.369 1.369 
P130 3 0.606 0.606 0.606 0.606 0.606 0.606 
WT 
P10 3 0.968 0.078 1.144 0.320 0.831 0.192 
P20 3 1.944 0.249 2.067 0.142 2.055 0.162 
P30 3 1.489 0.205 1.246 0.116 1.036 0.089 
P80 3 0.788 0.214 0.807 0.153 0.605 0.144 
P110 3 0.799 0.117 0.526 0.100 0.731 0.076 
 
Figure 4-11 Change in iba1+ cell density in the outer Crx and WT retina with age after correction by area size. 
The line graphs display the change of iba1+ cell density in Crx and WT retina at different locations after correction 
by the area size of the inner retina. Unit: Cell per µm2. A: Overall density of iba1+ cells against age; B: Density of 
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iba1+ cells in periphery against age; C: Density of iba1+ cells in intermediate area; D: Density of iba1+ cells in 
perioptic area against age. Data points: Mean; Error bar: SEM; n = 3 at each time point. Data seen in Table 4-5 
Table 4-5 The density of iba1+ cells in the outer retina of Crx miceafter correction 
age n 
Periphery Intermediate Perioptic nerve 
mean (× 10-
2/µm2) 
SEM mean (× 10-
2/µm2) 
SEM mean (× 10-
2/µm2) 
SEM 
P10 3 0.000 0.000 0.000 0.000 0.000 0.000 
P20 3 0.214 0.214 0.214 0.214 0.214 0.214 
P30 3 0.696 0.696 0.696 0.696 0.696 0.696 
P40 3 1.918 1.918 1.918 1.918 1.918 1.918 
P50 3 1.189 1.189 1.189 1.189 1.189 1.189 
P60 3 3.205 3.205 3.205 3.205 3.205 3.205 
P70 3 2.060 2.060 2.060 2.060 2.060 2.060 
P80 3 5.177 5.177 5.177 5.177 5.177 5.177 
P90 3 2.506 2.506 2.506 2.506 2.506 2.506 
P100 3 1.894 1.894 1.894 1.894 1.894 1.894 
P130 3 0.000 0.000 0.000 0.000 0.000 0.000 
Note: The iba1+ cells were absent in the outer retina of WT mouse. 
As has been described earlier, there was a subset of unique iba1+ cells with a flattened soma 
on the surface of RPE, in the subretinal space. To quantify the presence of those cells over 
time, their numbers were analysed separately. As shown in Figure 4-12(red lines), in WT 
retina, a very small number of these iba1+ cells were detected within the first postnatal 
month, and they were present only in the subretinal space in peripheral areas , which is in 
line with the previous publications indicating that BM derived microglial cells enter the 
retina via the retinal margin and blood vessels in the ciliary body during development 
(Santos et al., 2008, Jin et al., 2016).  
As for the Crx retina, more of these iba1+ cells were seen in the subretinal space in central 
than in peripheral areas (Figure 4-12, blue lines). Furthermore, the presence of these cells 
fluctuated in line with the degeneration wave and microglial activity, suggesting that the RPE 
may be a route for the BM derived microglial cells from choroid to enter the subretinal space 
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in response to photoreceptor degeneration. 
 
Figure 4-12 The changes in the number of iba1+ cells in the subretinal space. 
The line graphs display the change of iba1+ cell density in the subretinal space in Crx and WT retina at different 
location. Unit: Cell per µm. A: Overall number of iba1+ cells against age; B: The number of iba1+ cells in periphery 
against age; C: The number of iba1+ cells in intermediate area; D: The number of iba1+ cells in perioptic area 
against age. Data points: Mean; Error bar: SEM; n = 3 at each time point. Data seen in Table 4-6. 
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Table 4-6 The number of iba1+ cells in the subretinal space in Crx retina 
age n 
Periphery Intermediate Perioptic nerve 
mean ((× 10-3 
cells/mm) 
SEM mean ((× 10-3 
cells/mm) 
SEM mean ((× 10-3 
cells/mm) 
SEM 
P10 3 0.000 0.000 0.000 0.000 0.000 0.000 
P20 3 0.000 0.000 0.360 0.212 0.708 0.242 
P30 3 0.643 0.388 1.460 0.587 2.387 0.566 
P40 3 0.000 0.000 0.358 0.358 0.000 0.000 
P50 3 0.411 0.117 1.324 0.257 2.150 0.246 
P60 3 0.000 0.000 0.838 0.374 1.174 0.524 
P70 3 0.338 0.338 0.280 0.280 0.202 0.202 
P80 3 0.337 0.189 0.263 0.147 0.236 0.178 
P90 3 0.273 0.188 0.307 0.226 0.170 0.170 
P100 3 0.000 0.000 0.000 0.000 0.368 0.368 
P130 3 0.000 0.000 0.237 0.237 0.183 0.183 
3.3 The association between microglial activity, gliosis and photoreceptor 
degeneration in Crx retina. 
In order to further investigate the relationship between photoreceptor degeneration, 
microglial activity and gliosis, the time course of these events were reviewed and compared.  
3.3.1 The association between microglial activity and photoreceptor 
degeneration. 
Results presented so far in this chapter demonstrate that there are two waves of microglial 
activation in the outer retina, and the distribution of iba+1 cells is correlated with 
photoreceptor degeneration activity. To explore this correlation further, changes in iba1+ 
cells density in the outer retina were compared with changes in ONL thickness. Figure 4-13A 
suggests that the changes in iba1+ cell density occurred simultaneously with ONL thinning. 
The first increase in iba1+ cells occurred during the first wave of photoreceptor 
degeneration, followed by a 40% drop by the end of that period. The incidence of iba1+ cells 
then dropped to its lowest values around P50, coinciding with a period of slowing down of 
ONL thinning. The second wave of photoreceptor degeneration (starting around P60) 
triggered another increase in the incidence of iba1+ cells, followed by a sharp drop at the 
end of that second degeneration wave, by P80. The correlation between iba1+ cell density 
and ONL thickness was calculated from scatter plots of mean values of density of iba1+ cells 
against mean ONL thickness. Data from the two degeneration were analysed separately 
(Figure 4-13B and C). Pearson correlation analysis was used to calculate the correlation 
between these two variables, showing that there was a strong, negative correlation between 
ONL thickness and the density of iba1+ cells. 
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Figure 4-13 Correlation between ONL thinning and microglial activation during retinal degeneration. 
A: displays the time course of iba1+ cell density in the outer retina and ONL thinning. B: Correlation of ONL 
thickness against density of iba1+ in outer retina between P10-40. Each dot represent the data from one animal 
and the red line presents the best fit line of the data points. Pearson correlation: r = -0.8066, n=15, p<0.01. C: 
Correlation of ONL thickness against density of iba1+ in outer retina between P50-80. Each dot represents the 
data from one animal and the red line presents the best fit line of the data points. Pearson correlation: r = -
0.8872, n=10, p<0.01. 
3.3.2 The association between gliosis and photoreceptor degeneration. 
The results from GFAP filaments also suggested a bimodal distribution during the 
degenerating process. The timeline of gliosis and photoreceptor loss were therefore 
compared to determine whether gliosis coincided with photoreceptor degeneration. 
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Figure 4-14 Correlation between ONL thinning and gliosis during retinal degeneration. 
A: displays the changes in ONL thinning and the GFAP filaments over age. B: Correlation of the number of GFAP 
filaments and ONL thickness between P10-40. Each dot represent the data from one animal and the red line 
presents the best fit line of the data points. Pearson correlation: r = -0.7873, n=15, p<0.01. C: Correlation of the 
number of GFAP filaments and ONL thickness between P50-80. Each dot represent the data from one animal and 
the red line presents the best fit line of the data points.. Pearson correlation: r = 0.3895, n=10, p = 0.1932. 
Figure 4-14A reveals that the first wave of GFAP+ filaments rose rapidly and overlapped with 
the first photoreceptor degeneration wave. However, the high level of GFAP+ filaments was 
maintained during the first half of the period when the photoreceptor loss slowed down, 
and dropped during the second half of that period. The second rise of GFAP+ filaments level 
occurred between P60-80, coinciding with the second degeneration wave. Pearson analysis 
revealed that there is a significant, negative correlation between ONL thickness and gliosis 
activity between P30-40, however, this effect was not seen at P50-80. 
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3.3.3 The association between microglial activity and gliosis  
Results from Müller cells and microglial activity indicate that both events presented a 
bimodal distribution during the degenerating process. To further investigate the 
spatiotemporal relationship between these two events, the timeline of microglial activity 
and Müller glial activity were compared.  
 
Figure 4-15 Correlation between microglial activity and gliosis during retinal degeneration. 
A: displays the changes in the number of iba1+ cell in the outer retina and the GFAP filaments over age. B: 
Correlation of the number of GFAP filaments and iba1+ cells in outer retina between P10-40. Each dot represent 
the data from one animal and the red line presents the best fit line of the data points. Pearson correlation: r 
=0.9525, n=15, p<0.01. C: Correlation of the number of GFAP filaments and iba1+ cells in outer retina between 
P50-80. Each dot represent the data from one animal and the red line presents the best fit line of the data points. 
Pearson correlation: r = 0.3895, n=10, p = 0.2659. 
As can be seen in Figure 4-15A, the peak of microglial activity coincided with the Müller 
gliosis activity. However, these events correlated significantly only between P10-40 (Figure 
4-15B), during the first wave of degeneration, but not during the second wave, between 
P50-80 (Figure 4-15C).  
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4. Discussion 
In this chapter, the characteristics of resting and activated Müller cells and microglia were 
demonstrated by comparing GFAP filaments and the distribution and morphology of iba1+ 
cells in WT and Crx retinas. The results show that in the Crx retina, microglial activity is 
temporally correlated with photoreceptor degeneration. While there was also an intimate 
relationship between microglial activity and Müller gliosis during the first degeneration 
phase, this relationship disappeared at later stages of degeneration. 
4.1 Remodelling of Müller cells during photoreceptor degeneration in the 
Crx retina. 
Changes in the level of Müller gliosis were evaluated using the sensitive stress marker GFAP. 
In the healthy retina, GFAP is primarily expressed by astrocytes and its expression is 
restricted to low levels within the NFL (Eng, 1985). Upregulation of GFAP expression in 
response to insults is known to be a hallmark of Müller gliosis, characterised by the 
extension of GFAP+ filaments into the outer retina and the formation of glial scar, which 
have been reported in a wide range of retinal degenerative diseases including inherited 
photoreceptor degeneration. It is reported that, in rd1 mouse, the elevation of GFAP 
expression increases from the start of photoreceptor death and decreases during the 
subsequent cone degeneration phase (Chua et al., 2013). Recent findings revealed that there 
is variation of Müller gliosis levels among different RP models and the response is disease-
specific (Hippert et al., 2015) 
The results on WT retina from this study are in line with previous findings. However, in the 
Crx retina, although the extension of GFAP+ filaments was observed along with the 
photoreceptor degeneration process, there was variation in gliosis location in terms of 
retinal eccentricity and timing during the degeneration process.  
In the Crx retina, activated Müller cells exhibited two morphological forms. During the 
earlier degeneration stages, activated Müller cells had long GFAP+ filaments extending 
towards the outer retina, while at later stages when there were increasing numbers of 
photoreceptor “holes” with clusters of firework-like structures co-localising within these 
holes. Whilst fluctuation in GFAP expression was observed in the extended filaments, GFAP 
expression in those clusters was sustained once they formed. 
The formation of GFAP+ clusters in the photoreceptor ‘holes’ has been reported in other RP 
models as well, for example in the S334ter-line-3 rat (Ji et al., 2014, Lee et al., 2011) and 
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P23H rat (Fernandez-Sanchez et al., 2015). Results from this study revealed that in Crx 
retina, such Müller cell remodelling is associated with rod migration rather than with cone 
migration in RP models, where rods die before cones. In the Crx retina, rods and cones die 
concurrently and the rods remain well preserved during the later stage. Hence, the similarity 
in Crx and RP models is that in both cases, Müller cells clusters appear only at late 
degeneration stages, although in RP there is cone migration whereas in Crx, rod migration 
dominates. One hypothesis is that this type of remodelling may be mediated by a unique 
factor released along with the focal photoreceptor depletion. Further investigation on the 
crosstalk between Müller cells and photoreceptors may shed some light on the mechanisms 
of the remodelling process.  
4.2 The characteristics of resting microglial cell. 
As described in section 5.3 of Chapter 1, there are numerous surface markers and proteins 
available to label microglial cells. In this study, they were visualised with iba1, which stains 
all microglial cells, regardless of their activation status and origins. Hence, iba1+ cells 
represent the entire microglial population, including both innate and extrinsic microglial 
cells. Although iba1 labelling does not discriminate between resting and reactive microglia, 
the precise morphology of iba1+ cells can help to determine the status of the cells.  
The morphology of iba1+ cells observed in WT retina is consistent with the ramified 
structure of resting microglial cells illustrated in previous studies (Kierdorf and Prinz, 2017, 
Nimmerjahn et al., 2005), characterised by a tiny soma and numerous branching processes. 
This morphology is maintained from 1-3 months postnatal. Notably, fewer processes were 
observed in iba1+ cells from P110, which might be a sign of priming. However, the 
expression of MHC II, as well as transcriptional approaches, may be required in order to 
unequivocally determine the priming status. 
The distribution of iba1+ cells in WT retinal layers is also in agreement with the previous 
publication on resting microglia (Chen et al., 2002). Iba1+ cells are found in small numbers, 
exclusively in the layers between GCL and OPL), but never in the ONL. Notably, the density of 
iba1+ cells in the inner retina is relatively high during the first postnatal month, but then 
decreases beyond P30. In addition, a wave of microglial cells accumulating at the OPL was 
observed during the second postnatal week, which was in agreement with the previous work 
on the microglial distribution during development (Santos et al., 2008). As demonstrated in 
Section 5.2.1.1 of Chapter 1, microglial cells contribute to regulating the development of 
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synaptic connectivity during retinal development. The high incidence of microglial cells 
during early development is thus consistent with earlier findings.  
4.3 The characteristics of Microglial cells during photoreceptor 
degeneration in the Crx retina 
Microglial activation has been widely demonstrated in neurodegenerative diseases including 
inherited retinal degenerations (Brites and Vaz, 2014, Minett et al., 2016, Zeng et al., 2005). 
Results from this study are in line with previous studies of microglial activation during 
photoreceptor degeneration. Indeed, iba1+ cells in the Crx retina underwent morphological 
changes (from ramified to amoeboid structure) and infiltrated the outer retina with the 
progression of photoreceptor degeneration.  
Notably, in this study, another source of microglial recruitment was also found in the space 
between RPE and the photoreceptor outer segments. These cells displayed a monocyte 
structure which was distinct from the structure of microglial cells in the neural retina. This 
peculiar structure and location may suggest a separate source of those cells, e.g.: bone 
marrow derived macrophage (BMDM). (Yang et al., 2014) (Benhar et al., 2016) 
BMDM recruitment has also been reported in AMD models, in which the onset was prior to 
RPE apoptosis. It is suggested that, through direct contacting, the BMDMs not only enhance 
the RPE loss directly by phagocytosis, but also increase the susceptibility of RPE to apoptosis 
(Devarajan et al., 2016). In this study, the presence of these cells was correlated with the 
changes in microglial activity within the neural retina, but was more intense in the central 
area than in the periphery, which may be related to the more intense degeneration in the 
central area. The interaction with RPE was not investigated, however, the timeline of 
recruitment found in this study may indicate that it is a secondary process to the changes in 
the neural retina. Further investigation on the association between the infiltrated microglial 
cells and RPE may shed some light into the understanding on the disease progression. 
Furthermore, retinas were investigated at a 10 day intervals that spanned the major period 
of photoreceptor degeneration. The results provide a more detailed timeline of microglial 
activation during photoreceptor degeneration compared to previous studies. In the Crx 
retina, an increase of iba1+ cell density in the inner retina was initially observed as early as 
P10. Furthermore, microglial infiltration into the ONL was already detected as early as 
around P20, in agreement with previous findings on the upregulation of microglial-specific 
transcripts in the pre-degenerative phase (Gehrig et al., 2007).  
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Another interesting finding of microglial activity in the developing Crx retina is that the 
density of iba1+ cells in the inner Crx retina is much lower than it is in the WT retina 
between P15-20 (See Section 2.6 of Appendix). As discussed earlier, the increase of 
microglial density in the WT retina may relate to the development of synaptic connectivity, 
and early neural activity such as visual experience at eye opening (occurring at P12) may be 
crucial to the regulation of microglial activity. However, in the Crx retina, the mutations 
result in the failure of elaborating the outer segments of photoreceptors, which leads to a 
complete lack of light response and may result in low microglial activity levels. Further 
investigation on the development of synaptic connectivity in Crx retina may provide further 
insights on the role of microglial regulation in the establishment of synaptic connectivity.  
4.4 The correlation between Müller gliosis, microglial activation and 
photoreceptor degeneration in Crx retina. 
Photoreceptor death, Müller gliosis and microglial activation are the common events found 
in almost all types of outer retinal dystrophies, while how those events interact with each 
other remains to be elucidated.  
It is suggested that in RP, the initial change is that the genetic defects lead to oxidative stress 
which triggers the alteration of surface proteins in the photoreceptors. These stressed yet 
viable cells sequentially elicit the initial microglial activation and attract microglial cells to 
migrate into the outer retina. 
The exact sequence of photoreceptor death and microglial activity seems to be variable 
between disease models. A previous study on the sequential events in the rd1 retina 
demonstrated that changes in microglial density in the outer retina during degeneration 
followed a unimodal temporal distribution, with peak density occurring before the peak of 
apoptosis (Zeng et al., 2005). The authors hypothesized that microglial cells may be an 
instigator of photoreceptor degeneration, however, the results from another study in the rds 
retina seem to be contradictory to this assumption. Indeed, although changes in microglial 
density also followed a unimodal temporal distribution, peak microglial activation occurred 
at least 5 days after the peak of apoptosis (Hughes et al., 2003).  
In this study, we observed a bimodal temporal distribution in the microglial density in the 
outer Crx retina. The first peak occurred at P40 and the second peak, at P80. The Crx retina 
has a more severe genetic defect, which affects both rods and cones and the degenerative 
process is much slower than for both the rd1 and rds models, which provides us with a much 
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broader temporal margin to investigate and detect various changes. In the Crx retina, 
photoreceptor death peaks around P50-70, which is exactly in-between the two peaks of 
microglial activity. Comparison of the correlation of apoptosis and microglial activity 
between these studies suggests that the latter events may not be directly triggered by 
apoptosis. Our study further revealed that there was a clear temporal relationship between 
microglial activation and the rate of photoreceptor degeneration. Microglial activity 
decreased when the degenerating process slowed between P40-60. These results indicate 
that there might be an as yet unknown factor that controls microglial activation during the 
fast degenerating phase, whilst this factor is downregulated between the degeneration 
waves. 
Whilst there was a strong negative correlation between photoreceptor degeneration rate 
and microglial activity during both degeneration waves, significant correlation between 
Müller gliosis and other events was detected only the first wave of PR degeneration, but not 
during the second one. 
As described earlier, there were two forms of Müller gliosis, 1) the extension of GFAP+ 
filaments, which fluctuated along the degeneration process; 2) the formation of firework-like 
GFAP+ clusters in the later stages, which persisted once formed. Hence, it is hypothesized 
that the disappearance in the correlation between Müller gliosis and other events may be 
attributed to the formation of clusters, which is considered to be an irreversible change. 
Müller gliosis is usually considered to be a response towards injury and is assumed to be 
induced by photoreceptor death in retinal dystrophies (Chua et al., 2013). However, 
previous evidence from models of acute retinal degeneration indicate that the extension of 
Müller filaments may be the guide by activated microglial cells via physical interaction 
(Wang et al., 2011). The extended filaments may serve as scaffolds for microglial cells to 
translocate to the lesion site. Microglial cells show great plasticity in response towards 
changes in the retinal micro-environment and regulate Müller cell activity via neurotrophic 
factors such as nerve groWTh factor (NGF) and glial cell line-derived neurophic factor 
(Harada et al., 2002). Meanwhile, Müller cells may in turn feedback onto microglial cells via 
the TSPO-DBI pathway which reshapes the orientation of microglial processes (Wang et al., 
2014). It is proposed that there is dynamic bidirectional communication between Müller 
cells and microglial cells, which displays huge variation among different pathological 
conditions. This variation may be an explanation for the disparity in the outcomes of the 
migration and integration of stem cells post transplantation (Barber et al., 2013). Elucidating 
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the exact regulatory mechanism will not only help understanding the disease progress, but 
will also give information on the optimum time windows for therapeutic approaches.  
Furthermore, results from this study indicate that, dying photoreceptors during the fast 
degenerating waves may lead to an accumulation of other chemokines that amplify the 
inflammatory activity. However, it is unclear whether the exaggerated microglial activity 
could also accelerate photoreceptor degeneration and Müller gliosis. Another important 
question that needs to be clarified is whether the mechanisms involved in microglial 
activation are similar during the entire degeneration period, or whether microglial cells 
undertake different roles at different degeneration stages. Further experimental approaches 
to manipulate these factors during the degeneration process may shed light on the 
mechanisms underlying interactions between microglial activation and photoreceptor death.  
5. Conclusion 
In summary, by comparing the timeline of different events during photoreceptor 
degeneration in the Crx retina, we found that apoptosis seems to be independent from the 
fast degeneration waves and microglia activation, suggesting that trying to slow down 
apoptosis may not be an effective therapeutic strategy. By contrast, the synchronicity of 
microglial activation and photoreceptor degeneration presents a promising target for 
protecting photoreceptors. We propose a microglia-based explanation to photoreceptor 
degeneration and Müller gliosis based on our findings (Figure 4-16). However, it remains to 
be demonstrated whether microglial activation will ameliorate or exacerbate the 
degeneration process. In the following chapter, we study the effects of Neurostatin, a 
microglia inhibitor, on retinal degeneration in an isolated Crx retina model. 
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Figure 4-16 Pathological events during photoreceptor degeneration in the Crx retina 
Upper panel: Timeline plot of degeneration generated from our experimental observations. The phases defined as 
fast degenerating waves are highlighted. 
Lower panel: Proposed interaction between photoreceptors, microglial cells and Müller cells. Stressed 
photoreceptors send signals to microglial cells via altering the surface protein PS and transform microglial cells 
into the activating mode. Upon activation, microglial cells remove apoptotic cells via phagocytosis, however, they 
can also attack and remove stressed but viable photoreceptors directly via another process called phagoptosis. 
Microglial cells can accelerate degeneration via releasing proinflammatory factors such as IL-1β, TNFα, but also 
show protective effect via releasing anti-inflammatory factors such as IL-4, IL-13. During the process, a 
bidirectional Müller-microglial communication is also set via both releasing and receiving inflammatory factors. 
Meanwhile, microglial cells modulate the outgroWTh of Müller filaments via releasing factors such as BDNF, 
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whilst Müller cells can also regulate microglial activity via TSPO signalling. PS: phosphatidylserine; PR: 
photoreceptor; APR: apoptotic photoreceptor; MC: microglial cell; MG: Müller glia. 
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Chapter 5. Pharmacological Inhibition of 
Microglia Cells in Isolated Retina 
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1. Introduction 
The studies outlined in Chapter 3 and Chapter 4 have shown that photoreceptor degeneration in 
the Crx retina occurs in two main waves, and that strong microglial activation and Müller gliosis 
occur at the same time, suggesting an intimate relation between these events. The exact 
mechanism of this interaction remains to be elucidated. Evidence has shown that glial activation 
is not merely a reactive response towards disease, but can also result in neural cell death via 
either phagoptosis (phagocytosing viable neurons ) or via the release of cytotoxic factors that 
induce cell death (Flight, 2013, Brown and Neher, 2012, Madeira et al., 2015).  
In acute conditions such as infection, activated microglial cells are responsible for phagocytosing 
pathogens and removing dead neurons to protect the remaining neurons from further damage 
(Zinkernagel et al., 2013). The contribution of microglial cells during this stage is considered to 
be protective. By contrast, in chronic disease like retinal degeneration, although high level of 
anti-inflammatory cytokines such as interleukin – 10(IL-10) have been detected during the 
photoreceptor death phase (Noailles et al., 2016), microglial cells are considered to be cytotoxic 
in the long term. Hence, microglial activation is considered to be detrimental in chronic 
neurodegenerative diseases.  
However microglia also play an essential role in the maintenance of functional integrity in both 
developing and adult retina, and the complete depletion of these cells can be detrimental, 
leading to the degeneration of photoreceptor synapses and progressively impaired light 
responses (Wang et al., 2016). Therefore, selectively inhibiting pro-inflammatory pathways, but 
at the same time without blocking essential physiological function would be the ideal approach 
to reduce microglia-mediated photoreceptor death and mediate gliosis level. IL-15, the pro-
inflammatory cytokine, plays a key role in regulating inflammatory events in the CNS by 
controlling the response of T and B cells (Gomez-Nicola et al., 2010). It has been reported that 
overexpression of either endogenous or exogenous IL-15 can lead to infiltration of macrophage 
and T cells in neurodegenerative disease and trigger a series of inflammatory events such as 
activation of the NF-kB pathway and the mitogen-activated protein kinase (MAPK) pathway 
ERK1/2 and p38 (Gomez-Nicola et al., 2008, Gomez-Nicola et al., 2010, Ren and Dubner, 2010). 
Neurostatin, the O-acetylated form of a sialic acid also called ganglioside, can bind IL-15 with 
high affinity and therefore inhibit the sequential cascade of inflammation. Neurostatin was 
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previously reported to selectively inhibit glial activation without disturbing physiological 
function in a mouse model of drug induced glaucoma (Ganesh and Chintala, 2011). 
This chapter presents the results of in vitro effects of Neurostatin on microglial activation at 
different stages of degeneration in the Crx retina. 
2. Specific Methods 
2.1 Animals and procedures 
To test the efficacy of Neurostatin on inhibiting microglial activation, isolated P10 and P40 Crx 
retinas were incubated with Neurostatin in oxygenated artificial cerebrospinal fluid (aCSF). We 
performed these experiments at P10 and P40 because these ages correspond to the pre-
activation phase and the activation phase respectively (see Chapter 4). For each animal, one eye 
was used for Neurostatin incubation, and the other was incubated with plain aCSF as a control. 
No less than three Crx mice (one eye per animal) were included for each time point. Two WT 
mice were incubated with plain aCSF using the same protocol to test whether the mere 
incubation period can induce an inflammatory reaction.  
Following cervical dislocation, the eyes were enucleated and kept submerged in a petri dish 
filled with aCSF (118 mM NaCl,1 mM NaH2PO4, 25 mM NaHCO3, 3mM KCL, 1 mM MgCl, 2 mM 
CaCl2 and 10 mM glucose) continuously bubbled with 95% O2 and 5% CO2. The cornea and lens 
were gently removed using micro-scissors. Neurostatin shows high affinity to bind IL-15 at 
concentrations ranging from 200 nM to 5 mM. We chose to use a concentration of 500 nM 
Neurostatin prepared freshly in oxygenated aCSF on the day of the experiment. The eyecups 
were moved to a 20 ml centrifuge tube with 6 ml of either drug solution or plain aCSF for 
incubation. The eyecups were incubated in the centrifuge tube, equilibrating with 95% O2 and 
5% CO2 at room temperature, and were collected after 8 hours of incubation. 
The procedures for tissue fixation, immunohistochemistry, microscopy and data analysis are 
described in Chapter 2 and Chapter 4. 
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3. Results 
3.1 The effect of in vitro incubation with aCSF on WT retina. 
3.1.1 The morphological change of microglial cells in the WT retina after 
aCSF incubation. 
In order to understand whether incubation with aCSF can activate glial cells in an isolated retina 
preparation kept in vitro for 8 hours, iba1 and GFAP expression was examined in P80 WT retinas.  
The morphological examination on iba1+ cells showed that, although the somata of iba1+ cells 
in the inner retina remained small and round in shape following aCSF incubation, some of these 
cells exhibited larger processes (Figure 5-1B and C) (from GCL to OPL), except for only one or 
two cells per slice showing infiltration into the ONL. The infiltrated iba1+ cells exhibited a 
vertical orientation with their processes extending across the ONL (Figure 5-1F). These infiltrated 
iba1+ cells could only be detected in the periphery of the incubated retina but were completely 
absent from the central retina. 
Nevertheless, the morphology of iba1+ cells in these acutely treated WT retinas was entirely 
different from the activated form in age-matched Crx retinas (Figure 5-1H-J). Indeed, none of 
the iba1+ cells exhibited the same amoeboid features as seen in the Crx retina, suggesting much 
milder microglia activation than during retinal degeneration.  
Next, the expression of GFAP was compared in WT retinas after treatment. As it showed in 
Figure 5-1K-L, after incubation in aCSF, the expression of GFAP was restricted within GCL at a 
similar level as observed in untreated age-matched WT retina (Figure 5-1K), which was distinct 
from the GFAP response seen in Crx retina(Figure 5-1M).  
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Figure 5-1 Fluorescent micrographs showing the changes in glial cells in the WT retina with/without incubation and in 
the Crx retina without incubation. Scale bar: 50µm.  
A – F: P80 WT retinas without incubation (A, D) and with aCSF incubation for 8hrs (B, C, E, F); D: Iba1+ cell from inner 
WT retina without incubation; E: Iba1+ cell from inner WT retina with aCSF incubation for 8hrs; F: Iba1+ cell from outer 
WT retina with aCSF incubation for 8hrs; H – J: P80 Crx retina without incubation. I: Iba1+ cell from inner Crx retina; J: 
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Iba1+ cells from outer Crx retina. K-M: changes of GFAP expression. K: expression of GFAP in WT retina without 
incubation; L: expression of GFAP in WT retina with aCSF incubation for 8hrs; L: expression of GFAP in WT retina with 
aCSF incubation for 8hrs. M: GFAP expression in Crx retina without incubation.  
3.1.2 The distribution of iba1+ cells and quantification of GFAP expression in 
WT retina after aCSF incubation 
To further evaluate the changes on iba1+ cells and GFAP expression, the density of iba1+ cells 
and GFAP+ filaments were quantified. The data on the density of iba1+ cells suggested that, 
there were significantly more iba1+ cells in inner layers in incubated retinas than in age-matched 
naïve retinas (Figure 5-2A. Two way ANOVA: The effect of treatment: p = 0.001). Meanwhile, the 
data from GFAP filaments also showed a slight increase (Figure 5-2B. Two way ANOVA: The 
effect of treatment: p = 0.001). These results suggest that the process of isolating the retina 
together with aCSF incubating can trigger a mild glial activation. However, as presented in Figure 
5-2, the glial response caused by incubation was completely different in incubated Crx retinas. 
 
Figure 5-2 The changes of glial cells at different retinal eccentricities with and without incubation. 
The figures show detailed information on glial changes after 8hrs aCSF incubation. A: Density of iba1+ cells in the inner 
retina after treatment. B: Number of GFAP filaments after treatment. Data points: Mean; Error bar: SEM; n = 2 at each 
time point. Data seen in Table 5-1. 
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Table 5-1 Changes of glial cells at different retinal eccentricities after treatment 
   aCSF incubation Untreated 
 Location n mean SEM mean SEM 
Density of iba1+ cells 
(× 10-2/µm2) 
Perioptic area 2 1.41 0.21 0.79 0.21 
Intermediate 2 1.02 0.12 0.81 0.15 
Periphery 2 1.40 0.12 0.60 0.14 
Number of GFAP 
filaments(× 10-3/µm) 
Perioptic area 2 5.31 1.55 3.91 1.08 
Intermediate 2 6.24 1.15 4.39 1.29 
Periphery 2 13.10 3.53 5.43 1.22 
3.2 The effect of Neurostatin on microglia in Crx retina  
3.2.1 The effect of Neurostatin on retinas in the pre-degenerating phase 
To determine the effect of Neurostatin on microglial cells, the morphology and density of iba1+ 
cells were assessed following 8 hours incubation with Neurostatin. As demonstrated in Chapter 
4, although more iba1+ cells were observed in the inner layers of Crx retinas at P10 (see Figure 
4-7 in Chapter 4) than in age-matched WT retinas, there were no visible morphological changes 
in the iba1+ cells, and the microglial cells did not exhibit signs of infiltration in the ONL before 
P20. 
After 8 hrs incubation with plain aCSF, iba1+ cells in the P10 Crx retina were still restricted to 
inner layers and did not infiltrate into the ONL (Figure 5-3B). These iba1+ cells displayed a typical 
ramified structure with a tiny soma and numerous processes (Figure 5-3D, E). However, 
comparing to the age matched naive retina, the density of iba1+ cells in the inner Crx retina 
were significantly decreased after incubation regardless of either Neurostatin or plain aCSF 
incubated retinas (Two way ANOVA, location vs treatment, effect of treatment, p = 0.000). In 
the retinas incubated with Neurostatin, there were fewer but yet not significant iba1+ cells in 
the inner layers than in retinas incubated with plain aCSF (Post hoc: Neurostatin vs Control: 
Periphery: p = 0.864, Intermediate: p = 0.948, Perioptic area: p = 0.972, Dunn’s test). There was, 
however, no distinct morphological change in the iba1+ cells in Neurostatin treated retinas.  
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Figure 5-3 The effect of Neurostatin on iba1+ expression in P10 inner Crx retina 
A – F: Fluorescent micrographs showing the expression of iba1+ in the P10 Crx retinas. Scale bar: 50µm. A: Naive; B: 
Control; C: Neurostatin. D. Selected area of A, white square; E: Selected area of B, white square; F: Selected area of C, 
white square; G. The density of iba1+ cells in the inner retina among different groups. Data points: Mean; Error bar: 
SEM; n = 3 at each time point. Data seen in Table 5-2 
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Table 5-2 The effect of Neurostatin on iba1+ density in P10 Crx retina 
  Neurostatin aCSF incubation untreated 
Location n 
mean (× 
10-2/µm2) SEM 
mean (× 
10-2/µm2) SEM 
mean (× 
10-2/µm2) SEM 
Perioptic area 3 1.55 0.17 2.05 0.12 3.39 0.20 
Intermediate 3 1.43 0.17 2.02 0.15 3.26 0.22 
Periphery 3 1.23 0.21 2.06 0.25 3.01 0.28 
Next, the effect of Neurostatin on GFAP expression was investigated. As seen in Figure 5-4 A-C, 
the expression of GFAP was low and there was no conspicuous changes in GFAP expression after 
treatment with Neurostatin. Surprisingly, further analysis on the number of GFAP filaments 
suggested that there was a slight increase yet not significant on the GFAP filaments after 
Neurostatin treatment (Two way ANOVA, location vs treatment, effect of treatment, p = 
0.7996).  
Altogether, the results on iba1 and GFAP expression indicate that, in P10 Crx retina, incubation 
with Neurostatin may have a mild effect on reducing microglial cells in the inner retina, and it 
may trigger an upregulation on GFAP expression.  
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Figure 5-4 The effect of Neurostatin on GFAP expression in P10 inner Crx retina. 
A – C: Fluorescent micrographs showing the expression of GFAP in the P10 Crx retinas. Scale bar: 50µm. A: Naive; B: 
Control; C: Neurostatin. The expression of GFAP was very low in all three groups. G. The number of GFAP filaments in 
different groups. Data points: Mean; Error bar: SEM; n = 3 at each time point. Data seen in Table 5-3 
Table 5-3 The effect of Neurostatin on GFAP filaments in P10 Crx retina 
  Neurostatin aCSF incubation untreated 
Location n 
mean (× 
10-3/µm) SEM 
mean (× 
10-3/µm) SEM 
mean (× 
10-3/µm) SEM 
Perioptic area 3 3.48 1.17 1.51 0.59 2.13 0.48 
Intermediate 3 2.14 0.82 1.07 0.36 2.20 0.51 
Periphery 3 5.75 1.89 1.31 0.44 1.18 0.48 
3.2.2 The effect of Neurostatin on retinas in the microglial activating phase 
The results presented in Chapter 4 have illustrated that microglial activation and gliosis reached 
its first peak at P40. Almost all the iba1+ cells turned into the amoeboid mode, with an enlarged 
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soma and short processes. Infiltration of iba1+ cells in the ONL was commonly seen during this 
stage. Extended GFAP+ filaments was detectable across the retinas. To investigate the effect of 
Neurostatin on microglial activation during this first wave of degeneration, P40 retinas were 
incubated following the same methodology as in previous sections.  
 
Figure 5-5 The effect of Neurostatin on iba1+ cells in P40 Crx retina 
A – F: Fluorescent micrographs showing the expression of iba1+ in the P40 Crx retinas. Scale bar: 50µm. A: Naive; B: 
Control; C: Neurostatin. D. Selected area of A, white square; E: Selected area of B, white square; F: Selected area of C, 
white square; G: The density of iba1+ cells in the inner retina among different groups. H: The density of iba1+ cells in 
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the outer retina among different groups. Data points: Mean; Error bar: SEM; n = 3 at each time point. Data seen in 
Table 5-4 
Table 5-4 The effect of Neurostatin on iba1+ cell density in P40 Crx retina 
   Neurostatin aCSF incubation Untreated 
 
Location n 
mean 
(× 10-
2/µm2) SEM 
mean (× 
10-2/µm2) SEM 
mean (× 
10-
2/µm2) SEM 
Inner 
retina 
Perioptic area 3 1.27 0.09 1.85 0.09 5.64 0.52 
Intermediate 3 1.30 0.10 1.70 0.12 3.90 0.79 
Periphery 3 1.21 0.15 1.73 0.13 2.05 0.45 
Outer 
retina 
Perioptic area 3 2.75 0.35 2.89 0.28 5.90 0.58 
Intermediate 3 2.51 0.37 2.85 0.31 3.96 0.60 
Periphery 3 1.82 0.31 2.39 0.26 1.92 0.50 
In the incubated retinas either with or without Neurostatin, most of the iba1+ cells remained in 
the amoeboid form across the retina (Figure 5-5B, C), and infiltration of iba1+ cells into the ONL 
was widely seen in both groups (Figure 5-5E and F).  
Similar to the findings in the P10 retina, comparing to the age matched naive retina, there was a 
significant decrease in the density of iba1+ cells in the inner layers in all incubated retinas, 
regardless of whether incubated with Neurostatin and in those incubated with plain aCSF, 
although the density was comparably lower in the Neurostatin treated samples (Two way 
ANOVA: Treatment vs Location, Effect of treatment, p = 0.000). 
There were also significantly fewer iba1+ cells in the ONL in both incubated groups compared to 
untreated retinas ( Two way ANOVA: Treatment vs Location, Effect of treatment, p = 0.001). 
However, compared to retinas incubated with plain aCSF, Neurostatin did not decrease the 
density of iba1+ cells in the outer retina.  
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Figure 5-6 The effect of Neurostatin on GFAP in P40 Crx retina 
A – C: Fluorescent micrographs showing the expression of GFAP in the P40 Crx retinas. Scale bar: 50µm. A: Naive; B: 
Control; C: Neurostatin. D: The number of GFAP filaments in P40 Crx retina. Data points: Mean; Error bar: SEM; n = 3 
at each time point. Data seen in Table 5-5 
Table 5-5 The number of GFAP filaments in P40 Crx retina 
  Neurostatin aCSF incubation Untreated 
Location n 
mean (× 
10-2/µm) SEM 
mean (× 10-
2/µm) SEM 
mean (× 
10-2/µm) SEM 
Perioptic area 3 11.03 0.89 4.54 1.08 8.44 0.58 
Intermediate 3 9.81 0.78 3.78 1.27 10.01 0.65 
Periphery 3 10.26 1.88 4.34 1.32 7.86 1.23 
Next, the effect of Neurostatin on GFAP expression were investigated. The extension of GFAP 
filaments were detectable in all three groups (Figure 5-6). However, analysis on the number of 
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GFAP+ filaments revealed that, compared to the untreated retina, the number of GFAP 
filaments was significantly reduced after incubation in plain aCSF. However, the number of GFAP 
filaments was significantly increased after treatment with Neurostatin, indicating that 
incubation of Neurostatin may paradoxically upregulate GFAP expression in the isolated 
environment. 
3.3 Summary 
Table 5-6 demonstrates the differences in the glial response among different strains and 
treatments. In WT mice, the microglial response and the Müller response were consistent in 
both developing and adult retina following aCSF incubation. There was an mild increase in the 
iba1+ cell density in the inner retina and the number of GFAP filaments, however, the incubation 
did not lead to the rise of iba1+ cells in the outer retina.  
In Crx mice, following aCSF incubation, a decrease of iba1+ density in the inner retina and GFAP 
filament number were detected in both P10 and P40 retina, whilst there was a variation in the 
microglial response observed in the outer retina at different ages. The iba1+ cell density was 
largely reduced in the outer retina of P40 after incubated in aCSF, the treatment did not trigger 
any changes in the outer retina of P10.  
Comparing with aCSF treatment, there was no much difference in the microglial response in Crx 
retina following Neurostatin incubation, except for a slighter larger reduction in the iba1+ 
density in the inner retina. However, as opposed to reduction of GFAP filament number after 
aCSF incubation, the number of GFAP filaments was increased after Neurostatin treatment in 
both P10 and P40 Crx retina.  
Table 5-6 Summary of the responses toward treatment.  
 
WT P10 WT P80 Crx P10 Crx P40 
 aCSF  aCSF aCSF Neurostatin aCSF Neurostatin 
Iba1 in IR ↑ ↑ ↓ ↓↓ ↓ ↓↓ 
Iba1 in OR → → → → ↓↓ ↓ 
GFAP  ↑ ↑ ↓ ↑ ↓ ↑ 
IR: GCL to OPL; OR: outer retina; ↑: mild to moderate increase; ↓: mild to moderate decrease; →: no change; ↓↓: 
moderate to severe decrease. The changes were evaluated by comparing with the age-matched untreated retina.  
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4. Discussion: 
This study sought to test the effect of Neurostatin on glial cells in isolated Crx retina. The results 
showed that Neurostatin has a mild effect on reducing the density of iba1+ cells in the inner 
layers of isolated Crx retinas at both P10 and P40, but triggered a rise of GFAP expression at P40. 
In addition, the assessment on the response of microglial cells suggested that there was 
heterogeneity in microglial reactions in response to different insults.  
4.1 The glial response in the isolated retina under aCSF incubation  
It is known that microglial cells are highly sensitive to environmental changes and can provide 
immediate response and transform from a resting mode to a reactive mode in such conditions. 
Furthermore, microglial cells exhibit heterogeneous responses to different types of injuries 
(Gertig and Hanisch, 2014). Therefore, this current study first investigated whether the isolated 
retinal preparation together with aCSF incubation can trigger microglial activation and Müller 
gliosis.  
A previous study on the isolated rat retina with aCSF incubation revealed that there was an 
increased release of lactate dehydrogenase (LDH) (an indicator of neural damage) over time 
during incubation with aCSF (Tokuda et al., 2004, Romano et al., 1995). Another study using 
organotypic cultures of retinal wholemounts revealed that there was sustained microglial 
activation during in these cultures. However, the activation did not cause cytokine release, nor 
did it lead to additional apoptosis other than axotomy-induced apoptosis in the INL following 
retinal isolation preparation (Bauer et al., 2016).  
In this current study, the observed changes in iba1+ cells were in agreement with microglial 
activation observed in these earlier studies. Iba1+ cells displayed subtle morphological changes 
following incubation with a modest increase in cell density in the inner retina. Iba1+ cells were 
restricted to the inner retina and remained absent from the ONL. It should be noted that the 
increase in microglial density observed is probably due to cell proliferation of the innate 
microglial population, as there is no recruitment of BM-derived macrophage in the isolated 
retina. In addition, the morphology of iba1+ cells here was clearly distinct from iba1+ cells 
observed during the photoreceptor death phase of Crx retina. Furthermore, Bauer et al. (2016) 
demonstrated that the onset of microglial activation following incubation did not present until 
day 3, whilst the GFAP expression at day 0 was similar to the in vivo pattern. The results from 
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this study are in line with Bauer’s findings. Despite a mild increase in the number of GFAP 
filaments, the expression of GFAP in incubated retina was indistinguishable from the untreated 
retinas. 
Therefore, our results are in line with those previous studies; there is a mild microglial activation 
in the isolated retina during aCSF incubation which is quite distinct from the microglial activation 
during photoreceptor degeneration. The microglial activation in the inner retina here may be a 
combined effect of axotomy-induced Ganglion cell death and environment change caused by 
incubation. However, the activated microglial cells do not lead to further apoptosis and cytokine 
release, nor Müller gliosis. 
4.2 The glial response in the isolated Crx retina 
Maintaining isolated retinas in aCSF over time induces mild glial activation. Furthermore, Bauer 
et al (2016) suggested that the combination of culturing isolated retinas and LPS stimulation 
(classic M1 stimulation) can trigger microglial activation, characterized by increased production 
of TNF-α, IL-2 and IL-6, while the total number of microglial cells remained at the same level as 
they were without LPS stimulation. The authors suggested that LPS exposure produces a model 
that is similar to the neurodegeneration process.  
This current study investigated whether microglial activation in Crx retina is altered in the 
isolated retina under incubation. Our results show that, following 8 hours incubation in aCSF, 
the density of iba1+ cells in the inner layers of both P10 and P40 Crx retina decreased. 
Furthermore, there was also a sharp drop on the GFAP filaments in P40 Crx retina. As discussed 
in Chapter 4, an increase of microglial density was observed at P10 Crx retina, and microglial 
density reached its peak at P40 during the first activation wave. A study on microglial 
repopulation suggested that, the repopulation of microglial cells is mainly attributed to the 
proliferation of innate microglial cells (Huang et al., 2018). It is postulated that a continuous 
supply of stimulating factors may be necessary for glial activity during retinal degeneration. 
Incubation of isolated retinas in vitro for 8 hours may cause a decrease in the presence of these 
factors, resulting in fewer glial proliferation and explaining our findings.  
4.3 The effect of Neurostatin in isolated Crx retina  
Neurostatin has been previously reported to reduce the classical microglial activation, the p38 
and ERK1/2 activation, via blockade of IL-15 activity in cell culture (Gomez-Nicola et al., 2010). In 
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this present study, isolated Crx retinas were incubated with Neurostatin for 8 hrs to investigate 
the effect of Neurostatin on microglial activation.  
In the P10 Crx retina, comparing to the control group, there was a significant reduction of iba1+ 
cell density in the inner retina after Neurostatin treatment. However, the effect was less 
pronouced at P40. Although the density of iba1+ cells was slightly lower in the inner retina after 
incubation with Neurostatin, in the outer retina, it was higher in the Neurostatin group. As 
discussed previously, microglial activation in the P10 Crx retina may be a response towards 
incubation, whereas at P40 Crx retina, microglial activation is associated with photoreceptor 
degeneration.  
Furthermore, at P40, the most remarkable change in microglial cells in the inner retina was the 
proliferation of resident microglia. By contrast, the increase of microglial density in the outer 
retina was caused by the migration and infiltration of microglial cells from the inner retina into 
the outer retina. The recruitment of microglial cells into the outer retina is considered to be a 
result of changes in local cytokines and the alteration of the surface proteins on photoreceptors 
(Brown and Neher, 2012). The differences in the effect of Neurostatin on microglial activation 
between the inner and outer retina may indicate that Neurostatin interferes more with 
pathways involved in cell proliferation, than with cell migration. 
However, the effect of Neurostatin on GFAP expression seems to be contradictory to the 
microglial response, as the gliosis would normally be expected to be positively correlated with 
the reduction of microglial activitity via JAK-STAT signaling (Kim et al., 2002). One of the possible 
explaination is that, the iba1+ cell density could not accurately reflect the activity of specific 
microglial subsets being involved. Furthermore, it has been suggested that Neurostatin could 
directly regulate GFAP expression in the CNS via the ERK1/2 MAPK pathway, however, the 
repsonse of GFAP may vary among different location of the brain. For instance, treatment with 
Neurostatin (GM1 subtype) is able to cause a significant attenuation of GFAP increment in 
hippocamus, but shows no effect in the spetum (Oderfeld-Nowak et al., 1993). A limitation of 
the present study is that downstream effects, such as changes in cytokine levels, and the 
communication between microglia and Müller cells were not assessed. Hence, the exact 
pathways that were affected and the communication between glial cells were unknown . 
Further investigation into the effect of Neurostatin on microglial activation will require 
investigating a large number of possible downstream pathways. 
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5. Conclusion  
The results presented in this chapter showed that Neurostatin has a mild effect on reducing the 
density of iba1+ cells in the inner Crx retina both at P10 and at P40. Moreover, it may alter 
microglial activation status although the evidence for this is less clear. The data suggests, 
however, that the experimental conditions may have affected the results. Moreover, it is clear 
that ex vivo retinal preparations cannot provide information on the interaction between 
microglial activation and photoreceptor survival for a long period. The next set of studies 
therefore sought to investigate whether Neurostatin could provide a long term protective effect 
on photoreceptors in the Crx retina at different stages of degeneration. 
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Chapter 6. The Effect of Neurostatin on Microglial 
Activation and Photoreceptor Survival in Crx 
Retina 
  
 136 
 
  
 137 
 
1. Introduction  
Chapter 5 has shown that Neurostatin has a mild effect on reducing inner retinal microglial cell 
proliferation and increasing GFAP expression in an in vitro preparation of the Crx retina. 
However, Chapter 5 also shows that glial activation patterns are different in vitro and in vivo. 
One possibility is that microglia activation in vitro may result from a combination of the effects 
of RGC axotomy and inherent photoreceptor degeneration. An additional issue is that the supply 
of BM-derived microglial cells is impaired in isolated retinal preparations. Hence, in vitro 
approaches cannot provide reliable information on how manipulating glial activity can protect 
photoreceptors in the long-term. 
As described in Chapter 1, the states of microglial activation can be divided into two categories: 
M1 microglia, responsible for the neurotoxic response; M2 microglia, responsible for the 
neuroprotective response. Although these two states temporally overlap, microglial activation is 
considered to be cytotoxic in the long term.  
Earlier chapters in this thesis have shown that in the Crx retina, there are two waves of glial 
activation during photoreceptor degeneration, and these events are intimately related. 
Although the exact mechanism underlying this relationship is unknown, such temporal 
correlation between these two events raised the question whether it is indeed microglial and 
Müller activation that accelerates ensuing photoreceptor death, or whether it is the other way 
around, with glial activity resulting from fast photoreceptor degeneration.  
We hypothesized that dying photoreceptors during the fast degenerating waves may amplify 
inflammatory activity, and glial hyperactivity may in turn further accelerate photoreceptor 
degeneration. Therefore, manipulating glial activation may help to slow down the 
photoreceptor degenerating process. 
In this light, the aim of the study presented in this chapter was to investigate the long-term 
effects of microglial activation on photoreceptor loss at different degeneration stages, and to 
determine whether inhibiting microglial activity could improve photoreceptor survival.  
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Figure 6-1 Schematic diagram of the events during photoreceptor degeneration in the Crx retina 
Black arrows show the time points when Neurostatin was administered. 
2. Specific Methods:  
2.1 Animals and surgical procedures 
Neurostatin was applied via intravitreal injection at the beginning of the first activation wave 
and P55 the beginning of the second activation wave (Figure 6-1). The time points of 
Neurostatin administration were chosen according to the time course of microglial activation in 
Crx retina (see previous chapters). The effect of Neurostatin was assessed from 7 days to two 
months post-injection. 
A P25 and a P55 cohort of Crx mice were used, respectively corresponding to the beginning of 
the first and second activation waves. For each animal, the left eye was used for intraocular 
injection, while the right eye was not injected. 
Due to their invasive nature, even intravitreal injections with plain phosphate-buffered saline 
(PBS) can cause a reactive change in both Müller and microglial cells within 24 hrs, but then the 
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effect becomes less pronounced after 7 days (Seitz and Tamm, 2014). To exclude this potentially 
confounding effect, the earliest tissue collection was determined to be at 7 days post-injection 
(DPI). 
For the P25 cohort, retinas were collected at 7 days (n = 2 for each group), 15 days (n = 5), 30 
days (n=5) and 60 days (n = 4) post-injection (P25-7DPI, P25-15DPI, P25-30DPI, P25-60DPI, DPI: 
Days post-injection), while for the P55 cohort, retinas were collected at 15 days (n = 4) and 30 
days (n = 4) post-injection (P55-15DPI, P55-30DPI). 
The procedures for tissue fixation, immunohistochemistry, microscopy and data analysis are 
described in Chapter 2 and Chapter 4. 
2.2 Intravitreal injection and drug preparation  
Once under general anaesthesia (10% Domitor and 7.5% Ketamine, 100ul/10g body weight. 
Intraperitoneal injection), the left eye was treated with topical anaesthetic (oxybuprocain, 
Bausch & Lomb, UK) and mydriatic eye drops (cyclopentolate hydrochloride, Bausch & Lomb, 
UK). 2% carbomer eye gel (Bausch & Lomb, UK) was then generously applied on both eyes. A 20 
second interval was allowed between each drug. 
Prior to the injection, a cover slip was placed on the cornea of the left eye to view the fundus 
using direct microscopy. An incision was made in the ventral scleral limbus, using a 30-gauge 
needle. A 34-gauge Hamilton syringe (Hamilton CO. USA) was gently inserted through the 
incision into the vitreous cavity (Figure 6-2A). 1 µl of drug/placebo was injected while the fundus 
was monitored (Figure 6-2B). Eyes with signs of complications, such as haemorrhage, retinal 
detachment, or injuries to the lens or iris, were excluded. 
Trypan blue, which is widely used as a dye in intraocular surgeries, was added to visualise the 
solution injected in order to facilitate the injection procedure. In an ocular toxicity study of 
trypan blue in rabbit, it has been shown that intravitreal injection of a 0.2% trypan blue solution 
can lead to rhodopsin loss in the ventral retina, even though there was no functional change in 
ERG test. By contrast, no sign of retinal toxicity could be detected when using only 0.06% trypan 
blue in the solution (Veckeneer et al., 2001), suggesting that it is safe at this low concentration. 
In this study, we managed to visualise the injected solution at the much lower concentration of 
0.001%, and this is what we used for all our experiments.  
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5 mM Neurostatin solution (dissolved in distilled water with 0.001% trypan blue) was freshly 
prepared on the day of injection. The distilled water with 0.001% trypan blue was injected into 
animals in the control groups, as a vehicle control (placebo). 
Previous studies have suggested that, phosphate buffered saline (PBS) is not toxic to mouse 
retina and is considered to be the ideal agent for intraocular injection (Hombrebueno et al., 
2014). However, due to the chemical nature of Neurostatin, which can only reach the desired 
concentration in distilled water, hence distilled water was used as the agent in this study.  
 
Figure 6-2 Schematic graph of intravitreal injection and fundus image of mouse eye. 
A: The Hamilton syringe was inserted into the vitreous cavity through an incision made in the scleral limbus. B: mouse 
fundus. Blue arrowhead: optic nerve. 
3. Results 
3.1 The effect of Neurostatin on the first activation wave. 
Chapter 4 has shown that iba1+ cells exhibit a typical “activated” morphology, with enlarged 
soma and shorter processes. These changes become conspicuous from P30 and the infiltration 
of iba1+ cells into the ONL is detectable as early as P20, while the onset of photoreceptor loss is 
not detectable before P30. The Müller cells activation manifested itself as the extension of GFAP 
filaments towards the outer retina. The changes occurred from P40 and fluctuated throughout 
the degenerating process. In the later stage, stellete patterns of GFAP filaments were also 
observed to form into the focal photoreceptor defects.  
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To investigate the effect of Neurostatin on glial activity and photoreceptor survival in the Crx 
retina, Neurostatin was applied via intravitreal injection at P25, which corresponds to the 
beginning of the first activation wave. Retinas were collected at 7DPI, 15DPI, DPI 30 and 60DPI 
to investigate the short-term and long-term effects of Neurostatin. 
3.1.1 The effect of Neurostatin on glial activity following intravitreal 
injection. 
The morphology and incidence of iba1+ cells was investigated at P25-7DPI, P25-15DPI, P25-
30DPI and P25-60DPI . Iba1+ cells in the inner retina exhibited enlarged somata in both 
Neurostatin and control groups at P25-7DPI and P25-15DPI (Figure 6-3 A, D, G and J, arrows). 
The infiltration of iba1+ cells into the ONL was observed in both groups at P25-7DPI (Figure 6-3A 
and D, arrow heads). In addition, more iba1+ cells were present in both groups at P25-15DPI 
(Figure 6-3 G and J, arrowheads). These morphological changes are similar to those observed in 
age-matched untreated Crx retinas, suggesting that they reflect the age-related microglial 
proliferation. 
At P25-30DPI, amoeboid-shaped iba1+ cells were observed in both groups (Figure 6-4 A and D, 
arrows). Infiltration of iba1+ cells into the ONL was still detectable in both groups as well, 
although there were slightly fewer iba1+ cells in the ONL of the Neurostatin group (Figure 6-4A 
and D, arrowheads). At P25-60DPI, significantly fewer iba1+ cells could be detected in the inner 
retina in both groups (Figure 6-4 G and J), which may be a result of ageing rather than 
treatment.  
The investigation on GFAP expression showed that, there was a variation on the GFAP 
expression at different time point after treatment. At P25-7DPI, an obvious rise in GFAP+ 
filaments was observed in both groups (Figure 6-3B and E), followed by a decrease at P25-15DPI 
(Figure 6-3 H and K). The changes between these periods showed no difference between 
Neurostatin and control. Nevertheless, the occurrence of GFAP+ upregulation found here was 
much earlier than what has been found in the Crx retina in Chapter 4, whilst the downregulation 
of GFAP later on presented at the first peak of glial activation wave, indicating that this might be 
an effect of the injection itself.  
However, a month following injection, an effect of Neurostatin was detected. Comparing to the 
control groups, an clear increase was seen in GFAP+ filaments in retinas treated with 
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Neurostatin at both P25-30DPI (Figure 6-4B and E) and P25-60DPI (Figure 6-4 H and L), 
suggesting that Neurostatin may also have a long term effect on increasing Müller activity.  
 
Figure 6-3 Fluorescent micrographs of glial cells following Neurostatin treatment in early stages 
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Representative images showing the response of glial cells at different time point following Neurostatin treatment. A, 
D, G, J: Iba1; B,E,H,K: GFAP; C, F, I, L: Red: iba1, Blue: DAPI. Green: GFAP. Images were taken from central area of the 
retina. Scale bar: 50µm 
 
Figure 6-4 Fluorescent micrographs of glial cells following Neurostatin treatment in later stages 
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Representative images showing the response of glial cells at different time point following Neurostatin treatment. A, 
D, G, J: Iba1; B,E,H,K: GFAP; C, F, I, L: Red: iba1, Blue: DAPI. Green: GFAP. Images were taken from central area of the 
retina. Scale bar: 50µm 
 
Figure 6-5 Fluorescent micrographs of iba1+ cells in the outer most of ONL following intravitreal injection. 
Representative images showing the expression of iba1 in the outer most of ONL within the first two weeks following 
intravitreal injection. Red: iba1; Blue: DAPI; Images were taken from central area of the retina. Scale bar: 50µm 
In addition, an accumulation of iba1+ cell in the outermost part of ONL was seen in both groups 
at P25-7DPI and P25-15DPI (Figure 6-5 A-B and D-E arrows), which was not commonly seen in 
age-matched untreated retinas (Figure 6-5 C and F). These cells disappeared after a month post-
injection, suggesting that their appearance may have been related to the intravitreal injection 
procedure. 
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Figure 6-6 Changes of iba1+ cell density in the inner retina over time following treatment with Neurostatin. 
The figures show detailed information on microglial changes in the inner retina following treatment with Neurostatin. 
A: The overall density; B: The density in the peripheral retinal; C: The density in intermediate retina; D: The density in 
the perioptic nerve. Data points: Mean; Error bar: SEM; 7DPI (n = 2), P25-15DPI (n = 5), P25-30DPI (n = 5), P25-60DPI (n 
=4). Data seen in Table 6-1. 
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Table 6-1 Changes of iba1+ cell density in the inner retina over time following treatment with Neurostatin 
Treatment DPI N 
Perioptic nerve 
 
Intermediate 
 
Periphery 
mean (× 
10-2/µm2) 
SEM 
mean (× 
10-2/µm2) 
SEM 
mean (× 
10-2/µm2) 
SEM 
Neurostatin 
P25-7DPI 2 1.441 0.220 1.734 0.220 1.729 0.313 
P25-15DPI 5 1.309 0.058 1.569 0.058 1.756 0.141 
P25-30DPI 5 1.042 0.066 1.012 0.066 1.675 0.167 
P25-60DPI 4 0.580 0.064 0.770 0.064 0.632 0.128 
Control  
P25-7DPI 2 1.350 0.146 1.207 0.146 1.465 0.318 
P25-15DPI 5 1.519 0.082 1.480 0.082 1.832 0.133 
P25-30DPI 5 1.045 0.094 1.093 0.094 1.054 0.111 
P25-60DPI 4 0.354 0.075 0.508 0.075 0.324 0.108 
In order to quantify the changes in iba1+ cell density following Neurostatin treatment, the 
density of iba1+ cells in the inner retina and outer retina was assessed at different DPI. Figure 
6-6 illustrates changes in iba1+ cell density in the inner retina. In contrast with the data from ex 
vivo experiment in Chapter 5, the results showed that there was a significant increase of iba1+ 
cell density in the inner retina after treatment with Neurostatin (Two way ANOVA: Treatment vs 
DPI: Effect of treatment: p = 0.018). By contrast, data on the outer retina showed that the 
overall effect of Neurostatin on the iba1+ cells was not significant (Figure 6-7. Two way ANOVA: 
Treatment vs DPI: Effect of treatment: p = 0.786).  
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Figure 6-7 Changes of iba1+ cell density in the outer retina over time following treatment with Neurostatin. 
The figures show detailed information on microglial changes in the outer retina following treatment with Neurostatin. 
A: The overall density; B: The density in the peripheral retinal; C: The density in intermediate retina; D: The density in 
the perioptic nerve. Data points: Mean; Error bar: SEM; 7DPI (n = 2), P25-15DPI (n = 5), P25-30DPI (n = 5), P25-60DPI (n 
=4). Data seen in Table 6-2. 
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Table 6-2 Changes of iba1+ cell density in the outer retina over time following treatment with Neurostatin. 
Treatment DPI N 
Perioptic nerve 
 
Intermediate 
 
Periphery 
mean (× 
10-2/µm2) 
SEM 
mean (× 
10-
2/µm2) 
SEM 
mean (× 
10-
2/µm2) 
SEM 
Neurostatin 
P25-7DPI 2 3.110 0.337 3.003 0.412 1.484 0.366 
P25-15DPI 5 4.438 0.243 3.582 0.264 1.536 0.197 
P25-30DPI 5 3.569 0.223 2.978 0.211 1.515 0.206 
P25-60DPI 4 4.458 0.742 3.178 0.653 1.222 0.308 
Control  
P25-7DPI 2 2.495 0.361 1.759 0.299 0.753 0.335 
P25-15DPI 5 3.537 0.259 3.326 0.237 1.340 0.212 
P25-30DPI 5 3.859 0.326 3.570 0.372 2.059 0.313 
P25-60DPI 4 4.782 1.317 4.707 1.584 1.821 0.825 
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Figure 6-8 Changes of the number of GFAP+ filaments following treatment with Neurostatin. 
The figures show detailed information on the changes of Müller cells following treatment with Neurostatin. A: The 
overall number of GFAP+ filaments; B: The number of GFAP filaments in the peripheral retinal; C: The number of 
GFAP+ filaments in intermediate retina; D: The number of GFAP+ filaments in the perioptic nerve. Data points: Mean; 
Error bar: SEM; 7DPI (n = 2), P25-15DPI (n = 5), P25-30DPI (n = 5), P25-60DPI (n =4). Data seen in Table 6-3 
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Table 6-3 Changes of the number of GFAP+ filaments following treatment with Neurostatin. 
Treatment DPI N 
Perioptic nerve 
 
Intermediate 
 
Periphery 
mean (× 
10-2/µm2) 
SEM 
mean (× 
10-
2/µm2) 
SEM 
mean (× 
10-
2/µm2) 
SEM 
Neurostatin 
P25-7DPI 2 0.119 0.008 0.119 0.012 0.119 0.018 
P25-15DPI 5 0.033 0.003 0.033 0.004 0.033 0.004 
P25-30DPI 5 0.116 0.004 0.116 0.006 0.116 0.007 
P25-60DPI 4 0.074 0.007 0.074 0.009 0.074 0.012 
Control  
P25-7DPI 2 0.132 0.012 0.127 0.011 0.101 0.005 
P25-15DPI 5 0.048 0.005 0.050 0.005 0.041 0.004 
P25-30DPI 5 0.085 0.006 0.090 0.007 0.080 0.009 
P25-60DPI 4 0.016 0.002 0.022 0.004 0.043 0.005 
Next, the number of GFAP+ filaments was analysed. The number of GFAP+ filaments fluctuated 
during the recorded period. At 7DPI and 15DPI, the changes on the number of GFAP+ filaments 
were concurrent between Neurostatin and control groups. However, a significant increase of 
overall GFAP+ filament number was seen at both 30DPI and 60DPI (Figure 6-8, Two way ANOVA: 
Treatment vs DPI: Effect of treatment: p = 0.000). The results indicated that intravitreal injection 
with Neurostatin may have a delayed effect on upregulation of GFAP expression. 
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3.1.2 The effect of intravitreal Neurostatin injection on ONL thickness. 
 
Figure 6-9 Changes in ONL thickness over time following treatment with Neurostatin.  
The figures show detailed information on ONL thickness following treatment with Neurostatin. A: The overall ONL 
thickness; B: The ONL thickness in the peripheral retinal; C: The ONL thickness in intermediate retina; D: The ONL 
thickness in the perioptic nerve. Data points: Mean; Error bar: SEM; 7DPI (n = 2), P25-15DPI (n = 5), P25-30DPI (n = 5), 
P25-60DPI (n =4). Data seen in Table 6-4. 
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Table 6-4 Changes in ONL thickness over time following treatment with Neurostatin.  
Treatment DPI N 
Perioptic nerve 
 
Intermediate 
 
Periphery 
mean 
(µm) 
SEM 
mean 
(µm) 
SEM 
mean 
(µm) 
SEM 
Neurostatin 
P25-7DPI 2 46.621 1.149 51.063 1.649 50.873 2.130 
P25-15DPI 5 34.911 0.506 36.400 0.739 34.807 0.794 
P25-30DPI 5 30.419 0.918 33.293 1.001 31.452 1.243 
P25-60DPI 4 12.621 1.122 14.086 1.221 18.227 1.424 
Control  
P25-7DPI 2 47.718 2.125 46.567 1.282 47.440 1.779 
P25-15DPI 5 37.696 0.945 37.245 0.808 35.954 0.809 
P25-30DPI 5 26.671 1.044 27.782 1.207 25.740 1.025 
P25-60DPI 4 7.180 0.740 12.320 2.138 15.600 1.353 
The thickness of the ONL was then examined to investigate whether the treatment of 
Neurostatin could improve photoreceptor survival (Figure 6-9). These results show that the ONL 
thickness was significantly higher at around 30DPI (Two-way ANOVA: Treatment vs DPI: Effect of 
treatment: p = 0.001), suggesting that Neurostatin has a modest positive effect on 
photoreceptor survival, an effect that is perhaps mediated by affecting the microglial activation 
during the first activation wave. However, the ONL thinned out by ~75%, between 7DPI and 
60DPI in both the Neurostatin and control groups, indicating that treatment with Neurostatin 
alone may not be able to stop the degenerating process. 
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3.1.3 The effect of Neurostatin on photoreceptor death 
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Figure 6-10 Effect of Neurostatin treatment on photoreceptor death  
A-D: Representative images showing fluorescent micrographs of TUNEL+ cells. Green: TUNEL; Blue: DAPI. Images were 
taken from central area of the retina. Scale bar: 50µm. E: Bar chart showing the effect of Neurostatin on TUNEL+ cell 
density at P25-30DPI. Data points: Mean; Error bar: SEM; n = 2. Data seen in Table 6-5. 
Table 6-5 The effect of Neurostatin on TUNEL+ cell density at P25-30DPI 
As shown in Chapter 3, apoptosis is highly active between P50–70 in the Crx outer retina. To 
determine whether the level of apoptotic activity can be modified by Neurostatin, the density of 
TUNEL+ cells was quantified at P25-30DPI (Figure 6-10 A-D). The results revealed that 
significantly fewer TUNEL+ cells were detected following Neurostatin treatment (Figure 6-10 E). 
Closer inspection of the results according to retinal eccentricity revealed that the effect was 
much more pronounced in the central retina than in the periphery. These results suggest that 
Neurostatin may protect photoreceptor from dying. However, the effect is confined to the 
central retina. 
3.2 The effect of Neurostatin during the second activation wave. 
To determine whether Neurostatin has an effect during the second activation wave, the drug 
was injected into the vitreous at P55, and retinas were harvested at 15DPI and 30DPI.  
3.2.1 The effect of intravitreal Neurostatin on glial cells 
No obvious morphological changes were detected in iba1+ cells after treatment with 
Neurostatin (Figure 6-11). Importantly, at 30DPI, the morphology of iba1+ cells from both 
groups was characteristic of ageing tissue undergoing degeneration (von Bernhardi et al., 2015), 
with a small soma and few processes (Figure 6-11 G).  
Treatment 
location N 
Mean  
×10-2 
cells/µm2 STD SEM 
Neurostatin 
Perioptic nerve 2 
3.027 2.787 0.881 
intermediate 2 
6.035 3.445 1.218 
Periphery 2 
6.092 3.782 1.337 
Control  
Perioptic nerve 2 
8.998 2.758 0.689 
intermediate 2 
5.828 3.079 0.823 
Periphery 2 
5.581 2.173 0.627 
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Results on GFAP staining showed that, although the expression of GFAP was similar between the 
Neurostatin and control group at 15DPI, there was a distinct difference seen at 30DPI, as much 
more GFAP+ filaments were found in the group treated with Neurostatin.  
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Figure 6-11 Fluorescent micrographs of glial cells following treatment with Neurostatin during the second activation 
wave 
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Representative images showing the response of glial cells at different time point following Neurostatin treatment. A, 
D, G, J: Iba1; B,E,H,K: GFAP; C, F, I, L: Red: iba1, Blue: DAPI. Green: GFAP. Images were taken from central area of the 
retina. Scale bar: 50µm 
Next, the effect of Neurostatin on the density of iba1+ cells in different retinal layers was 
quantified. Overall, there were significantly fewer iba1+ cells in the inner retina at 15DPI (Figure 
6-12. Two-way ANOVA: Treatment vs DPI, p = 0.0321). Notably, this effect was more obvious in 
the perioptic area than other areas. However, no difference was detected between control and 
Neurostatin treated retinas at 30DPI. 
 
Figure 6-12 Bar chart showing the density changes of iba1+ cells in the inner retina following Neurostatin treatment 
during the second activation wave.  
The figures show detailed information on the effect of Neurostatin on the iba1+ cells at the second activation wave. A: 
Density of iba1+ cells in the inner retina at 15 days after treatment. B: Density of iba1+ cells in the inner retina at 30 
days after treatment. Data points: Mean; Error bar: SEM; n = 4 at each time point. Data seen in Table 6-6. 
Table 6-6 The effect of Neurostatin on iba1+ cells in the inner retina at the second activation wave. 
Treatment DPI N 
Perioptic nerve 
 
Intermediate 
 
Periphery 
Mean/ 
×10-2 
cells/µm2 
SEM 
Mean/ 
×10-2 
cells/µm2 
SEM 
Mean/ 
×10-2 
cells/µm2 
SEM 
Neurostatin 
P55-15DPI 4 0.766 0.074 0.880 0.077 0.938 0.060 
P55-30DPI 4 1.111 0.095 1.024 0.080 1.135 0.064 
Control 
P55-15DPI 4 1.259 0.108 1.161 0.116 1.219 0.074 
P55-30DPI 4 1.056 0.069 0.977 0.087 1.144 0.060 
 158 
 
Interestingly, iba1+ cell density changes took longer to develop following Neurostatin treatment 
in the outer retina than in the inner retina. Indeed, no changes were seen earlier than 30DPI 
(Figure 6-13), and even then, they were not significant (Figure 6-13: Two-way ANOVA: 
Treatment vs DPI: Effect of treatment: p = 0.158). 
Figure 6-13 Changes in iba1+ cells density in the outer retina following Neurostatin treatment during the second 
activation wave.  
The figures show detailed information on the effect of Neurostatin on the iba1+ cells at the second activation wave. A: 
Density of iba1+ cells in the outer retina at 15 days after treatment. B: Density of iba1+ cells in the outer retina at 30 
days after treatment. Data points: Mean; Error bar: SEM; n = 4 at each time point. Data seen in Table 6-7. 
Table 6-7 The effect of Neurostatin on iba1+ cells in the outer retina at the second activation wave 
Treatment DPI N 
Perioptic nerve 
 
Intermediate 
 
Periphery 
Mean/ 
×10-2 
cells/µm2 
SEM 
Mean/ 
×10-2 
cells/µm2 
SEM 
Mean/ 
×10-2 
cells/µm2 
SEM 
Neurostatin 
P55-15DPI 4 8.062 1.009 5.915 0.845 2.658 0.339 
P55-30DPI 4 5.017 0.627 4.843 0.583 3.310 0.418 
Control 
P55-15DPI 4 7.434 0.702 6.503 1.075 2.580 0.488 
P55-30DPI 4 6.924 1.120 7.027 0.881 3.515 0.522 
The quantitative analysis also suggests that there was an overt increase on GFAP expression 
following treatment with Neurostatin. At 15DPI, the differences on the number of GFAP+ 
filaments was only detectable in the central area of the retina, whilst the effect was more 
obvious in the periphery and intermediate area at 30DPI, indicating that the Neurostatin may 
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initially take effect in the central retina and spread to the periphery over time (Figure 6-14: Two-
way ANOVA: Treatment vs DPI: Effect of treatment: p = 0.000). 
 
Figure 6-14 Changes in GFAP filament number following Neurostatin treatment during the second activation wave. 
The figures show detailed information on the effect of Neurostatin on GFAP+ filaments at the second activation wave. 
A: Number of GFAP filaments at 15 days after treatment. B: Number of GFAP+ filaments at 30 days after treatment. 
Data points: Mean; Error bar: SEM; n = 4 at each time point.. Data seen in Table 6-8. 
Table 6-8 The effect of Neurostatin on GFAP filaments at the second activation wave 
Treatment DPI N Perioptic nerve 
 
Intermediate 
 
Periphery 
Mean/µm SEM Mean/µm SEM Mean/µm SEM 
Neurostatin 
P55-15DPI 4 0.116 0.007 0.116 0.008 0.114 0.006 
P55-30DPI 4 0.123 0.008 0.120 0.009 0.105 0.009 
Control 
P55-15DPI 4 0.127 0.007 0.113 0.008 0.085 0.006 
P55-30DPI 4 0.074 0.008 0.076 0.009 0.087 0.009 
3.2.2 The effect of Neurostatin on ONL thickness following intravitreal 
injection. 
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Figure 6-15 The change of ONL thickness after treated with Neurostatin at the second activation wave. 
A-D: Fluorescent micrographs showing the expression of DAPI (grey) in the retinal section following treatment. Scale 
bar 50µm. Images taken from central area of the retina. E: Bar chart showing the ONL thickness on different location 
of retina at 15DPI .F: Bar chart showing the ONL thickness on different location of retina at 30DPI. Data seen in Table 
6-9 
Table 6-9 The effect of Neurostatin on ONL thickness in the second activation wave. 
Treatment DPI N Perioptic nerve 
 
Intermediate 
 
Periphery 
Mean/µm SEM Mean/µm SEM Mean/µm SEM 
Neurostatin 
P55-15DPI 4 13.232 1.264 16.881 1.682 22.296 1.534 
P55-30DPI 4 12.604 0.755 16.362 1.313 15.697 0.959 
Control 
P55-15DPI 4 13.119 0.890 17.943 1.509 21.200 1.504 
P55-30DPI 4 11.048 0.686 12.108 0.764 13.632 0.754 
The ONL thickness was then measured at both 15DPI and 30 DPI, to investigate whether 
Neurostatin also has a protective effect on photoreceptors when applied during the second 
activation wave. The results show that, although there was no overt change at 15DPI, it prevents 
ONL thinning at 30DPI (Figure 6-15 E and F: Two-way ANOVA: Treatment vs DPI: Effect of 
treatment, p = 0.0489.).  
3.3 Treatment at different time-points leads to different microglial density 
levels, but the outcome is still photoreceptor preservation. 
Neurostatin has a protective effect on ONL thickness when applied at either P25 or P55. To 
investigate whether the timing of treatment could influence the long-term outcome, the density 
of iba1+ cells in different retinal layers, the number of GFAP+ filaments and the ONL thickness of 
P25-60DPI and P55-30DPI were compared. 
There was a significant increase in the density of iba1+ cells in the inner retina in both 
Neurostatin and control groups of P55-30DPI (Figure 6-16 A. Two-way ANOVA: Treatment vs 
DPI: Effect of DPI: p = 0.000).  
A similar effect was also observed with the density of iba1+ cells in the outer retina, where it 
was significantly higher in both Neurostatin and control groups when treated at P55 (Figure 6-16 
B:. Two-way ANOVA: Treatment vs DPI: Effect of DPI: p = 0.009) 
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Analysis on GFAP+ filaments displayed an effect that was similar to iba1+ cells. The number of 
GFAP filaments was significantly higher in both Neurostatin and control group at P55-30DPI 
(Figure 6-16 D:. Two-way ANOVA: Treatment vs DPI: Effect of DPI: p = 0.000)). 
However, for ONL thickness there was no difference between treatments at P25 and P55 (Figure 
6-16 C: Two-way ANOVA Treatment vs DPI: Effect of DPI: p = 0.4919), suggesting that the long-
term protective effect of Neurostatin on the ONL thickness was not dependent on whether the 
drug was administered during the first or the second activation wave. 
In summary, although the effect of Neurostatin on glial activity may differ during the first or 
second activation wave, overall the exact timing of administering the drug does not affect its 
long-term protective effect on photoreceptor survival. 
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Figure 6-16 Bar chart showing the comparison of the effect on the iba1+ cells and ONL between P25-60DPI and P55-
30DPI. 
A. The density of iba1+ cells in the inner retina at different DPI. B. The density of iba1+ cells in the outer retina at 
different DPI. C. The ONL thickness at different DPI. D. The number of GFAP+ filaments at different DPI. Data points: 
Mean; Error bar: SEM. 
4. Discussion  
This study sought to investigate the effect of Neurostatin on glial activation and photoreceptor 
loss at different degenerative stages. The results show that intravitreal Neurostatin injection 
somewhat prolongs photoreceptor survival. However, a single treatment with Neurostatin may 
not be sufficient to prevent photoreceptor depletion.  
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4.1 The modulation of glial activity in retinal degeneration. 
Previous studies have shown that microglial activation contributes to photoreceptor loss 
(Madeira et al., 2015, Zabel et al., 2016). Modulation of the immune activity can provide 
neuroprotective effects in several animal models of retinal degeneration (Roche et al., 2016, 
Syeda et al., 2015). A previous study has shown that depletion of MyD88 can reduce 
photoreceptor loss in the rd1 retina by interfering with the TLR/IL-1R pathway (Syeda et al., 
2015). Similarly, regulation of fractaline-CX3CR1 signalling via intravitreal injection of 
progesterone has a neuroprotective effect in the rd10 retina (Roche et al., 2016).  
Neurostatin has previously been reported to inhibit microglial activation via the NFkB, 
MARK/ERK pathways (Gomez-Nicola et al., 2010). Activity regulation of the NFkB and MARK/ERK 
is known to be correlated with the production of pro-inflammatory mediators. Furthermore, the 
MARK/ERK pathway is also known to be responsible for regulating the infiltration of immune 
cells and the cytokine production under pathological conditions (Lu et al., 2007). Blocking the 
MARK/ERK pathways is considered to be an effective way to attenuate microglial activation.  
A previous study on the xenotransplant of glioma in nude mice revealed that, intratumoral 
injection of Neurostatin can effectively inhibit the activation of epidermal growth factor 
receptor (EGFR), which further controls the activation of the downstream MAPK/ERK pathways 
by reducing the expression of ERK1 and ERK2 (Valle-Argos et al., 2010).  
This study is the first to present the effect of Neurostatin on microglial activation and 
photoreceptor survival in inherited retinal dystrophies.  
Both our in vitro and in vivo experiments show that microglial cells did not undergo major 
morphological changes following Neurostatin treatment, indicating that the drug may not be 
able to revert microglial cells to their resting mode. Furthermore, although a moderate 
reduction of iba1+ cell density was observed in isolated retinas, there were no conspicuous 
changes in vivo. It should be noted that retinas incubated in vitro were collected for fixation 
immediately after the incubation without washout, whereas for the in vivo experiments, the 
earliest examination was conducted at 7DPI. Due to the dynamic nature of microglial cells, it 
would not be surprising that the status of microglial cells changes over a period of time after 
treatment.  
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Furthermore, as the iba1 labelling can only reflect the overall microglial population without 
discriminating between different functional subsets, the density and the morphology of the 
iba1+ cells alone may not be able to fully reveal the changes in microglial cells caused by 
Neurostatin. As discussed in Chapter 1, it is likely that the microglial population consists of 
several different functional subsets, each of which is responsible for reacting towards a specific 
stimulus. Hence, it is presumed that during photoreceptor degeneration, although all of 
microglial cells become activated, only one or several of these subsets contribute to initiate the 
downstream pathways.  
Neurostatin is known to block the downstream pathways that are triggered by IL-15. Hence, it is 
reasonable to assume that IL-15 expressing microglial cells are sensitive to the Neurostatin 
treatment. Hence, the effect of Neurostatin on microglial activity should not be ruled out based 
on the data from iba1 labelling only. Further studies to investigate the functional subsets 
involved in microglial activation in Crx retina are therefore necessary to demonstrate this 
possibility. 
Downstream signalling molecules such as cytokines and chemokines may be more sensitive to 
changes in microglial activity. Furthermore, statistical power may be affected by the limited 
sample size used in this study, which may also influence the sensitivity of the parameters 
assessed, demonstrating the need for further studies. 
In a previous study on gliomas, Neurostatin was suggested to interfere with cell proliferation 
leading to a downregulation of GFAP, via inhibiting the expression of cell cycle promoters and 
the EGFR pathway, and via blocking the activation of MARKs and PI3K pathway (Valle-Argos et 
al., 2011). Another study on a mouse model of drug-induced glaucoma showed that intravitreal 
injection of Neurostatin could reduce RGC death by attenuating reactive gliosis (Ganesh and 
Chintala, 2011). In this study, Neurostatin showed an effect of upregulating GFAP expression in 
both in vitro and in vivo experiments, which contradicts the two previous studies. Neurostatin, 
also known as gangliosides, are sialic acid-containing glycosphingolipids which are abundant in 
the central nervous system. A wide spectrum of structures have been found in the chains of 
gangliosides, which result in a diversity in their functionality. In mammal, GM1, GD1a, GD1b, and 
GT1b are the most common structures. It is reported that, the effect of ganglioside GM1 on the 
level of GFAP varies between septum and hippocampus (Oderfeld‐Nowak et al., 1993), whilst a 
variation among different structure was also found in the effect of cell proliferation in the 
 166 
 
glioma model. In this study, disialoganglioside GD1b was employed, which was identical to 
thatused in the drug-induced glaucoma model. However, in the glaucoma model, ganglion cells 
were most affected whilst photoreceptors were well preserved, which may have resulted in a 
different glial reactivity. The different outcomes of these studies demonstrates the complexity 
of the underlying mechanism for glial activation and the diversity of response towards 
modulation, which highlights the need for a better understanding of glial activity in order to 
design effective therapies. Nonetheless, the upregulation in GFAP expression did not weaken 
the protective effect on photoreceptors, indicating that the changes on GFAP level may be the 
result rather than the initiator of microglial activity and photoreceptor degeneration.  
4.2 The long-term effect of Neurostatin on photoreceptor survival 
Although the data presented in this chapter did not provide sufficient direct evidence that 
Neurostatin can indeed revert microglial cells to their resting state, results do show that the 
drug can, to a certain extent, protect photoreceptors from dying, and that this holds regardless 
of whether the treatment is administered during the first or second wave of degeneration. The 
comparison of ONL thickness at the late stage of photoreceptor degeneration between groups 
treated at different time (P25-60DPI vs P55-30DPI) suggested that the timing of treatment does 
not affect the long-term overall outcome of photoreceptor survival.  
However, in the group treated during the first activation wave, preventing ONL thinning was 
more efficient in the group kept for 30DPI that in the group kept for 60DPI, which coincides with 
the second activation wave. The kinetics of Neurostatin in the vitreous cavity are not known, 
and it is plausible that the weaker effect of the drug after more prolonged post injection periods 
is due to complete intraocular disappearance of the drug. Hence a second treatment (or perhaps 
a continuous intraocular supply of the drug) is probably necessary to achieve better 
photoreceptor survival.  
It is important to note that, the Neurostatin treatment was not able to prevent the overall ONL 
thinning, in line with other studies on the modulation of microglial activation. It is perhaps not 
surprising since Neurostatin may only interfere with inflammatory pathways, whilst the genetic 
defects are not fixed. Hence this treatment may only contribute to reduce the amount of 
microglial-associated photoreceptor death. However, previous studies have shown that 
microglia may affect the turnover and cell replacement of retinal progenitors by 
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immunosuppression (Dick, 2009). Combining microglial modulation with other approaches such 
as stem cell transplantation may provide a more promising outcome. 
5. Conclusion 
The results present in this chapter demonstrated that a single intravitreal injection of 
Neurostatin in Crx mice can slow down the progression of photoreceptor loss, suggesting that 
microglial activation may normally contribute to photoreceptor loss during retinal degeneration. 
Although our results cannot provide sufficient insights about underlying mechanisms involved, 
this study paves the way to understand how photoreceptors respond to glial modulation at 
different stages of degeneration. Future work should aim to elucidate the specific functional 
subsets and downstream pathways that are involved.  
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Chapter 7.  General Discussion 
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The findings presented in this thesis document the dynamics of glial activity during photoreceptor 
degeneration in the Crx retina. Specifically, microglial and Müller activation in the Crx retina occurs 
in two waves, concurrent with the waves of photoreceptor death. These findings reveal that 
microglial activity and photoreceptor degeneration are intimately related. The results also suggest 
that, Müller cell activity is only associated with microglial activity and photoreceptor degeneration 
during the first degenerating wave, indicating that Müller cell activation may have entered an 
irreversible state during or after the second activation wave, in which they do not respond towards 
microglial modulation. Finally, this study has suggested that microglial activation may have 
detrimental effects during the degeneration process, whilst Müller gliosis could be a result of 
degeneration rather than an initiator, suggesting that being able to control microglial activity may 
have potential benefits on photoreceptor survival. In addition, this thesis has investigated the 
contribution of glial activation to photoreceptor survival different stages of degeneration. It 
demonstrated that intraocular injection with Neurostatin can slow down photoreceptor death 
regardless of whether the treatment is administered during the first or second degeneration wave, 
however, it also has an effect of increasing GFAP expression. 
1. Glial activity during photoreceptor degeneration 
Glial activation has been reported in a wide range of retinal disorders, but how exactly activated glia 
interact with neurons remains to be elucidated. However, it is widely accepted that there are many 
different patterns of microglial and Müller cell activation, depending on the specific stimuli and 
microenvironment linked to the onset of degeneration.  
The data from this study established a timeline of microglial activity according to the changes in the 
density of iba1+ cells in different retinal layers and Müller activity according to the changes in GFAP 
expression, demonstrating dynamic changes in the activity patterns.  
Previous studies in the rd1 and rd10 retina have attempted to explore a possible relationship 
between microglial activation and photoreceptor death assessed according to apoptosis (Zeng et al., 
2005, Hughes et al., 2003), but could not demonstrate such correlation. Our results in the Crx retina 
corroborate these findings.  
As discussed previously, iba1 labelling can only reflect the overall microglial population. Studying 
dynamic changes in microglial gene expression in response to photoreceptor loss could help reveal 
some of the mechanisms involved in the microglial-neuron interaction.  
Nevertheless, the changes in iba1+ expression described provides a basis for future studies that 
could focus more specifically on subsets of microglial cells. 
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As opposed to the intimate relationship between microglial activity and photoreceptor 
degeneration, there seems to be a functional variation between different waves of Müller activation. 
Müller activity only correlates with microglial activity and photoreceptor degeneration during the 
first wave, whilst the correlation disappears in the second wave.  
Recent findings have suggested that, in the brain, microglial cells are able to transform astrocytes 
into either neuroprotective or neurodegenerative phenotypes according to different 
insults(Shinozaki et al., 2017), which is in line with the M1 and M2 polarization in microglial cells. As 
the unique macroglia in the retina, Müller cells carry a similar functional responsibility as the 
astrocytes in the brain. Hence, it is speculated that the variation of Müller response may be related 
to the polarization of activated microglial cells. Further investigation on microglial - Müller 
communication may help to provide valuable information for effective therapies. 
2. Future implications and potential therapeutic strategies 
Although retinal dystrophies remains untreatable, with the introduction of advanced technologies, 
several new potential therapies are becoming available. Retinal prosthetic devices are being 
developed, aiming to circumvent photoreceptors and stimulate surviving neurons. Stem cell 
transplantation, on the other hand, aim to replace dead photoreceptors with newly generated ones, 
at the same time providing trophic support for the remaining cells against further photoreceptor 
degeneration (Ng et al., 2014).  
To date, Argus II is the only clinically approved retinal prosthetic model, and they provide only very 
limited vision for blind patients (Stingl et al., 2013). Stem cell therapy is still in its infancy, with still 
many challenges to overcome before becoming clinically efficient. Therefore, rather than trying to 
replace or circumvent dead photoreceptors, it is very important to develop effective therapeutic 
strategies that can rescue remaining photoreceptors, if the intervention is done early enough, such 
as gene therapy. Hopefully, controlling glial activity during the critical phases of degeneration will, in 
the future, help rescue photoreceptors as well.  
Previous studies have shown that, microglial activation contributes to photoreceptor death directly 
via phagocytosing viable photoreceptors, but also indirectly, by accelerating the rate of 
degeneration via releasing cytotoxic factors. Our results revealed that, although the application of 
Neurostatin showed a protective effect during both activation waves, it had a stronger protective 
effect against photoreceptor death (assessed by measuring the ONL thickness) when administered 
during the first activation wave, suggesting that early intervention of microglial activity may lead to a 
more successful outcome. 
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Hence, it would be interesting to examine whether continuous administration of Neurostatin from 
the onset of retinal degeneration would improve photoreceptor survival further. To achieve this, it 
will be necessary to devise an approach to continuously deliver the drug to the retina at effective 
dosage. Oral or topical administration may encourage compliance especially for the treatment of the 
early stage of the diseases (Jin et al., 2008). However, to get molecules like Neurostatin to pass 
through either the cornea/sclera or blood-retinal barrier in order to reach the retina remains 
challenging. On the other hand, although direct intraocular injections would help controlling the 
amount of drug reaching the retina, due to its invasive nature, repeated injections are undesirable. 
One possible approach would be to design a controlled drug release solution such as slow release 
from polymer nanoparticles. Nanoparticles have previously been reported to be successful for ocular 
applications (Conley and Naash, 2010). An experimental design using nanoparticles for slow release 
of Neurostatin may help to boost our understanding of the role of glial activity in retinal 
degeneration. 
Another promising approach is to combine microglial modulation with stem cell therapy. Microglial 
modulation may support stem cell therapy in three aspects. In the early stage of retinal 
degeneration, stem cells can serve as a trophic mediator to enhance survival of the remaining 
photoreceptors (Caplan and Dennis, 2006), whilst modulation of microglial activation can also slow 
down photoreceptor degeneration. In addition, immunological rejection and gliosis remain serious 
barriers to successful stem cell therapy. As the innate immune cells, microglial cells play an 
important role in both the immune response and the regulation of gliosis. . It would be very 
interesting to investigate whether the combination of these two treatments would amplify the 
outcome. (Garg et al., 2017). Furthermore, recent studies have reported that microglial cells can 
regulate differentiation of retinal progenitors (Dick, 2009). Modulation of the microglial activity can 
control photoreceptor regeneration kinetics via regulating the response of Müller cells towards cell 
death (White et al., 2017). Therefore, microglial modulation may help to facilitate stem cell therapy 
to restore retinal function.
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